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Abstract 
Title: Why and how new technologies fail or succeed to embed in routine 
health services: Lessons from the introduction of telehealth home 
monitoring. 
Background: New technologies were introduced in Doncaster to enable 
people with long-term illness self-manage their conditions and to reduce 
health care costs.  
Aim: To investigate why telehealth home monitoring embeds in routine 
healthcare setting. 
Methods: A case-study research method was used, drawing on lessons 
from (1) a randomised controlled trial; (2) observational study (before and 
after uncontrolled evaluation); and (3) qualitative study capturing the views 
of the stakeholders using semi-structured interviews. The study was 
informed by Normalisation Process Theory (NPT). The case-study research 
was carried out in accordance with approach advocated by Yin (2009). 
Results: The evidence shows that factors related to evaluation design, the 
technology, and staff could not be excluded as possible explanations for the 
performances of telehealth home monitoring. There was limited evidence to 
support the fact that factors related to geographical setting and patient 
groups provided possible explanation for the difference in the uptake of the 
new technology. Randomised controlled trial (RCT) showed poor uptake of 
telehealth, while evidence from service evaluation showed that telehealth 
was embedding in routine healthcare use in Doncaster.   
Conclusions: The interaction of factors related to evaluation design, 
technology, and staff cannot be rejected as causal factors for success or 
failure of new technologies to embed in routine healthcare setting. On the 
other hand, the evidence available could not allow the hypotheses related to 
setting and patients’ group to be accepted as to why new technologies fail or 
succeed in routine practice.  The evidence suggests that telehealth home 
monitoring was embedding in routine healthcare use in Doncaster. 
Word count: 279 words
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Chapter 1: Introduction 
This chapter introduces the thesis by outlining (1) the purpose of the thesis; (2) 
the original research questions, aim, and objectives; (3) the final research 
questions, aim, objectives, and hypotheses; and (4) the structure of the thesis. 
1.1 The purpose of the thesis 
This thesis is about why and how new technologies fail or succeed to embed in 
routine healthcare practice. In particular, the thesis looks at telehealth as an 
example of new technologies, which is used in the delivery of healthcare at a 
distance. This understanding is important to promote the uptake of worthwhile 
new technologies in routine use.  The purpose of the study is to help new 
technologies that are considered to be cost-effective or otherwise deemed 
worthwhile to embed in routine health service delivery in the future in order to 
improve access to health service, reduce hospital admissions, save costs of 
delivering healthcare, improve quality of life, and save lives. 
Telehealth technologies are being introduced in healthcare systems either as 
pilot projects or as part of routine service deliveries from around the world, 
including Britain. However, the level of uptake of these technologies varied; with 
some failing to embed in routine practice while others succeeding to do so. For 
example, a pilot of telehealth in Carlisle in the North West of England (Britain) 
which began in 2006 had to be halted after a short period of implementation 
(personal communication). Similarly, an initially ambitious scheme in North 
Yorkshire (England), which aimed to utilise 2000 telehealth kits for patients with 
long-term conditions also failed to achieve the recruitment target envisaged 
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(Evanstad, 2013). The healthcare organisations in North Yorkshire managed to 
recruit only 645 patients (of the expected 2000) by February 2013, and five of 
the six Clinical Commissioning Groups (CCGs) refused to engage (Evanstad, 
2013). The North Yorkshire scheme was part of a 5-year bigger Government 
programme in England to get 3 million people to use telehealth by 2017 
(3MillionLives, 2012).   This contrasts with lessons from the Veterans Health 
Administration (VHA) in the United States of America (USA), where telehealth 
appeared to have embedded in routine delivery of health service and over 
50,000 patients were receiving telehealth service by 2011 (Cruickshank, 2012).  
Telehealth home monitoring, or otherwise referred to as remote patient 
monitoring, in this thesis has been defined by the author as follows: 
“Remote patient monitoring is the remote exchange of patients’ data 
where patients measure their vital signs (oxygen saturation level in their 
blood (SpO2), pulse, breathing, or blood pressure), and answer 
symptoms questions from their home and the data is transmitted via 
internet to a healthcare professional who monitors the patients’ data and 
institutes appropriate management actions.”  Adapted from (Steventon et 
al., 2012) 
The role and potential benefits of new technologies, such as telehealth, in the 
delivery of healthcare at a distance had been identified in a number of published 
literatures. For example, Wanless (2002) argued that in order to secure a long-
term financially sustainable future delivery of high quality healthcare, and health 
outcomes for the British population, it was essential to engage the population 
fully in prevention and self-care agenda using assistive technologies such as 
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telehealth (Wanless, 2002). Some of the claimed potential benefits of telehealth 
technologies in the delivery of healthcare included: enabling users to gain 
control of their health conditions and to remain independent, efficient use of 
limited healthcare resources, such as reduction of hospital admissions, and 
saving the lives of people (Audit Commission, 2004, Steventon et al., 2012, 
Ekeland et al., 2010, Jones and Brennan, 2002, Department of Health, 2005a). 
There are, however, uncertainties around effectiveness and cost-effectiveness 
of some of these new technologies in routine delivery of healthcare on a range 
of health conditions and/or disease areas, and the evidence base for these 
remains inconclusive (Ekeland et al., 2010, Hailey, 2005, Steventon and 
Bardsley, 2012). Chapter 4 of this thesis assesses the evidence of effectiveness 
and cost-effectiveness of telehealth. There is also a poor understanding of why 
and how some of the technologies fail while others succeed when introduced in 
routine healthcare practice (Sheikh et al., 2011). 
Areas of potential gaps that new technologies can be used to address include 
self-care or remote care for people with long-term conditions (LTC).  Examples 
of LTC include patients suffering from heart disease, cancers, chronic 
respiratory diseases, and diabetes among others. LTCs are a major public 
health problem, and they  cause 36 million (63%) deaths globally each year 
(World Health Organisation, 2011). In Britain alone, 1 in 3 (17.5 million) of the 
population are considered to have a LTC (Department of Health, 2001). With 
ageing population, especially in the western world, more people live longer and 
are likely to suffer from LTCs. Therefore, the prevalence of LTCs is expected to 
increase. Self-care and telehealth are considered to play an important role in 
the management of people with LTCs. This should be viewed in light of current 
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healthcare challenges faced by healthcare organisations where there are limited 
healthcare resources, and difficulties in accessing healthcare (Department of 
Health, 2005a). 
1.2  How the research aims and objectives evolved 
The aims and objectives of the PhD research evolved over time. Initially, the 
aim of the research was to assess the effectiveness of telehealth. However, this 
was later changed to investigating why new technologies fail or succeed to 
embed in routine healthcare practice. The reason for the change of focus was 
that the pragmatic randomised control trial reported in Chapter 5 was 
considered to be unlikely to yield valid results in assessing the effectiveness of 
telehealth due to a number of reasons, including the difficulties in recruiting 
participants into the trial. The detail challenges encountered in conducting the 
pragmatic trial are discussed in Chapter 5. 
1.2.1  The original research question, aim, and objectives 
The idea of introducing telehealth in Doncaster came about following 
attendance by the author, at a conference in South Yorkshire (England) on the 
management of LTCs in 2006. At the conference, the emerging experience of 
telehealth in an English district in the North West of England was presented and 
discussed. Subsequently, further discussion took place in Doncaster at the local 
Respiratory Working Group, chaired by the author, where telehealth was 
discussed following a presentation by invited healthcare workers who were 
involved in piloting telehealth in Carlisle, North West England.  The pilot scheme 
at Carlisle suggested that telehealth was effective in reducing hospital 
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admissions among patients with chronic obstructive pulmonary disease 
(COPD), based on observational study (before-after uncontrolled service 
evaluation).  
Following a successful application to the Neighbourhood Renewal Fund (NRF) 
for assistive technology grant, it was decided to pilot the use of telehealth in 
Doncaster, focusing on patients with COPD. Given, the potential bias in 
evaluation of similar telehealth projects, such as the one in Carlisle, the steering 
group in Doncaster, led by the author, decided to evaluate the telehealth service 
using a pragmatic randomised controlled trial (RCT) in order ensure a robust 
assessment of its effectiveness. 
The original research was conceived, planned and conducted as a pragmatic 
trial between 2006 and 2009. The research commenced as a trial in Doncaster, 
a district healthcare setting in England (UK), as part of a service development. 
New technologies, like telehealth, emerged as part of a solution to address the 
problem of long-term conditions. It was being promoted then in the UK to 
improve health outcomes for patients, and to reduce healthcare costs 
associated with hospital admissions (Audit Commission, 2004). In order to test 
these claims, the pragmatic trial was adopted. The research was conceived in 
2006, and it received favourable ethical approval in February 2007.  The first 
patients started on the trial in October 2007. The research focused on patients 
with COPD, as an example of patients with LTC. The intention was to extend 
telehealth service subsequently to all other patients with LTCs if it was shown to 
be effective and cost-effective. The aim of the research was to address the 
question of effectiveness and cost-effectiveness of telehealth for patients with 
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COPD who were living in the community, after previous hospital admission due 
to the disease. It was envisaged that the trial would provide information for local 
health policy makers on the future options for commissioning of health service 
in relation to telehealth. The trial was subsequently adopted as a PhD project, 
with a formal registration with the University of Leeds, School of Medicine, on 
the 1st of December 2007.  
The timeline for the research, covering both the pragmatic trial and 
observational study period is shown in Figure 1.1. The service evaluation period 
for this research was from March 2010 when the first patients were started on 
the new telehealth service to October 2011. The telehealth service, however, 
continued after October 2011.  
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Figure 1.1: Timeline of undertaking the research work on telehealth  
May 2006 to October 2011 
 
 
The original research question, aim, objectives and hypotheses, were reported 
in the initial PhD Transfer Report (October 2009), and are outlined below. 
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1.2.1.1 Original research question 
The original research question of the trial was:  
What effects will telehealth monitoring have on people with COPD, the care 
they receive and resources required to maintain that care? 
1.2.1.2 Aim 
The original aim of the study was to assess the effectiveness and cost-
effectiveness of telehealth monitoring for patients with COPD. 
1.2.1.3 Objectives 
The following original objectives were formulated: 
1. To quantify the impact of telehealth monitoring on emergency hospital 
admissions rates from COPD. 
2. To determine acceptability of telehealth to patients with COPD and staff. 
3. To quantify the impact of telehealth on patients’ quality of life. 
4. To assess the costs of telehealth monitoring on the workload of primary 
care workers and emergency admissions in relation to COPD patients. 
5. To assess the practicalities (key challenges) of implementing telehealth 
monitoring.  
6. To determine the categories of COPD patients that benefitted most from 
telehealth, from among those with 2 or more hospital admissions in the 
previous 12 months compared to those with one previous hospital 
admissions in the previous 12 months. 
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7. To investigate which of the markers or combination of markers of state of 
respiratory health (vital signs and questions) were best for predicting the 
need for intervention to address any problem early. 
The trial was stopped prematurely. The reason for the stoppage was that there 
was no staff member available to monitor patients on telehealth service. It was 
also felt that the trial was prematurely implemented. An initial period of piloting 
the trial before its actual implementation would have highlighted some of the 
challenges. This would have informed a better implementation of the trial. Both 
staff and patients were considered not to be at equipoise. Despite the trial being 
able to recruit to the minimum number planned, it was unlikely to yield valid 
outcomes due to a number of biases encountered in the trial. 
1.2.2 The final research questions, aim, objectives and hypotheses 
The stoppage of the trial gave opportunity for Doncaster Primary Care Trust 
(PCT) to prepare and address some of the key challenges faced in recruiting 
patients and engaging community nurses in the implementation of telehealth 
service. The challenges that were addressed included the recruitment of a 
dedicated Telehealth Coordinator; and the removal of strict eligibility criteria 
associated with the pragmatic trial. This was done with consultation of 
community nurses at Telehealth Delivery (Steering) Group. The study was 
transformed from a pragmatic RCT to a service evaluation. The service 
evaluation was an observational study and in a sense a cohort study where 
patients were remotely monitored over time through telehealth service. It had 
two parts: the quantitative part, which assessed embeddedness of telehealth 
service and the details are reported in Chapter 6; and a qualitative part, which 
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focused on capturing the views of staff and patients who were involved in the 
observational study and it is reported in Chapter 7. The primary goal of the 
thesis, therefore, changed from assessing the effectiveness of telehealth, to 
investigating why and how telehealth embeds or not in routine health service 
(Chapter 7). The service development expanded to include patients with other 
LTCs, such as heart failure, COPD and diabetes; and not only those with 
COPD, as it was the case in the pragmatic trial.  
Even though the pragmatic trial was stopped, the author maintained an interest 
in doing PhD and new technologies. The objective for a PhD was pursued by 
investigating embeddedness of telehealth service through the observational 
study. The reason for the focus of the research on telehealth service was that 
there was still commitment by the organisation (Doncaster PCT) to roll out 
telehealth service. The organisation had already funded for a wider roll out of 
telehealth service. The author was leading the implementation of telehealth 
service for Doncaster PCT.  
Usually as part of standard service evaluation in the British National Health 
Service (NHS) such as in the PCTs, the level of service evaluation of 
intervention in health service context was not as detailed as it is presented here 
for a PhD. What the PhD level of evaluation added to the evaluation of 
telehealth in Doncaster was the critical appraisal of available evidence on 
telehealth, theoretical context to help with interpretation of the results, and 
critical assessment of potential sources of bias that might have influenced the 
outcomes of the evaluation. The end product of the evaluation included 
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knowledge generated to support practitioners and research in helping new 
technologies embed in routine healthcare practice. 
In 2010, a revised thesis plan (PhD Transfer Report, July 2010) was produced. 
The reason for the change of the thesis plan was that the prospect of recruiting 
the expected number of participants into the pragmatic RCT was considered to 
be less likely. There was a low uptake in recruitment experienced at the time, 
against an expected revised target of 80 participants, which was double the 
number initially planned. There were difficulties encountered in the process of 
recruitment, as a result, the trial was eventually stopped. It was therefore, felt 
necessary to revise the PhD thesis plan. The revised thesis plan focused on the 
investigation of why telehealth embedded or not in routine healthcare practice. It 
was not restricted to patients with COPD, but extended to patients with other 
LTCs, such as heart failure, and diabetes.  
The final research questions, aim, objectives and hypotheses were based on 
those agreed at the PhD transfer viva. They addressed why telehealth embeds 
or not in routine healthcare. The term “new technology” was used instead of 
“telehealth” as a generic label in order enable lessons learned to be generalised 
to other new technologies in healthcare. Issues to do with embedding (such as 
factors related to staff and organisational management, patient groups, etc.) 
appear to be similar for telehealth as they are with other new technologies. This 
is shown by examples of new technologies such whole body scanners when 
they were first introduced (Stocking and Morrison, 1978), and lessons learned 
from recent telehealth implementation in practice (May and Finch, 2009, May et 
al., 2011). 
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In order to investigate why and how new technologies embed or not in routine 
use, a case study research method was used, as recommended by Yin (2009), 
by developing prior hypotheses and sub-questions. Evidence was drawn from 
throughout the chapters of the thesis to answer the research questions.  Case 
study research methods allowed various sources of data to be used to try to 
answer the research questions (Yin, 2009).  
According to Yin (2009), a case study was technically defined as follows: 
1) “A case study is an empirical inquiry that 
• Investigates a contemporary phenomenon in depth and 
within its real-life context, especially when 
• The boundaries between phenomenon and context are not 
clearly evident.  
2) The case study inquiry: 
• Copes with the technically distinct situation in which there 
will be many more variables of interest than data points, 
and as one result; 
• Relies on multiple sources of evidence, with data needing 
to converge in a triangulating fashion, and as another 
result; 
• Benefits from the prior development of theoretical 
propositions to guide data collection and analysis.” 
 
The case study approach synthesizes the evidence generated in the thesis in 
Chapter 8, entitled “Synthesis”. 
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The final research questions, aim, objectives and hypotheses are outlined 
below. 
1.2.3.1 The research questions 
The final primary research question was: Why does a new technology embed or 
not in a routine health service?  
In order to address this research question, five sub-questions were formulated 
covering service design, technology, patient group, staff, and setting. The five 
sub-questions are outlined below:   
1. Setting: Is there something about Doncaster that made it more difficult to 
operate a randomised controlled trial (RCT) versus a service evaluation?  
2. Technology: Are there factors associated with the new technology1 used 
in the RCT versus the ones used in the observational study that made a 
difference in uptake of the new technology? 
3. Patients’ group: Are there factors related to the patients’ group recruited 
for the RCT as opposed to the observational study that made the 
difference in uptake of the new technology?   
4. Staff: Are there factors associated with staff involved in the RCT, as 
opposed to the observational study that made a difference in uptake of 
the new technology? 
                                            
1 The term new technology is generic and it encompasses the whole of the 
intervention (the service) and not just the physical equipment (see also Chapter 
3 on definition and description of telehealth service). 
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5. Evaluation: Are there factors associated with RCT methodology 
approach, as opposed to observational study that made a difference in 
uptake of the new technology?  
1.2.3.2 The research hypotheses 
The following hypotheses were developed, to aid data collection and to confirm 
or eliminate possible explanations, according to Yin’s case study research 
method (Yin, 2009): 
1. Doncaster is significantly different in its experience of uptake of new 
technology compared to other districts in England. 
2. There were factors associated with the new technology used in the 
RCT versus the ones used in the observational study that made a 
difference in the uptake of the new technology. 
3. There were factors related to the patients’ group recruited for the RCT 
as opposed to the observational study that made the difference in the 
uptake of the new technology. 
4. There were factors associated with staff involved in the RCT, as 
opposed to the observational study that made a difference in the 
uptake of the new technology. 
5. There were factors associated with the RCT methodology approach, 
as opposed to observational study that made a difference in the 
uptake of the new technology. 
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1.2.3.3  The research aim 
The aim of the study was to investigate why new technologies fail or succeed to 
embed in routine health service delivery.  
1.2.3.4  The research objectives 
The objectives of the research were: 
1. To investigate why telehealth, as an example of new technology in 
healthcare, failed to be taken up in randomised controlled trial, while it 
was successful in the observational study. 
2. To draw evidence from the rest of the thesis, including literature review, 
which contributes to answering the research question.  
3. To make recommendations on improving the uptake of new technology 
in routine health service delivery.  
A diagrammatic representation of the changes in the research aims and 
objectives is shown in Figure 1.2. 
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Figure 1.2: Original and final research aim and objectives 
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1.3 The structure of the thesis 
The thesis is structured into nine chapters. Chapter 1 introduces the thesis.   
Chapter 2 outlines the theoretical framework used in the thesis; the 
normalisation process theory (NPT). This is set in the context of other 
competing theoretical frameworks (Design-Reality Gap, and Theories of 
Practice) related to implementation of information systems and practices. As the 
focus of this thesis is about implementation of new technologies, theories 
related to implementation practices were selected and presented for 
comparison. The key criterion for the choice of theoretical framework was based 
on ability to help in answering the research question. Both Design-Reality Gap 
and Theories of Practice were considered to be abstract and high level theories. 
They were not specific enough to address the research question. In contrast, 
NPT was considered to be specific and focused and found to help in addressing 
the research question. Therefore, NPT was chosen as the appropriate 
theoretical framework to guide the work on the thesis.  
Chapter 3 describes the background information relevant to the research, which 
includes a description of Doncaster as the study setting, its health profile, and 
research activities in the area. It provides a definition and descriptions of 
telehealth service used in the study. The background information helps to set 
the scene and context for the thesis. 
In Chapter 4, a literature review of telehealth is presented, which assesses its 
effectiveness, cost-effectiveness, and practical challenges encountered in 
developing and implementing telehealth project. The literature review focused 
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mainly on systematic review articles. Even though the focus of the thesis 
changed to investigating why new technologies fail or succeed in routine 
practice, it was considered relevant to know whether or not they were 
worthwhile to embed in routine use. The literature review further addresses 
challenges related to implementation of telehealth in order to understand factors 
that determines successful implementation of telehealth service. The chapter 
concludes by examining factors for increasing update of participants in trials by 
drawing lessons from failed trials.  
Chapter 5 presents the findings of the pragmatic trial that assessed the 
effectiveness and cost-effectiveness of telehealth service, despite its premature 
stoppage. It was found that telehealth made no difference in reducing hospital 
admission rates among patients with COPD, and it was not cost-effective. The 
limitations and implication of the trial are discussed. 
Chapter 6 reports the findings of uptake of telehealth service as part of the 
observational study. Uptake of telehealth service by participants was used as a 
quantitative measure of embeddedness. The findings suggest that telehealth 
service was embedding in routine health service in Doncaster. The chapter also 
addresses compliance of patients to telehealth home monitoring. There was 
high compliance with telehealth usage, but the rates of red alerts were also very 
high, which brings into questions the reliability of telehealth home monitoring 
service. Patients were satisfied with the service. 
Chapter 7 presents qualitative research findings of why and how new 
technologies fail or succeed to embed in routine health service. This was based 
on the observational study participants and staff. A thematic analysis was 
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carried out and it presented the key themes emerging from the research that 
provided possible explanations as to why telehealth performed the way it did in 
the study setting. Factors related to staff, technology, service design, and 
patients were considered to provide possible explanations as to why and how 
telehealth performed the way it did in routine healthcare practice.  
Chapter 8 synthesizes all the findings of the research undertaken in the thesis. 
Syntheses were carried out in the context of NPT, which is described further in 
Chapter 2. The chapter concluded that factors related to the technology, staff 
and the methodological approach of evaluating the service could not be 
excluded as possible reasons why new technologies fail or succeed in routine 
service. There was limited evidence to accept hypotheses related to setting and 
patients’ group as explanations for the performance of new technologies in 
routine practice.  
The final chapter of the thesis (Chapter 9) provides a reflection on (1) the extent 
to which the research questions, aim, and objectives were met; (2) the author’s 
own learning, (3) the author’s roles and areas of potential conflicts, and (4) 
statements of original contributions to knowledge. 
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Chapter 2: Theoretical Frameworks  
2.1 Introduction 
In the previous chapter, an introduction to the thesis was made. The 
introductory chapter acknowledged the challenges faced in the early stage of 
the PhD research. The focus of the research changed when it was decided that 
the pragmatic randomised controlled trial (RCT) would not go ahead as 
planned. The primary goal of the pragmatic trial was to assess effectiveness of 
telehealth. However, it was realised that due to challenges encountered in the 
implementation, the trial was not going to yield valid results. The new focus of 
the thesis is therefore about embeddedness of telehealth in routine service. A 
conceptual framework was developed in order to guide the PhD research with 
fieldwork and later in the interpretation of the findings. The appropriate 
theoretical framework is used later in the thesis for the following purposes:  
(a) To understand what happened in Chapters 5 (the pragmatic trial) and 6 
(the service evaluation study) related to uptake of telehealth. The theory 
is used to work out how to investigate, and make sense of, what went 
well and not so well as far as embedding of telehealth was concerned in 
routine practice;   
(b) To guide the conduct of qualitative interviews reported in Chapter 7; and 
(c) To make sense of the totality of the findings of the thesis, in Chapter 8 
where the findings are synthesised.  
There are many theoretical frameworks in the published literature on the subject 
of implementation and effects of information technologies (IT), both in health 
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care and more generally. It was not possible to review all of them; therefore, 
three of the theoretical frameworks were chosen that were considered to be 
broadly representatives of the literature. The three theoretical frameworks were: 
(1) Design-Reality Gap (DRG) model (Heeks et al., 1999); (2) Theories of 
Practice (ToP) (Orlikowski, 2008, Orlikowski, 2000, Feldman and Orlikowski, 
2011); and (3) Normalisation Process Theory (NPT) (May and Finch, 2009). 
Design-Reality Gap model was selected because it represents a large body of 
literature that came out of management and business schools and had been 
used in information technology (IT) systems (Heeks et al., 1999, Heeks, 2006, 
Heeks, 2008). Meanwhile, Theories of Practice was chosen because it is a 
sociological framework that had been widely cited in health care and in other 
areas in recent years  (Orlikowski, 2009, Orlikowski, 2008). The reason for 
selecting NPT was because it represents a theoretical framework on 
implementation of new technology and it addresses issues related to 
embedding (May and Finch, 2009). NPT has been widely used in healthcare. 
The key criterion set for determining appropriateness of a theoretical framework 
is the ability to help in addressing the research question posed in Chapter 1. 
Both Design-Reality Gap model and Theory of Practice were considered to be 
high-level and abstract theories and did not shed light on the specific and 
focused research question. On the other hand, NPT appeared to be specific 
and most relevant in helping to answer the research question.  
Therefore, NPT was chosen as the theoretical framework used throughout this 
thesis to guide the conduct, and interpretation of the study. An overview of the 
22 
 
three theoretical frameworks is given in Figure 2.1, which outlines the decisions 
made to exclude two of them and to adopt one; and the reasons for doing so. 
Figure 2.1: Theoretical frameworks considered and the one selected for the 
study 
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In the sections below, the three theoretical frameworks are further described, 
and their relevance to this research work is examined in terms of their 
usefulness and limitations in contextualising and interpreting the findings of the 
thesis.  
2.2  Design-Reality Gap (ITPOSMO) model 
Heeks and colleagues argued that failure or success of health information 
system (HIS) could be evaluated or predicted by examining the gap that exists 
between design (project proposal) and current reality factors of a project 
(Heeks, 2006, Heeks et al., 1999, Heeks, 2008). In this regard, they developed 
a seven-dimensional model covering the following areas: Information (e.g. 
quantity, quality, flow etc.); Technology (e.g. computer hardware, software etc.); 
Process (e.g. decision-making, and actions); Objectives and values (e.g. 
objectives of medical and non-medical staff and other stakeholders); Staffing 
and skills (staff numbers, skills, and knowledge); Management and structures; 
and Other resources (e.g. investment, and time). These dimensions were 
summarised into an acronym referred to as ITPOSMO, representing each of the 
seven dimensions in the model (Figure 2.2). They argued that the smaller the 
design-reality gap, the more likely an information system would succeed; 
conversely the wider the gap the likely it was to fail. They developed a rating 
scale of 0-10 for each dimension to measure the gap between reality and 
design with 0 being no gap; 5 representing some degree of difference; and 10 
being major gap between design and reality. A maximum of 70 score was 
expected for all the seven dimensions. Projects that scored between 57-70 
were considered to be most likely to fail; 43-56 might well fail, 29-42 might 
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partially/totally fail; 15-28 might partially fail; and those with score of 0-14 might 
well succeed (Hawari and Heeks, 2010). 
An example of design-reality gaps involving public and private hospitals in 
relation to “staff and skills” was given. Public hospitals tended to have fewer 
nursing staff and fewer technology-related staff in comparison to private 
hospitals (Heeks et al., 1999). 
Figure 2.2: Design-Reality Gap: The ITPOSMO model and its seven 
dimensions 
Source: (Heeks, 2008) 
 
 
Heeks et al. (1999) offered the following definitions of failures and successes of 
health care information system, while acknowledging that such definitions were 
fraught with degrees of subjectivity: 
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Total failure: “a system never implemented or in which a new system is 
implemented but immediately abandoned.” 
Partial failure: “an initiative in which major goals are unattained or in 
which there are significant undesirable outcomes.” 
Sustainability failure: “an initiative that succeeds initially but then fails 
after a year or so.” 
Replication failure: “an initiative that succeeds in its pilot location but 
cannot be repeated elsewhere.” 
Success: “an initiative in which most stakeholder groups attain their 
major goals and do not experience significant undesirable outcomes.” 
Design-Reality Gap model provides some useful perspective in contextualising 
and interpreting the findings of this research. Its advantages include the 
following:  
(1) It offers opportunity for systematic assessment of several dimensions, 
when examining technology and human interaction;  
(2) The model provides mechanisms for quantifying the likelihood of success 
or failure of implementing a new technological project; 
(3)  The model also helps to contextualise success or failure of a study, 
based on definitions of successes or failures offered by the authors 
(Heeks et al., 1999, Heeks, 2008); and  
(4)  An additional strength of the model was its simplicity in examining the 
dimensions against Design-Reality Gap, with potential for adding any 
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dimension deemed necessary by stakeholders. The model had also 
undergone field trials in a number of IT systems (Hawari and Heeks, 
2010).  
However, there are a number of potential problems in the application of Design-
Reality Gap in routine practice. They include the following: 
(1) The true “design-reality” gap may not be clearly known at the time of 
assessment; hence such initial assessment or prediction could be 
inaccurate resulting from uncertain proposals.  
(2) The model does not offer assessment of relative merit (weight) of each 
dimension against each other, given that several elements could be at 
play in the model. Certain elements of the model might carry more weight 
than others in determining success or failure of an initiative. In addition, 
the effects of interaction of each dimension with one another had not 
been taken into account in deriving the overall likelihood of success or 
failure.  
(3) The model also has potential methodological limitations in how it 
assessed design-reality gap, including problems with subjectivity in 
assessing gaps, issues with definitions of successes, failures and 
inherent subjectivity involved, sensitivity of the tool, and “floor/ceiling” 
effects of the tool.  
(4) Examples of field practice where Design-Reality Gap had been applied 
could not be found where second generation telehealth were used. Most 
of the fields in which the model was applied were limited to information 
technology systems such as computer network or computerised 
coloscopy system (Heeks, 2006, Heeks et al., 1999). 
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Therefore, the Design-Reality Gap theoretical framework did not meet the 
criterion set in Figure 2.1, because it was considered to be a high level theory 
that was abstract and lacked focus in helping to answer the research question 
posed in Chapter 1.  
2.3  Theories of Practice 
Theories of Practice (ToP) is a broad field of theoretical framework, which has 
been widely used by scholars in the field of social science and its usage had 
been extended to information technology (Feldman and Orlikowski, 2011). 
Orlikowski (2008, 2009) argued that technology became meaningful if it 
interacted with people resulting into what she termed as technologies-in-
practice and the below quotes summarises Theories of Practice:  
“As humans interact with technological artifacts they constitute a 
technology-in-practice through their recurrent use of the technologies. 
However, their actions are at the same time shaped by the technologies-
in-practice they have enacted in the past. Thus, in their on-going and 
situated action, actors draw on structures that have been previously 
enacted (both technologies-in-practice and other structures) and in such 
action reconstitute those structure.” (Feldman and Orlikowski, 2011) 
Feldman and Orlikowski (2011) identified three main principles of ToP. The first 
principle stipulates that the actions undertaken by people in particular contexts 
have consequences in influencing their social life (every day actions were 
consequential). For example, the authors (Feldman and Orlikowski, 2011) noted 
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that the development of painting was driven by the high quality of paintings that 
the public demanded.  
The second principle states that it is false theory to categorise elements into two 
independent groups or dichotomies. The principle asserts that there are some 
inherent relationships between phenomena.  The principle rejects viewing 
elements in dichotomies, such as: objective and subjective, body and mind, 
structure and agency, cognition and action, etc.  
The third principle of ToP states that no phenomenon is considered to be 
independent of each other; which was referred to by the authors as rationality of 
mutual constitution (Feldman and Orlikowski, 2011). For example, it was 
observed that the relationships between social order (structures, institutions, 
etc.) were constantly influenced by agencies (human or technologies).  
Orlikowski (2000) highlighted that the consequences of technology-in-practice 
could result in (a) reinforcing the social status quo; (b) changes in practice and 
system; or (c) integration of technologies into social life (Orlikowski, 2000). 
Feldman and Orlikowski (2011) argued that ToP offers two important uses for 
researchers: firstly, it provides the basis for powerful theoretical generalisation; 
and secondly, it has the capacity to offer important practical implications for 
practitioners, in explaining and guiding actions. 
Orlikowsky (2009) acknowledged that it was not possible to guarantee a perfect 
translation of technological plan and design into its running code in the real 
world; nor exert any control over whether or how other people used the 
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technology and the possible unintended consequences of the technology in 
practical use.  
In essence, the ToP rested on the concept that social processes influenced the 
design and implementation of new technology and similarly, new technology 
also influenced social processes (Keen et al., 2012, Orlikowski, 2008).  
ToP was not chosen as the most suitable theoretical framework to use for the 
thesis because it did not meet the criterion set in Figure 2.1, in helping to 
answer the research question of the thesis.  
2.4  Normalisation process theory  
Normalisation Process Theory (NPT) is a theoretical framework that deals with 
implementation of new technologies and practices and how they get normalised 
or embedded into every day practice of individuals and groups (Finch et al., 
2012). NPT helps researchers to explore three main areas of interest in relation 
to implementation and embedding of new technologies (May and Finch, 2009). 
The theory proposes that:   
(1) Practices are embedded if they fit with the organisational structure and 
the social contexts; and by individuals and groups involved working 
together; 
(2) There are four stages through which practices become embedded in 
practices. These stages are coherence, cognitive participation, collective 
action and reflexive monitoring (Finch et al., 2012, May and Finch, 2009). 
What May and Finch (2009) meant by coherence was how people found 
a practice useful. They considered cognitive participation to be the 
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enrolments and engagement of people to do a particular work; while 
collective action was about efforts put in doing the work, which might 
include resistance, subversion, affirmation and compliance. Collective 
action encompassed (1) how people did the work e.g. professional-
patient interaction (interactional workability); (2) how practice was 
mediated and understood among the network of people related to it 
(relational integration); (3) how work was distributed and conducted 
based on division of labour (skill-set workability); and (4) how the work 
was incorporated within the social context (contextual integration) (May 
and Finch, 2009). Reflexive monitoring was described by the authors as 
the continuous evaluation of implementation process by participants.    
(3) Embedding is a continuous process of investment of efforts by the 
people involved in implementation of a practice.  
Each of the four stages of NPT raises a number of questions for researchers to 
consider, such as, those related to the exact nature of work that needs to be 
done, who does it, how, and the value placed by those who are involved in 
doing it (May and Finch, 2009). Figure 2.3 shows how the components of the 
theory are related to one another.
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Figure 2.2: Model of the components of normalisation process theory 
Source: (May and Finch, 2009), page 541. 
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2.4.1 NPT propositions 
There are 12 propositions that constitute NPT (May and Finch, 2009) and these 
are summarised in Table 2.1. 
Table 2.1: Propositions of Normalisation Process Theory (NPT) 
Source: Adapted from (May and Finch, 2009) 
DOMAIN PROPOSITIONS 
Coherence 
1. “Embedding is dependent on work that defines and 
organizes a practice as a cognitive and behavioural 
ensemble. (1.1)” 
  
2. “Embedding work is shaped by factors that promote or 
inhibit actors’ apprehension of a practice as meaningful. 
(1.2)” 
  
3. “The production and reproduction of coherence in a 
practice requires that actors collectively invest meaning in 
it. (1.3)” 
Cognitive 
participation 
4. “Embedding is dependent on work that defines and 
organises the actors implicated in a practice. (2.1)” 
  
5. “Embedding work is shaped by factors that promote or 
inhibit actors’ participation. (2.2)” 
  
6. “The production and reproduction of a practice requires 
that actors collectively invest commitment in it. (2.3)” 
Collective 
action 
7. “Embedding is dependent on work that defines and 
operationalizes a practice. (3.1)” 
  
8. “Embedding work is shaped by factors that promote or 
inhibit actors’ enacting it. (3.2)” 
  
9. “The production and reproduction of a practice requires 
that actors collectively invest efforts in it. (3.3)” 
Reflexive 
monitoring 
10. “Embedding is dependent on work that defines and 
organizes the everyday understanding of a practice. (4.1)” 
  
11. “Embedding work is shaped by factors that promote or 
inhibit appraisal. (4.2)” 
  
12. “The production and reproduction of a practice requires 
that actors collectively invest in its understanding. (4.3)” 
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 2.4.1 Justification of choosing NPT over other theories 
The focus of this research is around the implementation of new technologies 
and whether or not they embed in routine healthcare practice and how they do 
so. It is for this reason that NPT is considered to be the most appropriate 
framework to use (Murray et al., 2011, Winblad et al., 2009). Its usefulness has 
been proven in field studies in the healthcare system in a number of countries 
and in similar context, as in this research, involving telehealth service (Murray et 
al., 2011, Winblad et al., 2009). Therefore, NPT has been chosen to help guide 
the conduct of this research and to explain its findings.  
Design-Reality Gap model is not chosen as the preferred theoretical framework 
because of its focus on examining gaps between proposed and current 
situations. It was not focused enough to help in addressing the research 
question posed in Chapter 1.  
Compared with Theories of Practice (ToP), NPT is considered a better option 
because of its direct relevance to implementation of new technologies and field 
trials. Although ToP has a long history and origin of use in sociology, its 
application in the field of implementation of new technologies such as telehealth 
has been relatively limited. In addition, the three propositions of ToP are 
considered to be limited in providing a full explanation on why new technologies 
embed in routine practice. 
By using NPT to help explain the research, the validity of the theory is also 
being tested. Therefore, NPT is the principal theoretical framework chosen for 
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the thesis. It helps to explain the findings of the research, as well as test its 
application in this research. 
 
 
35 
 
Chapter 3: Background Information 
3.1  Introduction 
The first chapter of the thesis covers introduction to the whole thesis, while the 
second chapter describes the theoretical framework that will be used later on in 
the thesis. The introductory chapter explores the evolution of the research 
questions, aims and objectives over the course of the thesis. The initial focus of 
the thesis was on assessing effectiveness and cost-effectiveness of telehealth. 
However, the focus subsequently changed to investigating why and how new 
technologies embed or not in routine practice. Chapter 2 explores theoretical 
frameworks from the fields of management, information system, and 
sociological studies. The three theoretical frameworks considered were: Design-
Reality Gap, Theories of Practice, and Normalisation Process Theory (NPT). 
The latter was subsequently chosen to understand what happened in the 
pragmatic trial (Chapter 5) and observational study (Chapters 6 and 7); and to 
make sense of all the findings of the thesis. NPT was chosen as the theoretical 
framework because of its usefulness in helping to understand why practices 
embed or not in routine healthcare.  
The objectives of this chapter are: 
1. To provide background information and contexts to help in the 
understanding of the research presented in this thesis; 
2. To contribute evidence towards answering the following research 
question: 
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Is there something about Doncaster that made it more difficult to 
operate a randomised controlled trial (RCT) versus a service 
evaluation? (See Chapter 1) 
3. To define and describe telehealth service, as used in Doncaster.  
The chapter is structured as follows:  
• Study setting (Doncaster), its population, and socio-economic status; 
• Local health profile, long-term conditions(LTCs), chronic obstructive 
pulmonary disease (COPD) – the disease area that was the focus of 
pragmatic trial reported in Chapter 5; 
• Local health services structure and commissioning responsibility; 
• Research experience in the study setting compared with national and 
neighbouring areas, including recruitment into research studies; 
• Telehealth: definitions, policy contexts and description of the service. 
The study setting is one of five research sub-question of the thesis. The study 
setting is also important in the pragmatic trial, and the observational study. The 
local health service structure helps in understanding the commissioning and 
provision of health services in the study setting. In Chapters 6 and 7 where the 
observational study is reported, all the participants suffered from long-term 
conditions (LTCs). There are different types of diseases that can be classified 
as LTCs, such as high blood pressure, heart disease, chronic respiratory 
diseases, including COPD, diabetes, etc. COPD, one of the LTCs, was the 
focus of the pragmatic trial covered in Chapter 5. Telehealth is the key 
intervention in the whole work of this thesis. Its definition, policy context and 
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description are provided here. Later on in the thesis (Chapters 4-8), the 
effectiveness and cost-effectiveness of telehealth is assessed using literature 
review (Chapter 4), pragmatic trial (Chapter 5), and observational study 
(Chapter 7). Syntheses of the findings in the whole of the thesis are carried out 
in Chapter 8 in an attempt to answer why new technologies embed or not in 
routine practice. Reflections on the thesis are captured in Chapter 9. Therefore, 
the background information reported in this chapter is relevant to subsequent 
chapters of the thesis.  
An overview of Chapter 3 is shown in Figure 3.1. 
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Figure 3.1: Background information relevant to the thesis 
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3.2  Setting 
3.2.1 Location 
Doncaster is one of the local authorities (LAs) in England (Britain), located in 
the North of the country within the County of South Yorkshire. The geographical 
area that constitutes the local authority in Doncaster is the same as that of the 
then Doncaster Primary Care Trust (PCT), a healthcare commissioning 
organisation that was abolished on the 1st of April 2013. The major cities close 
to Doncaster are Sheffield in the West, Leeds in the North West, Hull in the 
East, and Nottingham in the South. Doncaster Metropolitan Borough Council 
(DMBC) covers an area of 219 square miles (567 square kilometres) 
(Doncaster Primary Care Trust, 2007).   
Doncaster is a town in transformation to be a city with an International Airport 
(Robin Hood Airport) within its territory and a range of other local developmental 
initiatives (Doncaster Strategic Partnership, 2005). 
3.2.2 Population 
The headline figures from 2011 Census indicated that the population of 
Doncaster had risen to 302,400 from the previous census in 2001 which put the 
population of the town at 288,000 (Office for National Statistics, 2012). 
Doncaster Primary Care Trust was responsible for providing healthcare for 
patients registered with general practitioners (GPs) in Doncaster. In April 2006, 
there were around 305,000 people who were registered with GPs in Doncaster. 
They included around 3.4% (10,500) of the population who resided outside 
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Doncaster in the neighbouring local authorities (Doncaster Primary Care Trust, 
2007). 
The age structure of the population of Doncaster was generally similar to that of 
England & Wales, with the exception of a notable lower proportion of young 
people aged 20-34 year-olds, which was thought to be due to those going out of 
the area for higher education or in search of employment (Figure 3.2). 
Figure 3.2: Population age structure (%): England & Wales and Doncaster 
 
 
 
 
 
 
 
 
 
 
 
Source: ONS (2004). 
 
In decades to come, it is widely recognised in Britain and most other developed 
countries that the problem posed by the ageing population was likely to 
increase, and it would pose a significant challenge to service providers, 
including health and social care service providers for older people (Stroetmann 
et al., 2003). 
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The distribution of age-sex structure of Doncaster’s population was generally 
similar between males and females, with the exception of older population 
where there were fewer males than females (Figure 3.3). 
Figure 3.3: Age and sex population structure of Doncaster 
 
 
 
 
 
 
 
 
 
 
Source: Public Health Intelligence Unit, Doncaster PCT (2007). 
According to the 2001 National Census, Doncaster recorded less black and 
minority ethnic population (2.3%) than that observed in England (9.1%), with a 
range of people from various religious backgrounds represented in Doncaster, 
although predominantly of Christian faith (79.6%). 
3.2.3  Socio-economic status 
According to the official Government’s Index of Multiple Deprivation (IMD) 2010 
for England, Doncaster was considered as a deprived local authority area, with 
an average deprivation score of 29.76,  and ranking as 39th most deprived local 
authority (out of 326 local authorities) in England – [rank of 1 was the most 
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deprived] (Department of Communities and Local Government, 2011).  Within 
Doncaster, the level of deprivation varied among the geographical communities 
in the districts (Figure 3.4). Doncaster is a former coalmining area and 
experienced a high rate of unemployment.  
 
 43
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Figure 3.4: Communities in Doncaster by levels of deprivation 
 
Source: Public Health Intelligence Unit, NHS Doncaster.
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3.3 Health profile: the burden of long-term conditions 
The World Health Organisation (WHO) defined chronic diseases as “diseases of 
long duration and generally slow progression” (WHO, 2011). The Department of 
Health in England considered a chronic disease as a “condition that cannot be 
cured but can be managed through medication and/or therapy” (Department of 
Health, 2001). Although there was no definitive list of long-term conditions 
(LTCs), the following diseases were considered to be part of them: heart 
disease, stroke, cancer, chronic respiratory diseases such as COPD, and 
diabetes (Department of Health, 2001, World Health Organisation, 2011). 
According to the WHO report entitled: Global status report on non-
communicable disease 2010 (World Health Organisation, 2011), of the 57 
million deaths that occurred worldwide in 2008, 63% (36 million) were due to 
non-communicable diseases (NCD). The report showed that 80% of the NCD 
occurred in low- and middle-income countries and the trend was projected to 
overtake that of communicable diseases, maternal, perinatal and nutritional 
diseases as the leading cause of deaths by 2030. 
In Britain, there were around 17.5 million adults living with LTCs in 2001 
(Department of Health, 2001). According to the same report, LTCs were more 
prevalent among the British older people with as much as two-thirds to three-
quarters of all people over the age of 75 years old were thought to suffer from at 
least one LTC. In 2005, the Government produced a strategy document on 
LTCs called National Service Framework (NSF) for Long-term Conditions in 
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order to improve the health and care of people with LTCs (Department of 
Health, 2005b).  
3.3.1 The prevalence of LTCs in Doncaster 
In Doncaster, one in five people (22%) lived with long-term conditions 
(n=63,000), according to the 2001 UK Census data; and the standardised 
illness ratio was 25% higher than that expected for England and Wales (Table 
3.1). LTCs affect both sexes and all age groups.  
Evidence from population prevalence of LTCs in Doncaster from disease 
registers held by general practitioners (GPs) showed the extent of prevalence of 
LTCs in primary care (Table 3.2). Although there was discrepancy between 
expected and observed prevalence in some disease areas, what was clear was 
that the list of LTCs was composed of non-communicable diseases and lifestyle 
behaviours that were harmful to health e.g. smoking (26.8%) and obesity 
(16.4%). Among the LTCs, the prevalence of COPD was 2.6% (7,637); heart 
failure 1.1% (3,139); hypertension 15.4% (44,638); and diabetes 6.5% (14,989) 
(Table 3.2). 
The prevalence model used for calculating the disease prevalence above had 
been derived by Public Health Observatory in England based on national rates 
of the diseases, which took into account levels of deprivation at local areas.
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Table 3.1: Number of household persons with limiting long-term illness  
Doncaster and national and neighbouring comparison 
 
          Number for Males   Number for Females 
     Age group  Age group 
AREA Number 
Percent of 
population 
Standardised 
illness ratio   Under 65 65-74 
75 & 
over All ages   Under 65 65-74 
75 & 
over All ages 
England & Wales 9,019,242 17.6 100.0   2,569,861 858,884 785,910 4,214,655   2,512,936 921,814 1,369,837 4,804,587 
England 8,369,174 17.3 98.5   2,379,296 794,510 733,244 3,907,050   2,329,385 854,786 1,277,953 4,462,124 
Yorkshire & 
Humber 920,892 18.9 107.0   266,704 90,226 77,420 434,350   252,596 98,118 135,828 486,542 
Barnsley MCD 53,179 24.6 138.8   17,291 5145 3824 26,260   15,192 5379 6348 26,919 
Doncaster MCD* 63,227 22.4 125.8   19,513 6556 4928 30,997   17,482 6725 8023 32,230 
Rotherham MCD 53,615 21.8 124.4   16,366 5310 4059 25,735   14,966 5777 7137 27,880 
Sheffield MCD 101,208 20.1 113.6   28,811 9617 8649 47,077   27,239 10,785 16,107 54,131 
*MCD = Metropolitan County District 
Source: The Information Centre for Health and Social Care. Compendium of Clinical and Health Indicators / Clinical and Health 
Outcomes Knowledge Base (www.nchod.nhs.uk or nww.nchod.nhs.uk) (accessed online on 18th August 2009; data based on 2001 
Census). 
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Table 3.2: Long-term condition on disease registers held by GP practices in Doncaster 
Long-term condition 
Practice 
Population 
  
Expected 
Prevalence   
Observed 
Prevalence 
(QMAS data)   Difference between 
expected and 
observed (%) n % n % 
Hypertension 290687 71144 24.5 44638 15.4 37.3 
Obesity 235710 53686 22.8 38629 16.4 28.0 
Asthma (treated in the previous 
year) 290687 26679 9.2 20418 7.0 23.5 
Coronary Heart Disease (CHD) 290687 15191 5.2 13986 4.8 7.9 
Chronic Kidney Disease 227653 13387 5.9 14797 6.5 -10.5 
Diabetes and Mellitus 231703 13094 5.7 14989 6.5 -14.5 
Chronic Obstructive Pulmonary 
Disease 290687 6949 2.4 7637 2.6 -9.9 
Hypothyroidism 290687 5808 2.0 8751 3.0 -50.7 
Stroke and Transient Ischaemic 
Attack 290687 5586 1.9 6478 2.2 -16.0 
Learning Disabilities 290687 4970 1.7 1139 0.4 77.1 
Heart Failure 290687 4282 1.5 3139 1.1 26.7 
Atrial Fibrillation 290687 3833 1.3 4753 1.6 -24.0 
Dementia 290687 3659 1.3 1510 0.5 58.7 
Palliative Care 290687 3180 1.1 343 0.1 89.2 
Cancer 290687 2066 0.7 3660 1.3 -77.2 
Treated Epilepsy  227653 1995 0.9 2314 1.0 -16.0 
Metal Health (Psychotic Disorders)  290687 1162 0.4 2001 0.7 -72.2 
Depression (and Diabetes or CHD) 290687 n/a - 25509 8.8 - 
Smoking 290687   n/a -   77936 26.8   - 
Data source: Doncaster PCT, Quality Outcome Framework (QOF) data, April 2009.
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3.3.2 The prevalence of COPD in Doncaster 
As shown in Table 3.2, Doncaster had 7,637 (2.6%) patients with COPD on its 
primary care disease registers held by GP practices in 2009. An analysis of a 
subset of COPD patients that were part of a locally enhanced service (LES) for 
COPD at the time further showed that of the 5,897 cases categorised for 
disease severity, 60% were mild, 29% were moderate, and 11% were severe 
COPD. The prevalence of COPD and its severity increased with increasing age 
as shown in Table 3.3. 
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Table 3.3: Prevalence of COPD by age groups and disease severity 
Prevalence among GP practices population in Doncaster on 01/01/2010 
Variables 
Numerator 
(cases) 
Percentage 95% CI 
AGE 
All ages: 5897 2.28 (2.23, 2.34) 
All ages 
(expected): 11239 3.85 (3.78, 3.92) 
<65 years 1938 0.91 (0.87, 0.95) 
65-74 years 1886 8.16 (7.81, 8.52) 
75+ years 2073 9.77 (9.38, 10.18) 
SEVERITY 
All COPD 5897 2.28 (2.23, 2.34) 
Mild 3530 1.37 (1.32, 1.41) 
Moderate 1735 0.67 (0.64, 0.70) 
Severe 632 0.25 (0.23, 0.26) 
AGE & 
SEVERITY 
<65 years: 
Mild 1246 0.58 (0.55, 0.62) 
Moderate 512 0.24 (0.22, 0.26) 
Severe 180 0.08 (0.07, 0.10) 
65-74 years old: 
Mild 1094 4.74 (4.47, 5.02) 
Moderate 581 2.52 (2.32, 2.73) 
Severe 211 0.91 (0.80, 1.04) 
75+ years: 
Mild 1190 5.61 (5.30, 5.93) 
Moderate 642 3.03 (2.80, 3.27) 
Severe 241 1.14 (1.00, 1.29) 
 
The pattern of disease distribution within Doncaster varied across the 
communities therein (Figure 3.5), which was consistent with the known pattern 
of local levels of deprivation (Figure 3.4). 
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Figure 3.5: COPD modelled prevalence counts by communities in Doncaster 
 
Source: Public Health Intelligence and Evaluation Unit, Doncaster PCT (2011) 
Note: The corresponding areas of deprivation are shown in Figure 3.4 
3.3.3 Life expectancy and mortality 
Life expectancy at birth in Doncaster was 75.1 years for males, and 79.8 years 
for females, (compared to 76.5 for males; and 80.8 for females in England), 
according to Public Health Profile for Doncaster carried out in 2008 (Doncaster 
PCT, 2008). Life expectancy at birth continued to increase steadily for both 
males and females in both Doncaster and England & Wales, although it was 
lower in Doncaster compared to that of England & Wales (Doncaster PCT, 
2008).  
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All-cause mortality rate was significantly higher in Doncaster than that seen in 
England and Wales. The main causes of mortality were from cancers and 
circulatory diseases (including coronary heart disease), and COPD (Doncaster 
PCT, 2008).   
From 1993 to 2009, death rates from COPD showed a gradual decline in 
England and Wales, Yorkshire and the Humber, and in Doncaster. However, 
the mortality rate from COPD in Doncaster remained higher than that of the 
regional average and that of England & Wales (Figure 3.6).  
Figure 3.6: Mortality trend from bronchitis, emphysema and other COPD. 
Directly standardised mortality rates (DSR) from bronchitis, emphysema 
and other COPD (ICD9 490-492, 496 adjusted; ICD10 J40-J44): 1993-
2009, all persons. 
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Source of data: The NHS Information Centre for health and social care. 
Compendium of Clinical and Health Indicators / Clinical and Health Outcomes 
Knowledge Base (www.nchod.nhs.uk or nww.nchod.nhs.uk) 
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The distributions of mortality rate from COPD among geographical communities 
in Doncaster are shown in Figure 3.7, which shows evidence of concentration of 
deaths in most deprived areas. 
 
Figure 3.7: COPD Mortality by communities in Doncaster. 
Directly standardised mortality rate (DSR) from COPD by communities in 
Doncaster (5 year 2005-2009). 
 
 
Source: Public Health Intelligence and Evaluation Unit, Doncaster PCT (2011) 
Note: The corresponding areas of deprivation are shown in Figure 3.4. 
 
3.3.4 Hospital admissions: COPD 
Hospital admissions from COPD posed a significant challenge to Doncaster 
PCT due to the increasing yearly trend in admission rate and its associated 
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healthcare costs. The rate of hospital admissions from COPD was projected to 
increase in the future, if the existing trend continued (Figure 3.8). 
Figure 3.8: Directly standardised rate (DSR) of hospital admission from COPD 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Public Health Intelligence and Evaluation Unit, Doncaster PCT (2011) 
 
The pattern of distribution of hospital admissions over a three-year period 
(2009-2011) by geographical communities in Doncaster showed that hospital 
admissions were concentrated in particular communities in the borough (Figure 
3.9), that were also considered to be deprived. 
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Figure 3.9: Map of COPD admissions directly standardised rate (DSR) 
Distribution by communities in Doncaster (3 year: 2007-2009) 
Source: Public Health Intelligence and Evaluation Unit, Doncaster PCT (2011) 
 
3.3.5 Commissioning of local health service 
At the time of undertaking this research (2006-2012), the strategic 
responsibilities for the delivery of health services and improvement of public’s 
health in Doncaster rested with Doncaster PCT. Doncaster PCT was 
responsible for commissioning health services at various levels in Doncaster: 
community-based (e.g. district nursing, school nursing, health visitors, etc.) 
secondary and tertiary health care services both at hospital settings. Its annual 
health budget was over £0.5 billion in 2010/11. Doncaster PCT had 46 GP 
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practices, 36 community pharmacies, 66 Optometry practices and 47 dental 
practices in 2011. It commissioned secondary healthcare services from the 
following main local hospital providers: Doncaster & Bassetlaw Hospitals NHS 
Foundation Trust, Rotherham Doncaster and South Humber Mental Health NHS 
Foundation Trust, Sheffield Teaching Hospitals NHS Trust, and Rotherham 
NHS Foundation Trust (Doncaster PCT, 2008). The main tertiary hospital 
providers for Doncaster patients were the Royal Hallamshire Hospital in 
Sheffield, part of Sheffield Teaching Hospitals; and the Leeds Teaching 
Hospitals in Leeds. 
However, on 1 April 2013 changes to the National Health Service (NHS) re-
organisation came into force in England following the enactment of Health and 
Social Care Act 2012 (Crown Copy Right, 2012). The Act saw the abolition of 
PCTs, and the creation of Clinical Commissioning Groups (CCGs) to take over 
some the responsibilities for commissioning secondary care (hospital) services. 
It also transferred public health functions to local authorities, and created Public 
Health England (PHE) whose duties was to improve and protect the health of 
the people of England and to support public health in local authorities. The Act 
also created NHS England whose responsibilities included commissioning of 
primary care services and specialised health services. 
3.4  The experience of Doncaster in research 
3.4.1 Objectives and source of data 
This section provides backgrounds to later chapters in addressing the research 
question related to poor uptake into the pragmatic randomised controlled trial 
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and to determine if the poor uptake of recruitment into the RCT was associated 
with the design of the study; and the experience of Doncaster in undertaking 
research.  The section addresses the following research question: 
Is there something about Doncaster that made it more difficult to operate 
a randomised controlled trial (RCT) versus a service evaluation? 
The objective of this section was to investigate the experience of Doncaster in 
undertaking research compared with other similar areas in England. The local 
experience in Doncaster of recruiting study subjects into national portfolio 
studies was examined and comparison was made with other PCTs in England.  
Comparison of approval of research study by local research ethics committee 
was collated for research activities covering several years.  
South Yorkshire Comprehensive Local Research Network (CLRN) office was 
contacted for comparative data of recruitments of subjects into portfolio studies 
for Doncaster PCT and other PCTs in England. Data was requested with a 
breakdown of observational and interventional studies. Analysis was carried out 
on recruitment into research studies for all PCTs; including Doncaster PCT. 
Additional data was obtained from the local research ethics committee in 
Doncaster, based on approval of research studies. 
Population for the PCTs was obtained from the population estimate for 2009 
from the National Office for Statistics (ONS) in England. This population 
estimate was used to calculate the recruitment rate into portfolio studies per 
100,000 for each PCT in the country.  
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3.4.2 Results of recruitment into portfolio studies  
Of the 146 PCTs in England during the financial year from 1 April 2010 to 31 
March 2011, Doncaster ranked as the 8th top PCT with the highest total 
recruitment of participants into national portfolio studies. The rate of total 
recruitment of participants in Doncaster PCT was 793.1 per 100,000 population, 
in comparison with the average of all the PCTs (187.6 per 100,000), (Figure 
3.10). 
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Figure 3.10: Recruitment of participants into portfolio studies  
Rates per 100,000 population, Doncaster versus all PCTs in England, 
2010/2011 (n=146 PCTs). 
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Recruitment rates per 100,000 population into portfolio study were categorised 
according to the degree of increasing complexity as follows: (1) large studies 
(simple studies with over 10,000 subjects); (2) observational studies; and (3) 
interventional studies. A comparison of recruitment rates into interventional 
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studies between participants in Doncaster and all the 146 PCTs was made. It 
showed that Doncaster recruitment rate into interventional study was 84.4 per 
100,000, which was more than double that of the average for all the PCTs (34.9 
per 100,000). Doncaster PCT ranked as the 13th highest PCT (of the 146 PCTs) 
in recruiting into interventional studies in comparison with all PCTs in England 
(Figure 3.11). 
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Figure 3.11: Recruitments of participants into interventional studies  
Rate per 100,000 population for Portfolio studies: Doncaster vs. all PCTs 
in England, 2010/2011 (n=146 PCTs). 
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The experience of researchers in Doncaster in recruiting participants into 
portfolio research studies between 2008/09 and 2010/11 also showed that the 
average number of participants per interventional study was 30 compared to 
156 for observational studies (Table 3.4). 
Table 3.4: Recruitments into various types of studies in portfolio research 
Doncaster: 2008 to March 2011 
Type of study 
No. of 
Portfolio 
studies 
 
Number of participants recruited 
 
2008/09 2009/10 2010/11 Total 
Interventional 
studies: number 6 
 
3 41 138 182 
Average rate of 
participants per 
study 
(interventional 
study) n/a 
 
1 7 23 30 
Observational 
studies: number 13 
 
329 91 1602 2022 
Average rate per 
study 
(observational 
study): n/a 
 
25 7 123 156 
Total number of 
cases in all studies: 19 
 
333 139 1763 2234 
Average rate per 
study (total): n/a 
 
18 7 93 118 
Note: Data obtained from South Yorkshire CLRN, 28th March 2011.  
 
In comparison with some neighbouring districts in South Yorkshire, the number 
of recruitment was higher in Doncaster. The exception to Doncaster was 
Sheffield which had higher number of research activities, and it had two 
universities and a teaching hospital; it also had a high volume of research 
activities (Table 3.5). 
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Doncaster Primary Care Trust achieved its target for participants’ recruitment 
into portfolio study for the year 2010/11, although the local provider, Doncaster 
and Bassetlaw Hospitals (DBH) did not achieve its target (Table 3.6).
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Table 3.5: Number of participants recruited into Portfolio studies 
South Yorkshire CLRN by intervention (Int.) and observational (obs.) studies, 2008-2011 
   2008-09  2009-10  2010-11* 
Trust  Int. 
studies 
Obs. 
studies 
Total  Int. 
studies 
Obs. 
studies 
Total  Int. 
studies 
Obs. 
studies 
Total 
Barnsley PCT  0 155 155  53 71 124  130 808 938 
Doncaster PCT  3 329 332  41 91 132  94 1602 1696 
Rotherham PCT  0 67 67  3 42 45  13 1260 1273 
Sheffield PCT  1839 157 1996  870 446 1316  443 321 764 
* Up to 4th April 2011 
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Table 3.6: Recruitment into portfolio studies against allocated target by area for year 2010/11 in South Yorkshire 
TRUSTS 
 Total number of 
recruitment for year 
2010/11 
 
Target of recruitment 
for 2010/11 
 
Remarks 
Barnsley Hospital  287  245  Target met or exceeded 
Barnsley PCT  1140  84  Target met or exceeded 
Doncaster & Bassetlaw 
Hospitals 
 
331 
 
845 
 
Target missed by >5% 
Doncaster PCT  2238  169  Target met or exceeded 
Rotherham PCT  1702  50  Target met or exceeded 
RDASH Mental Health  36  52  Target missed by >5% 
Sheffield Children's  317  328  Target missed by <=5% 
Sheffield Health & Social Care  161  55  Target met or exceeded 
Sheffield PCT  1006  1132  Target missed by >5% 
Sheffield Teaching Hospitals  4682  4044  Target met or exceeded 
The Rotherham NHS FT  604  413  Target met or exceeded 
South Yorkshire  12504  7417  Target met or exceeded 
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3.4.3 Time-trend of recruitment into portfolio studies 
Complexity weighted recruitment per million population increased steadily in 
Doncaster over the years from 2008/09 to 2010/11. Recruitment peaked in the 
third and fourth quarters of 2010/11. However, in comparison with the 
recruitment observed in South Yorkshire as a whole and England, Doncaster 
recruitment was low in the first two years when CLRN was established. In 
2010/11, the research activities in Doncaster reached a level that was 
comparable to that observed in England (Figure 3.12). 
Figure 3.12: Complexity-weighted recruits per million populations 
Doncaster PCT; Doncaster PCT & Doncaster and Bassetlaw Hospitals; 
South Yorkshire CLRN; and England; 2008/09 to 2011/12 
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Data source: South Yorkshire CLRN 
The SY CLRN had dedicated research nurses embedded in each districts to 
support recruitment. There was reported evidence that having a dedicated staff 
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on site was essential for recruitment of participants into research study, as 
reported by one of the research nurses (SYCLRN, 2010): 
“X Trust [hospital provider in South Yorkshire] is 95 over recruitment on a 
relatively small number of targeted cases. Jenny [not the real name of 
staff] reported that X Trust’s success was because the research nurse 
team, which has made a huge impact on recruitment in X Trust over the 
past few months, work on site.”  
There was no dedicated research nurse in Doncaster for the implementation of 
telehealth project. The two nurses that were allocated for the telehealth 
implementation during the pragmatic trial period did not have protected time to 
undertake the required work. 
3.4.4 Non-Portfolio studies in Doncaster  
The data on approval of research studies by the Local Research Ethics 
Committee in Doncaster during the period from 2005 and 2011 showed that 
80% of the studies were non-RCT studies and 20% were RCTs (Table 3.7).  
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Table 3.7: Non-portfolio research activities in Doncaster  
Based on recorded studies held by Doncaster PCT that had local research 
ethics committee approval 
Start year 
Non-RCT   RCT   Total 
n % n % n % 
2005 6 66.7 3 33.3 9 100.0 
2006 26 72.2 10 27.8 36 100.0 
2007 11 57.9 8 42.1 19 100.0 
2008 19 90.5 2 9.5 21 100.0 
2009 14 93.3 1 6.7 15 100.0 
2010 24 85.7 4 14.3 28 100.0 
2011 16 94.1 1 5.9 17 100.0 
Total 116 80.0   29 20.0   145 100.0 
Note: 19 studies with details unknown were not included in the above tables; 
studies were recorded to have started from March 2005 to September 2011. 
3.5  Telehealth service 
Against the background of the burden of LTCs in Doncaster, and the 
opportunity offered by the introduction of assistive technology by the 
Government (Department of Health, 2005a), Doncaster PCT decided to pilot the 
use of telehealth service for the care of patients with LTCs. This section 
explores what telehealth is and it describes telehealth service introduced in 
Doncaster. The section describes telehealth service, as one of the interventions 
to support self-care for people living with LTCs, taking patients with COPD as 
an example to focus on. Telehealth, as used in this study, focuses on remote 
patient monitoring (part of telehealth). The contexts of remote patient monitoring 
in England and in Doncaster are also described. 
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3.5.1 Definition of telehealth and remote patient monitoring 
This section aims to provide the context to help in understanding telehealth. 
There is much confusion in the published literature in relation to definitions of 
telehealth and related terms. This confusion has resulted from the use of 
terminologies that are either too broad (e.g. e-Health), which makes comparison 
of study results difficult; or the use of different terms (e.g. telehealth, 
telemedicine or telehealthcare or telemonitoring) for similar technological 
interventions. 
It is important to place telehealth and related definitions in the wider context of 
electronic health (e-Health). This context is best illustrated by Figure 3.13 
(Pawar et al., 2012), in which telehealth is considered as a subset of e-Health. 
Under the entity of telehealth, Pawar and colleagues (2012) regarded remote 
patient monitoring (similar to the type used in the study setting in Doncaster for 
this research), as being part of telemedicine (Pawar et al., 2012). 
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Figure 3.13: Remote patient monitoring as a subset of telehealth and e-health  
 
 
 
Source: (Pawar et al., 2012) 
 
This research is about remote patient monitoring as it involved the remote home 
monitoring of patients in their own homes by healthcare professionals.  
E-Health encompasses medical informatics, public health and business 
application of delivering healthcare using internet and related technologies 
(Eysenbach, 2001, Pawar et al., 2012). Such a wide remit of e-health has made 
evaluation and comparison of related interventions a major challenge to 
researchers and practitioners in the field. Telemedicine can be considered as a 
subset of telehealth, as shown in Figure 3.13. Attempts to differentiate between 
the two had often resulted in more confusion. Even the World Health 
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Organisation (WHO) agreed that the term telehealth was much broader than 
telemedicine, and it regarded telehealth as a preferred terminology to use 
because it addressed public health agenda; education for health, public and 
community health, health systems development and epidemiology (World 
Health Organisation, 2003, Pawar et al., 2012, Darkins and Cary, 2000).  
Examples of telehealth technological devices ranges from telephone alone or in 
combination with other devices, videophone, computer, mobile phone,  still 
image video phones, radio, fax, internet (Grigsby et al., 2005, Wootton et al., 
2006).  
The telehealth work involved in this study entailed regular monitoring of patients 
in their own home by community nurses. Steventon et al (2012) offered a 
definition of telehealth remote home monitoring that was used as part of Whole 
System Demonstrator (WSD) in England, and it closely reflected the remote 
home monitoring used in this research:  
“Telehealth involves the remote exchange of data between a patient and 
healthcare professionals as part of the patient’s diagnosis and healthcare 
management.” (Steventon et al., 2012), p2. 
The limitation of the definition of remote patient monitoring offered by Steventon 
and colleagues (Steventon and Bardsley, 2012) was that it did not describe the 
types of information collected for self-management, and patients’ diagnoses  
were not part of the local telehealth service in Doncaster. The type of telehealth 
remote home monitoring used in Doncaster was similar to that in the WSD in 
that it involved monitoring patients’ blood pressure and blood sugar to support 
self-management of patients (Cartwright et al., 2013).  
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In light of the limitation of definition described by Steventon and colleagues 
(2012), a modified definition of remote patient monitoring, which reflected the 
service in this research, was advanced by the author of this thesis, as follows: 
“Remote patient monitoring is the remote exchange of patients’ data 
where patients measure their vital signs (oxygen saturation level in their 
blood (SpO2), pulse, breathing, or blood pressure), and answer 
symptoms questions from their home and the data is transmitted via 
internet to a healthcare professional who monitors the patients’ data and 
institutes appropriate management actions.”  Adapted from (Steventon et 
al., 2012)  
This definition of remote patient monitoring is used throughout this thesis in 
reference to the type of telehealth service employed in this research, including 
literature review. Therefore, in this thesis, where the term telehealth is used, it 
refers to remote patient monitoring. Unless otherwise stated, the use of term 
telehealth also refers to telehealth service (Section 3.5.3). 
3.5.2 The policy contexts of remote patient monitoring 
The role of new technology in England, in the delivery of future high quality 
health care, was set out in a 20-year vision report produced by Sir Derek 
Wanless in 2002. Wanless (2002) described the best option for improving the 
future health of the nation in England as that of full level of engagement by the 
population with preventive and self-care using new technologies. He described 
this option as a fully engaged scenario, in comparison to other options of “do 
nothing” or partial engagement by the population with preventive agenda 
(Wanless, 2002). In 2005, the Government’s strategy on assistive technology 
Building Telecare in England (Department of Health, 2005a) started to 
72 
 
 
implement this vision by offering initial grant of £80 million to local authorities in 
England. The Department of Health defined telecare as:  
“…the continuous, automatic and remote monitoring of real-time 
emergencies and lifestyle changes over time in order to manage the risks 
associated with independent living.” (Ellis, 2008a) 
An example of telecare that was operated by Doncaster Council was a pendant 
alarms system that older people at risk of falls could wear on the neck. When 
the alarms were pressed after a fall, it would alert staff members who remotely 
monitor the alarms generated.  Although majority of the Government’s £80 
million grant allocated in 2005 was for telecare, some local authority areas 
working in partnerships with the NHS (National Health Service in Britain), used 
it for piloting telehealth service.  
The Whole System Demonstrator (WSD) was another major cluster randomised 
controlled trial (RCT) study funded by the Department of Health in England in 
2008 to investigate the effectiveness and cost-effectiveness of telehealth, at a 
cost of £31 million (Ellis, 2008b). The role played by telehealth was also 
recognised by the Audit Commission as having the potential to provide better 
and less expensive care, while promoting self-care and patients’ independence 
(Audit Commission, 2004). In 2011/12, an initiative called Delivering Assistive 
Living Lifestyles at Scale (DALLAS) was launched, which aimed to target 3-5 
clusters of communities (each cluster aimed to recruit 10,000 users): one in 
Scotland and the others in England. These communities were to be given 
assistive living technologies, and some of these technologies would be 
telehealth (Technology Strategy Board, 2011). The project was budgeted at £23 
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million; with £5m funding from the Scottish Government and £18m from 
England. 
On the 6th of December 2011, the British Prime Minister, David Cameron, gave 
a speech at the Financial Times (FT) Global Pharmaceutical and Biotechnology 
Conference in London where he affirmed his Government’s determination to roll 
out telehealth to 3 million people in England: 
“Just look at our approach to tele-health – telemedicine – getting new 
technology into patients’ homes so they can be monitored remotely. 
We’ve done a trial, it’s been a huge success and now we’re on a drive to 
roll this out nationwide with an aim to improve three million lives over the 
next five years with this technology.” (Cameron, 2011) 
The importance which the Government attached to investment in technology in 
health was further reflected in the speech by the Chancellor of the Exchequer 
on 28 May 2012 in which he committed £180 million, as part of life science 
strategy announced by the Prime Minister in December 2011 (Osborne, 2012b). 
The Chancellor, in a later speech (9 November 2012), also gave the support of 
the government to the scientific community to realise the social and economic 
benefits of several areas of new technologies, including those in health 
(Osborne, 2012a). Some examples of the technologies in health sited by the 
Chancellor included sport vest worn by footballers that measured heart beats of 
players, which could enable coaches to monitor their players (pioneered in 
Spain); and the use of robots in medicine. Although this might seem unrelated 
to telehealth, what it suggested was that the future technologies are likely to be 
those that are incorporated into day-to-day activities of ordinary people. The 
broad eight areas of the new technologies that the Government pledged its 
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support for included: efficient computers (data revolution), synthetic biology, 
regenerative medicine, advance material science, robotic and automatic 
system; agri-science, and satellite application (Osborne, 2012a). 
The purposes of the Government’s drive for new technology in health appeared 
to be not only about improving the quality of life of people using these 
technologies, but also to have commercial edge globally:  
“Now this will make an extraordinary difference to people. Diabetics will 
be taking their blood sugar levels at home and having them checked 
remotely by a nurse; heart disease patients will have their blood pressure 
and pulse rates checked without leaving their home at all. This is dignity 
and convenience and independence for millions of people. And it’s not 
just a good healthcare story; it’s going to put us miles ahead of other 
countries commercially too as part of our plan to make our NHS a driver 
of innovation in UK life sciences.” (Cameron, 2011) 
In January 2012, the Department of Health in England signed a Concordat with 
the UK telehealth and telecare industry for rolling out telehealth and telecare in 
the health and social care with the aim of improving the lives of 3 million people 
in England over a 5-year period: 2012-2017 (Department of Health, 2012). Part 
of this drive could be attributed to the determination of the telehealth and 
telecare industries to find markets for selling their new technologies in health 
and social care, coupled with keen interest among some researchers to see that 
the technologies got implemented. 
The history of telehealth in England between 2002 and 2012 is summarised in 
Figure 3.14. 
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Figure 3.14: The history of telehealth and telecare in England 
 
Adapted from (Clark, 2009, Biddle and Chahaian, 2011)
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3.5.3 Description of telehealth service (system) 
The devices used for the telehealth during the pragmatic trial in Doncaster 
between 2007 and 2009, was the Genesis Monitor model (Figure 3.15a 
below), which was the size of a radio alarm clock. It had blood pressure cuff, 
pulse oximeter, weighing machine, and thermometer as peripheral devices, 
which were connected to the base unit. Patients with COPD used the 
weighing machine only at the start (or when determined by a nurse), but they 
monitored daily their vital signs, which included blood pressure, pulse and 
body temperature. The base unit was connected to a landline telephone 
from where readings from the machines were transmitted to a central 
monitoring location in a health centre located in Thorne area of Doncaster. 
Patients without functional landline telephones could not use the machine at 
this time and were excluded, as per pragmatic trial’s exclusion criteria.   
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Figure (3.15a): Telehealth Equipment: Genesis Monitor (Model), 2007 
 
 
An improved model (RTX Model) (Figure 3.15b) used during the service 
evaluation study period, which came into use about two years later following 
the introduction of Genesis Monitor, had wireless features utilising blue tooth 
technologies for its peripheral devices. The blue tooth technologies enabled 
some of the machines to operate without the need to connect to landline 
telephones. Patients without landline telephone who were deemed eligible 
for the study were given these new devices, unlike in the pragmatic trial. 
Figure (3.15b): Remote patient monitoring machine (RTX3371 Model), 2010 
 
 
The following vital signs could be captured via the device: blood pressure 
(systolic and diastolic), oxygen saturation (SpO2), heart beat (pulse) per 
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minute, weight (kilogramme). A peripheral device for measuring blood 
glucose levels was also available for patients with diabetes. The parameters 
of the vital signs were set by healthcare professional for individual patients, 
taking into account recommended national guidelines by the National 
Institute for Health and Care Excellence (NICE) in England. Any breach of 
parameters set for each vital sign generated a red alert, which required a 
healthcare worker to investigate and take appropriate course of action. 
In addition, there was a bank of questions that could be chosen by 
healthcare workers to ask patients on a regular basis, if required. The 
Genesis Monitor (older device) had a bank of 51 questions. An example of 
such questions was:  
“Are you experiencing more difficulty breathing today compared to a 
normal day?”  
Detail of the questions used in the pragmatic trial is found in Chapter 5. They 
were asked to all patients in the trial. However, during the service evaluation 
study, the questions were optional, and were not the same as those used 
during the trial. 
While the focus on telehealth service appeared to be around the technology 
(“The Black Box”) that measured vital signs and answered some symptoms 
questions, there were in fact multiple interventions that could be identified in 
a telehealth service (system). These included the following: (1) the 
technology itself used for remote patient monitoring (“The Black Box”), 
including the associated internet communication system and data 
transmission to a monitoring centre; (2) telephone contacts between 
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healthcare professionals and users; also described in the literature as the 
plain old telephone system (POTS) that was used for exchanging real-time 
information (Sheikh et al., 2011); and (3) advice by appropriate healthcare 
professionals to users, including actions on implementing management plan. 
Recognition of these interventions (wider contexts) is important to the 
understanding of how telehealth service (system) operates. The author’s 
perspective on diagrammatic representation of telehealth service with the 
different components is shown in Figure 3.16. 
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Figure 3.16: A depiction of how telehealth service works 
Enabling communication between a patient and a healthcare 
professional (author’s perspective) 
 
As shown in Figure 3.16, users of telehealth service took their vital signs: 
blood pressure, level of oxygen saturation (SpO2), heart rate, temperature; 
and they also answered symptom questions through the technology. While 
users were able to measure their vital signs and answer symptoms 
questions, however, they were not able to access historical data about 
themselves. They could observe and note the vital signs readings at the time 
of undertaking the measurements. The data was transmitted remotely via 
internet to a web-based storage where healthcare professionals gained 
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access to the data using secure user names and passwords to specified 
sites and patients under their care, subject to the level of authorisation 
granted to them by a designated staff that had the overall responsibility. 
The community nurses reviewed the patients’ vital signs readings and any 
response to individually tailored questions only from Monday-Friday during 
working hours from 09:00 hours to 17:00 hours. The system was not 
considered to be for emergency use, and if there was any urgent matters 
outside working hours, patients were advised to contact usual emergency 
services. Hence, any readings that patients might have performed during out 
of hours, including weekends, were only responded to by the nurses during 
working hours, Monday-Friday. The expectation was that patients would take 
their vital sign readings and answer symptom questions twice a day; in the 
morning and in the evening at agreed time between the patient and their 
healthcare worker. 
According to the four classes of telehealth described by Cartwright and 
colleagues (2013), the first generation telehealth had non-reactive data 
collection (store and forward) where providers did not respond immediately; 
in the second generation of telehealth patient data was transferred for 
decision making purpose, but there was some delays by health service 
providers as the system operated during office hours.  While third generation 
telehealth was characterised by constant analytical and decision making 
components with 24 hours per day and seven days a week operation; and 
finally the fourth generation was an extension of the third generation 
involving more complex surgical and medical procedures (Cartwright et al., 
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2013). The Doncaster telehealth was considered to be a second generation 
telehealth service. 
3.5.4 Selection process of preferred supplier of telehealth service 
The implementation of telehealth service in Doncaster could be categorised 
into two main phases: the pilot phase (in which 20 devices were purchased); 
this was where the RCT study design was used. It was intended that 
additional 60 devices were going to be used during the pragmatic trial 
phase, but this did not happen. The second phase (or service evaluation) 
was the roll out phase (where the existing 80 devices were replaced with 
newer ones and additional 100 devices were purchased bringing a total of 
180 commissioned telehealth devices). The first telehealth service involving 
the pragmatic trial was commissioned in 2007/2008, while the roll out phase 
was commissioned in 2009/20010, with phased implementation over a two-
year period. 
A committee was formed to consider the specification required for procuring 
the right telehealth technology. The committee consisted of nine members 
including community nurses, project manager for assistive technology, 
information technology manager, information governance representative, 
commissioning manager for physical disability and sensory impairment; and 
a public health consultant. 
Potential suppliers of telehealth were invited to tender through the NHS 
Purchase and Supply Agency (PASA) framework, in line with Department of 
Health procurement rules in England. The invitation contained information 
with questionnaires that were completed by the suppliers. The questionnaire 
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asked for information on (1) cost of telehealth machine, (2) equipment and 
data storage, (3) service support and help facilities, (4) training, and (5) 
experience of the suppliers in delivering telehealth to users. These five areas 
were weighted in the assessment as follows: cost – 40%; equipment – 30%; 
training - 10%; service, support and help facilities – 10%; and experience – 
10%. Each of these components had detail elements that were assessed by 
the panel before arriving at their final score. 
The suppliers were invited for a demonstration day, and later for a formal 
interview lasting for a whole day, with each supplier being interviewed for 
about one hour by a panel of PCT staff. The panel consisted of seven 
members from different disciplines, and they included: project manager, IT 
manager, community matrons, and public health. The process of selection of 
the preferred supplied was as follows: first the nine potential suppliers were 
invited, of which six applied; four of them were subsequently interviewed; 
and finally one was chosen as the preferred supplier.  
Individual members of the panel separately scored each supplier’s 
performance against the five dimensions described above. The scores were 
then collated to derive the panel overall scores. A separate meeting of the 
panel was held to discuss the combined scores of the panel. The panel 
finally chose Tunstall as the preferred supplier of telehealth service in 
Doncaster.   
When it was felt that more than 20 devices might be needed for telehealth 
service, a business case was made for additional 60 devices. As the 
additional telehealth was expanding on existing telehealth programme, it 
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was not deemed necessary to undertake a new process of procurement. 
Hence, the additional 60 devices were purchased from Tunstall. Ethical 
approval was sought and obtained for the amendment to increase the 
number of machine in use in the RCT. 
During 2009/10, it was decided to roll out telehealth service in Doncaster 
following the pragmatic trial. However, it was felt necessary to undertake a 
tender process, similar to the one described at the pragmatic trial period. It 
was realised that the existing devices that were in use were already 
outdated, even though they were less than two years in use. One of the 
requirements for potential suppliers was to replace existing devices in use 
with newer ones. Tunstall emerged as the preferred choice of supplier. 
3.6 Summary 
This chapter describes the relevant backgrounds to the research and 
provides information to address some of the research questions, posed in 
the introduction of the thesis. Doncaster is a health district (PCT), 
coterminous with the local authority, and it is located in South Yorkshire (in 
the North of England). It had a population of 302,400 and was considered to 
be a deprived area. Long-term conditions are a major public health problem 
in Doncaster in terms of high disease prevalence, morbidity and mortality 
burden. Locally, one in five people suffered from a long-term condition such 
as heart disease, diabetes, respiratory disease, cancer, etc.  
It has been shown that Doncaster had a more favourable research 
experience in relation to recruiting subjects into research activities when 
compared with other PCTs in England and within the same county of South 
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Yorkshire.  Evidence shows that majority of the research activities were for 
observational studies (non-RCT), than interventional studies (RCTs). 
Telehealth service was considered to have a role in managing patients with 
LTCs. It involved the delivery of healthcare at a distance. Telehealth service 
in this thesis means remote patient monitoring, and a full definition has been 
offered in this chapter. Telehealth service can be described as consisting of 
multiple intervention; the device, telephone service, and professional advice. 
The device was capable of monitoring patients’ vital signs (blood pressure, 
level of oxygen saturation in the blood [SpO2), pulse rate, weight, etc.) and 
answering individually tailored sets of questions.   
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Chapter 4: Literature Review on the Effectiveness and Cost-
Effectiveness of Telehealth Services 
4.1  Introduction 
The first three chapters of the thesis provided an introduction, theoretical 
framework and backgrounds to the research. The first chapter outlined the 
evolution of the research aims and objectives from that of initially assessing 
effectiveness of telehealth to investigating why and how new technologies 
embed or not in routine practice. In the second chapter, the principal theoretical 
framework, normalisation process theory (NPT), was identified and described. 
The third chapter described relevant backgrounds information to the research, 
which included the study setting, demographic characteristics, health profiles, 
research experience in the study setting, and a description of telehealth 
services used in the study setting. 
Figure 4.1 describes the focus of the current chapter, which assesses the 
evidence of effectiveness and cost-effectiveness of telehealth services. In 
addition, it describes evidence from the literature on the implementation of new 
technologies and failed trials. Throughout the chapter, reference will be made to 
Figure 4.1 and the relevant numbered boxes.  
There were two groups of patients of interest in relation to assessing the 
evidence of effectiveness and cost-effectiveness of telehealth services. One 
group of patients was broad and included those with long-term conditions 
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(LTCs), as shown in Boxes 1a.i and 1b.i. They were the potential target group 
for telehealth service, as described in Chapter 1.  
The second group was patients with chronic obstructive pulmonary disease 
(COPD). The latter group is a subset of systematic reviews assessing the 
effectiveness and cost-effectiveness of telehealth service among patients with 
LTCs, as shown in Boxes 1a.iii and 1b.iii of Figure 4.1. This group of patients 
was chosen because they were identified and targeted for telehealth service 
when the service was first introduced in Doncaster, the study setting. The 
headline findings of effectiveness and cost-effectiveness of telehealth service 
for patients with COPD are in Box 1c.ii. 
As the focus of the thesis changed, to investigating why new technologies fail or 
succeed to embed in routine practice, a review of the literature on 
implementation of new technology was undertaken (Boxes 2 and 2a).  The final 
part of the review assessed the evidence from the literature related to factors 
associated with the successes and failures of pragmatic randomised controlled 
trials (RCTs) (Boxes 3 and 3a). This section is relevant later on in the thesis in 
helping to contextualise what went wrong in the pragmatic trial that is reported 
in Chapter 5 and how recruitment into trials could have been improved. 
Therefore, the objectives of this chapter are: 
1. To assess the evidence of effectiveness and cost-effectiveness of telehealth 
services in managing patients with long-term conditions (LTCs) in general, 
and COPD in particular. 
88 
 
 
2. To identify factors which determine the success or failure to implement a 
telehealth service in routine practice. 
3. To identify factors why RCTs fail to recruit to their target sample sizes.
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Figure 4.1: Literature review systematic reviews on effectiveness and cost-effectiveness of telehealth: decisions, actions and 
reasons  
 
 
Literature Review 
(1a.iii) Focus: Systematic reviews 
focusing on patients with COPD 
(COPD is a sub-set of LTCs). 
Reason: Patients with COPD were 
the focus of the pragmatic trial of 
telehealth service. 
(1c.ii) Headline findings:  
(1) Effective in reducing hospital 
admissions, and emergency hospital 
visits;  
(2) Limited evidence of cost-effectiveness;  
(3) Limited evidence of improving quality of 
life;  
(4) No difference in mortality rates. 
(5) Patients were satisfied 
Technical issues: 
(1) Variation of interventions (definitions);  
(2) Small number of RCTs involving COPD;  
(3) Varied outcome measures, and patients 
groups. 
(4) Different contexts 
(5) Varied quality of studies 
1b.iii) Decision: To appraise only 
systematic reviews on patients with 
COPD. 
Action: Appraised systematic 
reviews on COPD 
Reason: systematic reviews is the 
top in the hierarchy of evidence 
(1a.i) Focus: systematic reviews 
focusing mainly on patients with 
LTCs. Reason: Patients with LTCs 
are the wider target audience for 
telehealth service. 
(1c.i) Headline findings:  
(1) Some modest evidence of effectiveness;  
(2) Mixed evidence of cost-effective;  
(3) Limited improvement in quality of life;  
(4) Some effects on mortality rates. 
Technical issues: 
(1) Varied interventions (definitions);  
(2) Different outcome measures used. 
(3) Varied quality of studies (1a.ii) Excluded: 
Individual studies 
included in the 
systematic reviews. 
Reason: Appraised 
in systematic 
reviews. 
(1b.i) Decision: To appraise 
systematic reviews on LTCs. 
Action: Appraised systematic 
reviews on LTCs 
Reason: systematic reviews is the 
top in the hierarchy of evidence 
(1b.ii) Decision: To review other 
significant studies published after the 
most recent systematic reviews 
(2011):  
Action: Appraised Whole System 
Demonstrators (WSD) RCTs; 
Reason: To update findings from 
systematic reviews. 
(1) Is telehealth 
effective 
and cost-
effective? 
(2) 
Implementation 
of new 
technology 
(3) Failed trials 
(2a)  Decision / action: To review broad literature on implementation of new 
technologies from systematic reviews. Reason: To assess why new 
technology fails or succeed to embed in routine practice.  
 
(3b)  Focus/ Decision: Examine failed RCTs. Reason: To capture reasons 
why some RCTs failed to recruit to the expected level, while others 
succeed to do so. 
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4.2 Methods 
4.2(1a.i and 1b.i): Is telehealth effective and cost-effective? 
The focus of this first part of the literature review was to find systematic 
reviews on effectiveness and cost-effectiveness of telehealth services. The 
following search question was formulated to aid the search of articles: 
“What is the evidence of effectiveness and cost-effectiveness of 
telehealth services among patients with long-term conditions (LTCs) 
in routine healthcare use?”  
Evidence of cost-effectiveness was sought, but there was very little evidence 
about costs, and the literature review focused on effectiveness of telehealth 
in practice. 
The search strategy included the use of the following terms: telehealth or 
telemedicine, or home telemonitoring, AND effectiveness, AND cost or cost 
analysis, AND chronic diseases. Employing features in the medical subject 
headings (MeSH), articles covered under the searched terms and related 
terms were included in the search of bibliographic databases.  
The following sources of databases were searched: (1) evidence based 
medicine reviews, which contained Cochrane reviews, and Cochrane-style 
reviews; and (2) Medline, with a focus on systematic reviews articles. 
The original search was conducted in 2012, capturing systematic reviews 
articles from 1991 up to 2012. The search was later updated in order to 
identify new articles published between 2012 and 2015. The evidence based 
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medicine reviews databases that were originally searched included the 
following: 
• Cochrane Database of systematic reviews: 2005 to May 2012,  
• American College of Physicians (ACP) Journal Club: 1991 to May 2012, 
• Database of Abstracts of Reviews of Effects: 2nd Quarter 2012,  
• Cochrane Central Register of Controlled Trials: May 2012,  
• Cochrane Methodology Register: 2nd Quarter 2012,  
• Health Technology Assessment: 2nd Quarter 2012,  
• NHS Economic Evaluation Database: 2nd Quarter 2012. 
The updated literature search of articles published between 2012 and 2015 
included the following databases: Web of Science core collection; BIOSIS 
Previews; BIOSIS citation index; Data citation index; KCI – Korean Journal 
Database; Medline; and SciELO (Scientific Electronic Library Online) citation 
index. 
The original literature search of Medline was performed on 14th February 
2012, involving Ovid Medline (1996 to February Week 1, 2012) with full 
search history shown in Annex 1.1, Table A1.1. This is shown as an 
example of database that was searched. The updated literature search 
history for the period 2012 and 2015 carried out in Web of Science is shown 
in Annex 1.1, Table A1.2 
The systematic reviews were updated with pragmatic trials articles from the 
WSD telehealth project (Steventon and Bardsley, 2012, Henderson et al., 
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2013, Cartwright et al., 2013, Steventon et al., 2014) (Box 1b.ii of Figure 
4.1).  
4.2(1a.ii) Exclusion and inclusion criteria 
The inclusion criteria for articles were: (1) systematic review articles; (2) 
articles related to patients with long-term conditions; (3) the intervention 
used closely reflected the definition of telehealth service as defined in 
Chapter 3; and (4) articles that addressed effectiveness or cost-
effectiveness of telehealth service.  
Articles were excluded if they: (1) did not meet the operational definition of 
telehealth stated above; (2) were not related to a long-term condition; (3) 
they were not systematic reviews (except the WSD pragmatic trial articles, 
given the status of the trial, being so large and undertaken in the NHS in 
England); and (4) they did not address effectiveness or cost-effectiveness of 
telehealth service. 
4.2(1a.iii) Patients with COPD 
From among the systematic review articles assessing effectiveness and 
cost-effectiveness of telehealth services for patients with LTCs, a subset of 
these related specifically to patients with COPD. This subset was appraised 
separately under a section on COPD in this chapter.  
The studies were appraised using an appropriate critical appraisal tool – the 
Critical Appraisal Skills Programme or CASP tool (Public Health Resource 
Unit (England), 2006b, Public Health Resource Unit (England), 2006a). For 
the systematic reviews, there were 15 questions in the CASP tool that were 
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used to assess the quality of each study, and they explored the focus of the 
review, the validity of the results, their application in practice and 
generalisation. Each question was scored as follows: 2 = yes (where it was 
fully answered); 1 = somewhat (where it was partially answered); and 0 = no 
or can’t tell (where the question was not answered). At the end of appraisal 
of each systematic review article, a total score was derived; the maximum 
score was 30. The total score out of 30 was expressed as a percentage to 
enable broad comparison with other systematic reviews. Appraised articles 
were assigned a low score if the total score was <60.0%; 60.0 – 74.0% was 
moderate; and 75.0% or more was high quality. Interpretation of the 
conclusions of each study was made by considering the total score and 
assigning an overall assessment, based on SIGN evidence-based criteria for 
assessing quality of study outlined in Table 4.1. 
Table 4.1: Overall assessment of quality of study 
Code Description 
++ All or most of the criteria have been fulfilled. Where they have 
not been fulfilled the conclusions of the study or review are 
thought very unlikely to alter. 
+ Some of the criteria have been fulfilled. Those criteria that 
have not been fulfilled or not adequately described are 
thought unlikely to alter the conclusions. 
- Few or no criteria fulfilled. The conclusions of the study are 
thought likely or very likely to alter. 
Source: (SIGN, 2011), p55. 
  
The framework for assessing quality of studies by SIGN (2011) was also 
used in assessing the quality of articles reviewed. The reason for this choice 
was based on the fact that the framework has been used widely, for 
example by NICE, as part of its evidence-based recommendations. 
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Articles from the WSD pragmatic RCTs were appraised using relevant 
CASP tool for trials, and a similar process was used to that of appraising the 
systematic reviews. 
4.2(2) Implementation of new technology 
The search words employed for undertaking literature search on 
implementation of new technology were “Telehealth or telemedicine and 
challenges or success factors”.   
Articles on the implementation of new technology related to key challenges 
for successes and failures of telehealth projects were identified from a range 
of sources, including systematic reviews captured in the above search. 
Specific searches that were carried out included specialist websites for 
telemedicine, Medline, Web of Science, EMBASE, evidence based reviews 
and internet google search. The references of the articles were screened for 
relevant papers on implementation of new technology. Further search for 
books on telehealth was conducted at the University of Leeds Library and 
the NHS Library service in Doncaster. Searches for specialist telehealth 
centres, included those in the UK and elsewhere in the world; Norway (The 
Norwegian Centre for Integrated Care and Telemedicine, 2009), Scotland 
(Scottish Centre for Telehealth, 2009), (NHS Institute for Innovation and 
Improvement, 2009), and England (Swinfen Charitable Trust, 2009). 
The focus of the literature search was to identify systematic review articles.  
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4.2(3) Failed trials 
Literatures on failed trials were identified through my own professional 
networks, from Health Technology Assessment (HTA) Programme web sites 
and articles, [the HTA is part of the UK National Institute for Health 
Research (NIHR)], Google search, and retrieval of relevant articles from the 
systematic review list of references. All the databases covered under the 
Web of Science were included in the search, including Medline, Web of 
Science core collection, BIOSIS citation index, BIOSIS Previews, Data 
citation index, KCI – Korean Journal Database, and SciELO citation index 
(Table 4.3). From Web of Science, articles that were related to, or cited the 
primary article, were screened to identify other potential new systematic 
review articles. The focus was to identify systematic reviews articles. The 
search terms used included “failed trials” or “failed RCTs” or “failed 
randomised controlled trials” (Table A1.3 in the Annex 1.1). 
4.3 Results 
4.3(1) Is telehealth effective and cost-effective?  
4.3(1b.i) Effectiveness and cost-effectiveness of telehealth 
service among patients with LTCs: findings from systematic 
reviews 
The original search of evidence-based medicine databases identified 12 
articles, and the Medline search yielded 25 review articles, making a total of 
37 potential systematic review articles.  Of these, 24 were excluded and the 
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reasons for their exclusion are set out in Figure 4.2a, leaving 13 articles that 
were included in the literature review.  
97 
 
 
Figure 4.2a: (Original search) Systematic review articles related to 
effectiveness and cost-effectiveness of telehealth service for patients 
with long term conditions: 1991 to 2012 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Systematic reviews search on LTCs 
from Medline: n=25 
EXCLUDED: n=16 
• 1 article excluded 
due to Duplicate: 
n=1 
• 10 articles excluded 
because it did not 
address 
effectiveness or 
cost-effectiveness 
or meet definition of 
telehealth used in 
the thesis; 
• 5 articles excluded 
due to limited 
information 
Systematic Reviews search on 
LTCs from Evidence Based 
Medicine Reviews Full Text Multi-
file Database: n=12  
 
EXCLUDED: n=8 
• 6 articles were 
excluded because 
they were RCTs;  
• 2 article excluded 
due to limited 
information 
 
INCLUDED: n=9 INCLUDED: n=4 
Total systematic review articles on LTCs included: n=13 
(Including systematic review articles on COPD: n=3) 
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Figure 4.2b: (Updated search) Selection process of systematic review 
articles on telehealth:  
Update from 2012 to 2015 (11 July 2015) 
 
 
 
 
 
Technology Enabled 
Care Services (TECS) 
Evidence Databases: 
n=345 
Web of Science 
databases: 
n=30 
Cochrane 
Database of 
Systematic 
Reviews: n=2 
Level 1: Identification 
Level 2: Screening 
Level 3: Quality assessment 
Level 4: Inclusion 
n=377 
Duplicates: n=8 
Screening based on 
title and abstract: 
n=369 
Full-text assessed 
for eligibility: n=14 
Excluded articles:  
• n=2 not related 
to effectiveness 
nor cost-
effectiveness; 
• n=1 did not 
conform with 
the definition of 
telehealth used 
in the thesis 
Included in the SR: 
n=11 LTCs 
(including 2 COPD) 
Excluded: n=355 
Included in meta-
analysis: n= N/A 
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The updated literature found 377 potential systematic review articles, and 11 
systematic reviews were included in the appraisal that related to all long 
term conditions (LTCs), including two articles that focused on COPD (Figure 
4.2b). The two articles on COPD were appraised in the relevant section of 
the chapter for COPD, while the 9 articles were assessed under the section 
on LTCs.  
The original (n=13) and the updated literature search (n=11) made up a total 
of 24 systematic review articles that were included in the review on 
effectiveness and cost-effectiveness of telehealth service. The updated 
literature search was used to update the original literature review findings 
and adjust the overall conclusions of the chapter in light of most recent 
evidence. 
The qualities of the nine systematic reviews are shown in Table 4.2. 
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Table 4.2: Summary of appraisal of systematic review articles on effectiveness and cost-effectiveness of telehealth for patients with 
LTCs (excluding COPD): based on updated literature search 
 Systematic review articles and their appraisal scores: 2 = Yes; 1 = somewhat; 0 = No or can’t tell) 
QUESTIONS (Purcell et 
al., 2014); 
(Pando
r et al., 
2013); 
(Laver et 
al., 2013) 
(Kotb et 
al., 2015) 
(Bergmo, 
2014) 
(Merriel 
et al., 
2014) 
(Kitsiou 
et al., 
2015) 
(Huang 
et al., 
2015) 
(Xiang 
et al., 
2013) 
REVIEW FOCUS          
1. Did the review address a clearly 
focussed issue?  
2 2 2 2 2 2 1 2 2 
2. Did the review assess a clearly 
focussed technology? 
2 2 1 2 1 1 1 1 1 
3. Did the authors look for the 
appropriate sort of papers? 
2 2 2 2 1 2 2 2 1 
VALIDITY OF REVIEW RESULTS          
4. Do you think the important, 
relevant studies were included? 
1 2 1 2 2 1 1 1 2 
5. Did the review’s authors do 
enough to assess the quality of 
the included studies? 
2 2 2 2 1 2 1 2 1 
6. Were the studies accurately 
described? 
2 2 2 2 2 2 2 1 2 
7. Are the results of individual 
studies reported in a clear and 
meaningful way or just listed with 
no real flow? 
2 2 1 1 2 2 2 2 2 
8. If the results of included have 
been combined, was it reasonable 
to do so? (overall result presented 
from more than one study or 
0 1 1 1 0 2 1 2 2 
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 Systematic review articles and their appraisal scores: 2 = Yes; 1 = somewhat; 0 = No or can’t tell) 
QUESTIONS (Purcell et 
al., 2014); 
(Pando
r et al., 
2013); 
(Laver et 
al., 2013) 
(Kotb et 
al., 2015) 
(Bergmo, 
2014) 
(Merriel 
et al., 
2014) 
(Kitsiou 
et al., 
2015) 
(Huang 
et al., 
2015) 
(Xiang 
et al., 
2013) 
meta-analysis) 
9. Did the review demonstrate 
awareness of its own limitations? 
2 2 1 0 2 2 1 1 0 
RESULTS          
10. Does the review present an 
overall result? 
 
0 2 1 2 0 2 1 2 2 
11. How precise are the results? 0 1 2 2 1 2 2 2 2 
APPLICABILTY          
12. Implications for policy makers and 
or those considering implementing 
such technologies? Appropriate 
based on findings? 
2 2 0 1 1 1 1 2 2 
13. Are the results generalisable 
beyond the confines of the setting 
in which the work was originally 
conducted? 
1 1 0 1 1 1 0 1 1 
14. Were all important outcomes 
considered? 
1 1 1 1 1 1 1 1 1 
15. Are you able to assess the benefit 
versus harm and costs? 
2 2 1 1 1 1 1 1 1 
CASP Total Score (%) 21/30 
(70.0) 
26/30 
(93.3) 
17/30 
(56.7) 
22/30 
(73.3) 
18/30 
(60.0) 
24/30 
(80.0) 
19/30 
(63.3) 
23/30 
(76.7) 
22/30 
(73.3) 
Note: A study with a total score of <60.0% was considered of low quality; 60.0 – 74.0% was moderate; and 75.0% or more was high quality. 
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4.3.1.1 Telehealth and LTCs 
The findings from systematic review articles on effectiveness and cost-
effectiveness of telehealth varied. A systematic review of systematic reviews 
published in 2011 included 162 articles published between 1997 and 2010 
(Sheikh et al., 2011). The main conclusion was that there was limited evidence 
of effectiveness of e-Health for improving patients’ outcomes. For specific 
disease areas, the authors found that telehealth was effective in reducing 
hospital admissions in cases with severe asthma, severe COPD, and diabetes. 
For severe cases of asthma, the odds ratio (OR) for hospital admission over 12-
months period was reported to be 0.21 (95% CI: 0.07, 0.61); significantly lower 
hospital admissions among users of telehealth compared to the control group. 
The evidence around improving quality of life was found to be weak for patients 
with asthma [mean difference in Juniper’s Asthma quality of life of 0.08 (95% CI: 
0.01, 0.16); minimum clinical importance difference was 0.5]. Similarly, the case 
for cost-effectiveness of telehealth was uncertain (Sheikh et al., 2011).  The 
authors also reported that many patients were satisfied with telehealth, and 
patients accepted telehealth more readily if it was offered in addition to face-
face consultations rather than instead of it. Another review found that the levels 
of patients’ satisfaction with telehealth were consistently well over 80% and 
frequently at 100% when the relationships between patients with staff were 
explored. Satisfaction was also high among patients on how they felt about 
consultation with staff, including the technical aspects of telehealth (Williams et 
al., 2001).  
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Ekland and colleagues (2010) also undertook a systematic review of reviews, 
which involved 80 review articles published between 2005 and 2009. They 
appeared to have posed a focused question to conduct a review of reviews on 
the impacts and cost of telehealth services. The definition that they used for 
what constituted telehealth was broad, and it included all information and 
communication technologies (ICT) used in health care and internet-based 
interventions for health and social care. As a consequence, the reviews were 
heterogeneous in nature, and they were unsuitable for combination in a forest 
plot. The qualities of many studies included were low, and limited information on 
CASP total scores was presented. Of the 61 articles assessed by the authors, 
they found 20 (32.7%) review articles which concluded that telehealth was 
effective,19 (31.1%) studies found the evidence of telehealth to be promising 
but inconclusive, and 22 (36.1%) which concluded that there was limited and 
inconsistent evidence of the effectiveness of telehealth (Ekeland et al., 2010). 
The disease areas covered in the systematic reviews included chronic heart 
failure, respiratory conditions (i.e., COPD and asthma) and diabetes. From this 
systematic review (Ekeland et al., 2010), it can be deduced that there was  
mixed effectiveness of telehealth for managing patients with LTCs, with some 
limited evidence of effectiveness of telehealth service. The authors 
recommended that future studies should focus on the themes of economic 
analyses, patients’ perspectives, larger studies such as controlled interventions, 
and to consider telehealth interventions to be complex interventions.  
A Cochrane systematic review on asthma found that telehealth resulted in non-
significant increase in the odds of emergency department visits over a 12-
months’ period, with odds ratio (OR) of 1.16 (95% CI: 0.52, 2.58) (McLean et 
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al., 2010). The authors found a significant reduction in hospital admission over a 
12-months’ period: OR 0.21 (95% CI: 0.07, 0.61). This review asked a focused 
question: “to assess the effectiveness of telehealth interventions in people with 
asthma”. The study was well conducted, with clear inclusion and exclusion 
criteria. It contained tests for heterogeneity, based on meta-analysis results, 
and it showed that the key studies upon which the main conclusions were 
drawn were homogeneous. The application of findings to other settings 
remained questionable due to a number of factors, including the precise nature 
of the interventions used, the local contexts, and the challenges posed by 
complex interventions. 
4.3.1.2 Telehealth and cardiovascular disease / heart failure 
A meta-analysis of telehealth interventions for patients with heart failure found 
risk ratio (RR) compared to usual care for all-cause mortality to be 0.66 (95% 
CI: 0.5, 0.81); all-cause hospital admission RR was 0.91 (95% CI: 0.84, 0.99); 
and the RR for hospital admission related to chronic heart failure was 0.79 (95% 
CI: 0.76, 0.94) (Anker et al., 2011). The authors reviewed 11 RCTs, involving 
2710 participants in the review. The findings in the meta-analysis were similar to 
that carried out by Inglis and colleagues (2010) on patients with heart failure 
who reviewed 25 RCTs involving 8,323 participants (Inglis et al., 2010).  
Another systematic review consisting of 13 reviews assessed the effectiveness 
of telemonitoring for managing patients with cardiovascular disease (Purcell et 
al., 2014). The systematic review was of a high quality (total appraisal score of 
75%), and the authors’ assessment showed that  9 out of the 13 articles 
reviewed were considered to be Level 1 in the hierarchy of evidence 
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(systematic review of RCTs). The main outcomes measures of the systematic 
review were: (1) blood pressure and medication used as a marker of 
hypertension management; and (2) mortality, hospital admissions, quality of life, 
cost, and acceptability of telehealth for heart failure. The authors reported that 
all the review articles found benefits associated with telemonitoring, although 
the level of benefit varied, and none of them reported negative effects of 
telemonitoring or harm to patients. The authors concluded that telemonitoring 
had the potential to reduce the burden related to hypertension and heart failure 
in primary care. The main limitations of the review were that the outcomes 
measured varied among studies; the definitions of telemonitoring also differed 
from one study to the other, and as the review focused only on systematic 
reviews, some large trials were reported to have been excluded. The excluded 
trials might have negative results, posing potential source of bias. The review 
recommended that future research needed to investigate how and why 
telemonitoring interventions work to improve health outcomes (Purcell et al., 
2014). 
The effectiveness of telehealth in primary prevention of cardiovascular disease 
(CVD) in the community was assessed in a separate systematic review by 
Merriel et al. (2014). The review involved 13 trials with a combined total of 
10,057 participants. They found no clear evidence of overall risk reduction 
(based on Framingham 10-year CVD risk) among patients on telehealth 
intervention (standard mean difference of -0.37%, 95% CI: -2.08%, 1.33%). 
Similarly, there were no statistically significant differences in reduction of 
individual risk factors for systolic blood pressure, total cholesterol, high density 
lipoprotein, and smoking between the telehealth and the control groups. The 
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telehealth interventions used varied, and most of the studies were conducted in 
setting in developed countries, hence their generalisation to low- and 
developing countries were limited. 
Meanwhile, a Health Technology Assessment report published in 2013 
examined clinical effectiveness and cost-effectiveness of home telemonitoring 
for heart failure patients who were recently discharged from hospital (Pandor et 
al., 2013). They found a statistically non-significant benefit of remote monitoring 
during office hours in reducing all-cause mortality by 24% (hazard radio [HR] of 
0.76, 95% credible interval (CrI): 0.49, 1.18); and by 51% when monitored 24 
hours per day, seven days a week (24/7), HR 0.49, 95% CrI: 0.20, 1.18). 
Similarly, there were non-statistically significant reductions in all-cause hospital 
admissions observed in telemonitoring group with medical support during office 
hours by 25% (HR 0.75, 95% CrI: 0.49, 1.10) and by 19% (HR 0.81, 95% CrI: 
0.33, 2.00) when monitored 24/7. No change was observed for patients who 
received usual care (structured telephone support): HR 1.06, 95% CrI: 0.44, 
2.53). Findings on cost-effectiveness are separately presented in the relevant 
Sub-section 4.3.1.5.  
Xiang et al. (2013) undertook a meta-analysis to examine the effectiveness of 
telehealth for patients with chronic heart failure (CHF). They identified 33 trials 
with a combined total of 7530 participants. The main findings of the meta-
analysis were that there was a reduction in all-cause mortality (relative risk [RR] 
of 0.76, 95% CI: 0.66, 0.88); hospital admissions related to CHF (RR 0.76, 95% 
CI: 0.61, 0.85) and length of hospital stay (-1.41, 95% CI: -2.43, -0.39). The 
meta-analysis was judged to be of a moderate quality (73.3%). The telehealth 
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technologies used in this review appeared to be broadly similar. It was difficult 
to generalise the findings of the review beyond limited developed countries such 
as US, UK, and a few European countries where the original individual studies 
were conducted. 
Comparative effectiveness of different forms of telehealth interventions was 
undertaken involving 30 trials with a total of 10,193 participants (Kotb et al., 
2015). Kotb and colleagues found that telemonitoring reduced the odds of all-
cause mortality (Odds Ratio [OR] 0.80, 95% CI: 0.66, 0.96); and hospital 
admissions due to heart failure (OR 0.64, 95% CI: 0.39, 0.95) when it was 
compared to usual care. The authors also found that using electrocardiographic 
data also significantly reduced hospital admissions due to heart failure (OR 0.7, 
95% CI: 0.52, 0.98). The study was considered to be of a moderate quality 
(73.3%).  
Kitsiou et al. (2015) undertook a systematic review with a meta-level synthesis 
to determine the effectiveness of home telemonitoring for patients with heart 
failure. They found reduction in all-cause mortality among intervention groups 
(RR ranged from 0.64 to 0.86) compared to usual care. The effects were 
statistically significant among heart failure patients who were stable and had 
been recently discharged from hospital within 28 days for all-cause mortality 
(RR 0.66, 95% CI: 0.54, 0.81); and all-cause hospital admissions (RR 0.67, 
95% CI: 0.42, 0.97). However, the qualities of the individual studies included in 
the review were low. Kitsiou (2015) argued that future research agenda on 
telehealth should move away from whether or not it was effective, to addressing 
what features of telehealth were considered to be effective, for which patients, 
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under what circumstances, how long and why. They supported further research 
into how and why telehealth worked or not in particular context, and the 
interaction of human behaviour and outcomes of telehealth. 
4.3.1.3 Diabetes 
The effects of telehealth for the glycaemic control among patients with type 2 
diabetes was investigated in a systematic review involving 18 trials and 3798 
participants (Huang et al., 2015). Four of the articles were assessed as being of 
high quality, nine were moderate, and five were low. The authors found that 
there was a mean reduction of HBA1c, a measure of glycaemic control, by -0.54 
(95% CI: -0.75, -0.34; p<0.005). However, the findings may not be 
generalisable to non-Asian settings, as the trials included were mainly from 
Asia, and there was limited description of telehealth interventions that were 
used.  
4.3.1.4 Stroke 
A Cochrane systematic review assessed the effectiveness of tele-rehabilitation 
service for managing patients with stroke in order to improve their ability to 
perform activities of daily living (Laver et al., 2013). The review included 10 
trials, which had a total of 993 participants. The authors found no improvement 
in activities of daily living among the intervention groups using tele-rehabilitation 
compared to usual care (standard mean difference of 0.00, 95% CI: -0.15, 
0.15). The review is of a moderate quality and includes studies that were 
considered by the authors to be of poor quality and heterogeneous. The 
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intervention used in the trials varied, making generalisation of the findings 
difficult.  
4.3.1.5 QALYs and cost-effectiveness 
One systematic review study involving patients with diabetes concluded that 
telehealth had the potential to be  cost-effective for delivering diabetic 
retinopathy screening (Jones and Edwards, 2010). However, the review was not 
able to present cost comparison figures in a meta-analysis, and the poor 
methodologies of the studies that were reviewed limited the generalisation of 
the findings. Meanwhile, Polesena and colleagues (2009) undertook an 
economic evaluation of telehealth in the management of chronic diseases 
based on published studies between 1998 and 2008, involving 22 studies 
(including 6 systematic reviews) and 4871 patients. They concluded that 
telehealth had the potential to reduce  costs (Polisena et al., 2009).  Due to the 
methodological limitations of the studies included, the authors concluded that 
the evidence available was only suggestive of cost-effectiveness of telehealth. 
An earlier systematic review (2002) was not able to find evidence to establish 
cost-effectiveness of telehealth because none of the studies reviewed 
undertook cost utility analysis (Whitten et al., 2002). 
Studies on quality adjusted life-years (QALYs) are limited in the published 
literature in relation to telehealth. Bergmo (2014) undertook a systematic review 
to examine QALYs and cost-effectiveness. The review included 17 economic 
evaluation studies that measured outcomes using a range of quality of life tools: 
EuroQol-5D (EQ5D), SF-6D, Quality of Wellbeing (QWB), and Health Utility 
Index (HUI). The review found small but positive gain in mean QALYs 
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associated with the use of telehealth (range: 0.001 to 0.118). However, the 
findings on cost-effectiveness was mixed; with six studies reporting statistically 
significant benefit of cost-effectiveness, three studies did not find QALYs gained 
to be statistically significant, four studies did no report confidence intervals nor 
p-values, and three did not report differences in QALYs. 
A Health Technology Assessment (HTA) systematic review of cost-
effectiveness of telehealth published in 2013, found that telemonitoring during 
office hours was cost-effective compared with usual care; with an estimated 
incremental cost-effectiveness ratio (ICER) of £11,873 per quality adjusted life 
years (QALY) compared to £228,035 per QALY for usual care (structured 
telephone support human-to-human contact) (Pandor et al., 2013). In the UK, 
the threshold set by the National Institute for Health and Care Excellence 
(NICE) for determining an intervention to be cost-effective was £20,000 to 
£30,000. Below this threshold, an intervention is considered to be cost-effective, 
while those above this are deemed as not cost-effective. The review was 
appraised as being of high quality (26/30, 90.3%). However, the interventions 
used in the study varied. In addition, the cost-effectiveness was based on 
assumption that the cost assumption was constant over time, this might not be 
the case as lessons from the WSD pragmatic trial showed that the first three 
months’ experience of hospital admission were different from the rest of the trial 
period (Steventon et al., 2012). 
A summary of assessment of confidence in the conclusions reached by the 
authors of the systematic reviews can be found in Table 4.3. 
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Table 4.3: Summary of evidence from systematic reviews on effectiveness and 
cost-effectiveness of telehealth for patients with LTCs (other than COPD)  
Author 
(year) 
Disease 
area 
Authors’ main conclusions % CASP 
Total Score 
(Max. = 30) 
Overall 
assessment 
(SIGN, 
2011)* 
Cardiovascular disease / heart failure systematic reviews 
(Purcell et 
al., 2014) – 
SR of SRs 
Cardiovascu
lar disease 
(CVD) 
Telemonitoring had the potential 
to enhance primary care 
management of CVD by 
improving patient outcomes 
(blood pressure, all-cause and 
heart failure related hospital 
admissions, all-cause mortality, 
and improved quality of life) and 
reducing health costs. 
70.0% 
(21/30) 
+ 
(Merriel et 
al., 2014) 
Cardiovascu
lar disease 
There was some evidence 
suggesting that telehealth might 
be effective in reducing specific 
individual risk factors for CVD. No 
strong evidence for the 
effectiveness of multifactorial 
telehealth programmes for 
primary prevention. 
80.0% 
(24/30) 
+ 
(Xiang et 
al., 2013) 
Chronic 
heart failure 
(CHF) 
Telehealth demonstrated clinical 
effectiveness in reducing all-
cause mortality, CHF-related 
hospital admissions and length of 
stay. 
73.3% 
(22/30) 
++ 
(Kotb et 
al., 2015) 
Heart failure Structured telephone support and 
telemonitoring significantly 
reduced the odds of deaths and 
hospital admissions due to heart 
failure. 
73.3% 
(22/30) 
++ 
(Kitsiou et 
al., 2015) 
Heart failure Home telemonitoring intervention 
improved survival rates and 
reduced risk of heart failure-
related hospital admissions. 
63.3% 
(19/30) 
 
- 
 
(Pandor et 
al., 2013) 
Heart failure There was statistically non-
significant reduction in all-cause 
mortality; and cost-effectiveness 
analyses suggested that home 
telemonitoring during office hours 
was an optimal strategy. 
90.3% 
(26/30) 
++ 
Miscellaneous 
(Huang et 
al., 2015) 
Diabetes Telehealth showed significant 
improvement in glycaemic control 
in type 2 diabetes. 
76.7% 
(23/30) 
+ 
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Author 
(year) 
Disease 
area 
Authors’ main conclusions % CASP 
Total Score 
(Max. = 30) 
Overall 
assessment 
(SIGN, 
2011)* 
(Laver et 
al., 2013) 
Stroke There was insufficient evidence of 
effectiveness of tele-rehabilitation 
for managing patients with stroke 
56.7% 
(17/30) 
- 
(Bergmo, 
2014) 
QALYs There was small but positive gain 
in QALYs; and mixed evidence of 
cost-effectiveness. 
60.0% 
(18/30) 
- 
*Note: 
++ All or most of the criteria have been fulfilled. Where they have not 
been fulfilled the conclusions of the study or review are thought very 
unlikely to alter. 
+ Some of the criteria have been fulfilled. Those criteria that have not 
been fulfilled or not adequately described are thought unlikely to 
alter the conclusions. 
- Few or no criteria fulfilled. The conclusions of the study are thought 
likely or very likely to alter. 
 
4.3(1b.ii) Update from WSD pragmatic RCTs 
The WSD was the largest RCT undertaken in England at the time of writing this 
thesis. The objective of the RCT was to assess the effectiveness of telehealth 
services. Four of the published papers from the WSD pragmatic trials are 
reviewed here. The papers addressed the effectiveness of telehealth in relation 
to hospital admissions and mortality (Steventon et al., 2012), impact on quality 
of life (Cartwright et al., 2013), cost-effectiveness (Henderson et al., 2013), and 
effects on patients with type 2 diabetes (Steventon et al., 2014) . All the trials 
were individually appraised using CASP tool designed for trails.  
The WSD study, Steventon et al. 2012, had 3,230 participants with LTCs that 
consisted of 1,525 COPD patients (47.2%), the rest being patients with diabetes 
or heart failure. The telehealth interventions used in this study included pulse 
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oximeter, glucometer, weighing scales, and symptom questions. The study 
design used cluster randomisation, with GP practices as units of randomisation. 
The authors admitted there was the possibility of selection bias due to 
awareness by recruiters of allocation groups. Although the authors aimed for 
comparable baseline characteristics of their participants, in practice, the 
intervention groups were younger, and had fewer patients with COPD and heart 
failure. Emergency admissions at baseline, prior to start of telehealth, were 
fewer in the intervention group than they were in the control group and this 
persisted into the first quarter of the trial.  
If the first quarter findings of the study were to be excluded in the analyses, the 
authors noted that none of the main outcome findings of the study would have 
been statistically significant. The patients and staff were not blind to the trial 
intervention. The study found a statistically significant reduction in hospital 
admission in favour of the intervention group with an odds ratio (OR) of 0.82 
(95% CI: 0.70–0.97, p=0.017), which was just at the statistically significant 
margin; and mortality was 4.6% in intervention group versus 8.3% in the control 
group (OR=0.54, 95% CI: 0.39–0.75), significantly lower in the intervention 
group. There was no statistically significant cost difference between the groups, 
although some marginal benefit was attributed to the intervention group.  
Findings from a cost-effectiveness study showed that the incremental cost per 
quality adjusted life years (QALY) was £92,000, which was well above the 
recommended NICE upper threshold of £30,000 per QALY (Henderson et al., 
2013). It was unclear how data was handled in the analysis stage for some 
patients, as the authors noted that 17 patients were randomised into usual care 
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but ended up receiving telehealth; while 6 patients who were randomised into 
telehealth did not receive telehealth service (Henderson et al., 2013).  
Similarly, the WSD trial that examined the effects of telehealth on quality of life 
and psychological outcomes found no significant difference between the two 
arms of the trial (Cartwright et al., 2013). The interventions used and how they 
were implemented varied in the three trial sites in England, depending on the 
patients’ clinical condition and clinician assessment. The authors used generic 
quality of life measures, but could have considered using some specific disease 
quality of life measures such as those for heart failure (Minnesota Living with 
Heart Failure) and COPD (St George’s Respiratory Questionnaire).  
One of the most recent papers from the WSD pragmatic trial, published in 2014, 
reported the effects of telehealth on glycaemic control for patients with type 2 
diabetes (Steventon et al., 2014). It found that the level of glycaemic control 
was 0.21% lower in patients who were in the telehealth group than those in 
usual care (95% CI: 0.04%, 0.38%; p = 0.013). The authors acknowledged that 
improvement was modest but conceded that it was unlikely to produce 
significant patients benefit. There were 513 patients in the trial with type 2 
diabetes and 300 of them were selected for the intervention. There was 
potential for selection bias and not all patients’ characteristics were similar 
between the two arms of the trial in respect of sex, age, and prior medication 
prescription experience. 
A summary of the scores of the trials from the WSD project are shown in Table 
4.4. 
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Table 4.4: Summary of appraisal score of trials on telehealth against CASP tool 
for appraising RCTs:  
The effects on health outcomes for patients with LTCs. 
Questions Score: 2 = Yes; 1 = Somewhat; 0 = No or can’t 
tell. 
Trial 1: 
(Steventon 
and 
Bardsley, 
2012) 
Trial 2: 
(Cartwrig
ht et al., 
2013) 
Trial 3: 
(Henderso
n et al., 
2013) 
Trial 3: 
(Stevent
on et al., 
2014) 
(A) Are the results of the review 
valid? 
    
1. Did the trial address a clearly 
focused issue? 
2 2 2 2 
2. Was the assignment of patients 
to treatments randomised? 
1 2 1 2 
3. Were all of the patients who 
entered the trial properly 
accounted for at its conclusion? 
2 2 1 2 
Is it worth continuing? Yes Yes Yes Yes 
Detailed questions     
4. Were patients, health workers 
and study personnel ‘blind’ to 
treatment?  
1 0 1 1 
5. Were the groups similar at the 
start of the trial? 
2 2 2 1 
6. Aside from the experimental 
intervention, were the groups 
treated equally? 
1 2 1 2 
(B) What are the results?     
7. How large was the treatment 
effect? 
1 2 2 1 
8. How precise was the estimate of 
the treatment effect?  
2 2 1 2 
(C) Will the results help locally?     
9. Can the results be applied in 
your context? (Or to the local 
population?) 
1 1 1 1 
10. Were all clinically important 
outcomes considered?  
1 1 2 1 
11. Are the benefits worth the harms 
and costs?  
1 0 2 1 
TOTAL SCORE: Maximum: 2 x 11= 
22 (%) 
15 
(68.2%) 
16  
(72.7%) 
15  
(68.2%) 
16/22  
(72.7%) 
Note: All the four trial articles were from WSD project. 
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Synthesis of trials on telehealth and its effects on patients with LTCs is 
summarised in Table 4.5. 
Table 4.5: Synthesis of trials involving telehealth for patients with LTCs 
Trial 
reference, 
country, and 
sample size 
Main conclusions, Intervention and 
duration 
Total 
CASP 
score 
Overall 
assessment 
(SIGN, 
2011)* 
(Steventon et 
al., 2012) – 
WSD, UK, 
n=3230 
Conclusions: Telehealth was 
associated with lower mortality and 
emergency admission rates (for patients 
with COPD, heart failure, and diabetes).  
Intervention: pulse oximeters, 
glucometer, weighing scales. Duration: 
12 months. 
15/22 
(68.2%) 
+ 
(Henderson et 
al., 2013), UK, 
n=1573 
Conclusions: Telehealth did not seem 
to be cost-effective addition to standard 
support and treatment for patients with 
COPD, heart failure, and diabetes (cost 
per QALY was £92,000). The probability 
for achieving cost-effectiveness was 61% 
(at £30,000 per QALY – NICE threshold 
for cost-effectiveness) if the cost of the 
equipment were to reduce and there was 
increased working capacity.  
Intervention: pulse oximeters, 
glucometer, weighing scales. Duration: 
12 months. 
15/22 
(68.2%) 
+ 
(Cartwright et 
al., 2013), UK, 
n=1573 
Conclusions: Home based telehealth 
did not improve quality of life or 
psychological outcomes for patients with 
COPD, diabetes, or heart failure over 12 
months. The findings suggested that 
concerns about potentially deleterious 
effect of telehealth were unfounded for 
most patients. Intervention: pulse 
oximeters, glucometer, weighing scales. 
Duration: 12 months. 
16/22 
(72.7%) 
+ 
(Steventon et 
al., 2014) 
Conclusion: Telehealth led to modest 
improvement in glycaemic control among 
people with type 2 diabetes, as 
measured by HbA1c, over 12 months. 
Intervention: glucometer 
16/22  
(72.7%) 
+ 
*Note: + = some of the criteria have been fulfilled. Those criteria that have not 
been fulfilled or not adequately described are thought unlikely to alter the 
conclusions. 
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In conclusion, the evidence from the WSD pragmatic trials showed that 
telehealth services appeared to be effective in reducing hospital admissions. 
However, the trial found that overall telehealth was not cost-effective, and it did 
not improve quality of life of patients with LTCs. The study suggested that the 
concerns about the deleterious effects of telehealth were unfounded. The trials 
also suggested that telehealth was associated with a modest reduction in 
mortality rates among patients with LTCs. Telehealth had limited effects in 
improving glycaemic control among patients with diabetes. 
4.3(1c.i)  Headline findings related to LTCs 
Table 4.5 provides a summary of the evidence on effectiveness and cost-
effectiveness of telehealth (headline findings described in Figure 4.1, Box 1c.i.).  
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Table 4.5: Summary of evidence of effectiveness of telehealth 
Outcome measures   Long-term conditions   
 SRs RCTs: 
WSD 
Overall 
assessment 
 
(1) Hospital 
admissions 
 Reduced only for 
some LTC 
(COPD, diabetes, 
and heart 
disease) 
Reduced  Limited 
evidence 
 
(2) Quality of life  Limited effect No effect No effect  
(3) Mortality  Reduced 
mortality for 
COPD, and 
diabetes, and 
heart failure 
Reduced Limited 
evidence 
 
(4) Cost-
effectiveness 
 Mixed Not cost-
effective 
Not cost-
effective 
 
(5) Patients' 
satisfaction 
 Satisfied Satisfied Satisfied  
(6) Clinical 
markers: e.g. 
HBA1c, BP, and 
cholesterol 
  Improved Improved Improved  
(7) Use of health 
and social care 
services 
   n/a No effect No effect   
 
The syntheses of the evidence from systematic reviews and update from WSD 
pragmatic trial, suggest that there was some evidence of effectiveness of 
telehealth in reducing hospital admissions and mortality among patients with 
some LTCs, such as, heart failure, diabetes, asthma, and COPD. Telehealth 
had limited impact on quality life but patients appeared to be generally satisfied 
with it. The evidence on cost-effectiveness of telehealth was mixed. However, 
there were technical issues related to different interventions, outcome 
measures, and variation in quality of the studies appraised in the systematic 
reviews. These pose some limitations in generalising the findings of the articles. 
119 
 
 
4.3(1b.iii and 1c.ii) Systematic reviews focusing on evidence of 
effectiveness and cost-effectiveness of telehealth service for 
patients with COPD 
There were a total of six systematic review articles on COPD; four from the 
original literature search, and two from updated search. Five of the systematic 
reviews were quantitative and dealt with the effectiveness of telehealth services. 
They are reviewed in this section. 
One systematic review article was a qualitative study, and it was about 
implementation of telehealth. The qualitative paper is appraised under the 
Section 4.3(2) related to the implementation of new technology. 
4.3(1c.iii) Summary of evidence from systematic review and COPD 
A summary score of the appraisal of the quantitative systematic reviews are 
shown in Table 4.6 below. 
120 
 
 
Table 4.6: Summary of systematic reviews on effectiveness of telehealth for 
patients with COPD 
Author 
(year) 
Authors’ main conclusions CASP Total 
Score (Max. 
= 30) 
Overall 
assessment 
(SIGN, 
2011)* 
(McLean et 
al., 2011) 
Telehealthcare in COPD appeared 
to have an impact on the quality of 
life of patients and the number of 
times patients attended emergency 
departments. Telehealth made no 
difference to mortality rates. 
22/30 (73%) + 
(Polisena 
et al., 
2009) 
Telehealth had the potential to 
reduce costs, but its impact from a 
societal perspective was uncertain. 
17/30 (57%) + 
(Polisena 
et al., 
2010) 
Home telehealth was found to 
reduce rates of hospitalisation and 
emergency department visits; 
mortality rates were greater in the 
telehealth group. 
18/30 (60%) + 
(Cruz et 
al., 2014) 
There was limited evidence of the 
effectiveness of home telemonitoring 
to reduce healthcare utilisation and 
improve health-related outcomes in 
patients with COPD (Cruz et al., 
2014). 
12/30 (40%) - 
(Udsen et 
al., 2014) 
Lower average cost per patients was 
found in the telemonitoring group 
compared to usual care, but the 
quality of studies was poor. 
21/30 (70%) + 
*Note: 
+ Some of the criteria have been fulfilled. Those criteria that have not 
been fulfilled or not adequately described are thought unlikely to 
alter the conclusions. 
- Few or no criteria fulfilled. The conclusions of the study are thought 
likely or very likely to alter. 
(1) Effectiveness of telehealth for patients with COPD  
McLean et al. (2011) undertook a Cochrane systematic review of telehealth 
services for patients with COPD. The authors found clinically significant 
increases in quality of life, as measured by St Georges Respiratory 
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Questionnaire (SGRQ),  [mean difference of -6.57 (95% CI: -3.62, 0.48); 
minimum clinically significant difference was defined as a change of -4.0] 
(McLean et al., 2011). It can be noted that the 95% CI of mean difference in 
quality of life suggested that telehealth made no difference in quality of life. The 
review also showed that there was significant reduction in hospital emergency 
department attendance over 12 months period (odds ratio (OR) of 0.27 (95% 
CI: 0.11, 0.66)); and an odds ratio for more than one hospital admission within 
12 months was 0.46 (95% CI: 0.33, 0.65). Mortality was not found to be 
statistically different between the intervention and controlled groups: OR=1.05 
(95% CI: 0.63, 1.75). The review found that patients were generally satisfied 
with telehealth services.  
The number of studies included was 21, representing 1,004 patients. The main 
limitation of the review is that the definition of telehealth used varied and it 
encompassed various interventions e.g. telephone, videoconferencing, and 
‘store and forward’ technologies (spirometry). This poses a challenge in 
comparing the effects of the studies to the interventions used. An assessment 
against the CASP systematic review criteria shows that the review overall score 
was 22/30 (73%) – moderate quality, as shown in Table 4.7. An example of the 
appraisal of the review against the appropriate CASP tool is shown in Annex 1.2 
(McLean et al., 2011). Similar appraisals were undertaken for all the systematic 
reviews.  
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Table 4.7: Summary score of systematic reviews on COPD studies 
QUALITY ASSESSMENT QUESTIONS Systematic reviews reference number 
(see below) and their appraisal scores 
(keys): 2 = Yes, 1 = Somewhat; 0 = No 
or can’t tell 
1 2 3 4 5 
REVIEW FOCUS      
1. Did the review address a clearly 
focussed issue?  
2 1 2 2 2 
2. Did the review assess a clearly 
focussed technology? 
1 1 2 1 1 
3. Did the authors look for the appropriate 
sort of papers? 
2 2 2 1 1 
VALIDITY OF REVIEW RESULTS      
4. Do you think the important, relevant 
studies were included? 
2 2 2 1 1 
5. Did the review’s authors do enough to 
assess the quality of the included 
studies? 
2 2 2 2 1 
6. Were the studies accurately described? 1 1 1 2 2 
7. Are the results of individual studies 
reported in a clear and meaningful way 
or just listed with no real flow? 
1 1 1 1 1 
8. If the results of included studies have 
been combined, was it reasonable to do 
so? (overall result presented from more 
than one study or meta-analysis) 
1 0 0 2 0 
9. Did the review demonstrate awareness 
of its own limitations? 
2 2 1 1 1 
RESULTS      
10. Does the review present an overall 
result? 
2 2 1 2 0 
11. How precise are the results? 2 0 1 2 0 
APPLICABILTY      
12. Implications for policy makers and or 
those considering implementing such 
technologies? Appropriate based on 
findings? 
2 1 1 1 0 
13. Are the results generalizable beyond 
the confines of the setting in which the 
work was originally conducted? 
0 0 0 1 0 
14. Were all important outcomes 
considered? 
1 1 1 1 1 
15. Are you able to assess the benefit 
versus harm and costs? 
1 1 1 1 1 
CASP TOTAL SCORE: 
numerator/denominator (%) 
22/30 
(73%)  
17/30 
(57%) 
18/30 
(60%) 
21/30 
(70%) 
12/30 
(40%) 
Note: References number: 1 = (McLean et al., 2011); 2 = (Polisena et al., 2009); 
3 = (Polisena et al., 2010); 4 = (Udsen et al., 2014); and 5 = (Cruz et al., 2014) 
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Polisena et al. (2010) reviewed evidence on the effectiveness of telehealth for 
patients with COPD. They included nine studies with a combined population 
858 patients. The review addressed a focused issue related to effectiveness of 
telehealth for patients with COPD, and it also focused on ‘second generation’ 
telehealth (similar to the type used in this thesis). Seven of the nine studies 
were RCTs, while the other two studies were observational studies (one 
prospective study and the other a pre-post study). 
The authors did not undertake a meta-analysis, given that they found variation 
in the characteristics of the control groups, study designs, and differing clinical 
outcomes. The findings on hospital admissions, based on two RCTs, showed 
that there were low proportions of hospitalisation in a group that received 
telephone support compared with  usual care: 46% versus 66%, p=0.003 in one 
study; and 32% versus 51%, p=0.01 in another study. On the other hand, the 
findings on bed-days of care were mixed, with some studies reporting low 
reduction following the intervention, while others reporting higher rates of bed 
days of care. Hospital emergency department visits were reported to be lower 
among the telehealth group than the group receiving usual care. Two studies 
did not find any difference in quality of life, while another two studies concluded 
that telehealth improved patients’ quality of life. 
Cruz et al. (2014) undertook a systematic review of effectiveness of home 
telemonitoring in reducing hospital admission and improving quality of life for 
patients with COPD. They analysed nine studies (7 RCTs and 2 non-RCTs) with 
varying duration of follow up ranging from two to 12 months. The quality of the 
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systematic review article was assessed as medium (70%) using critical 
appraisal score tool for systematic reviews. A meta-analysis found that the risk 
ratio of hospitalisation was statistically significantly lower, at 0.72 (95%CI: 0.53, 
0.98); p-value = 0.03; and the mean change in quality of life, as measured by 
St. George’s Respiratory Questionnaire, also showed statistically significant 
improvement: -0.53 (95% CI: -0.97, -0.09); p=0.02 (Cruz et al., 2014). The main 
limitations of the review were limited number of articles included in the review, 
and for those articles that were included; the studies were of small sample sizes 
ranging from 30 to 165 participants. The duration of the studies were also short: 
three articles followed patients for less than six months; five articles followed 
patients for 6-9 months; and one article managed to follow patients for 12 
months. On the basis of the findings of the review, there was limited evidence to 
support the use of home monitoring in routine practice. 
(2) Economic evaluation of telehealth and COPD 
A systematic review by Polisena et al (2009) assessed the cost-effectiveness of 
telehealth for patients with chronic disease, including COPD. The review 
identified 22 original studies (14 RCTs, four case-control studies, and four pre-
post studies), with a combined total number of 4871 participants. Only three of 
the studies focused on COPD patients. The technology assessed varied, and 
included telephone-based care, remote patient monitoring (vital signs 
monitoring), and video-based telecare. There were limited description of the 
technologies used, and no information on compliance. The findings of the 
review were heterogeneous, and therefore not combined, due to different 
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patients’ population groups, study designs, interventions, and comparison 
groups.  
The authors concluded that most studies found that telehealth saved costs, 
from the perspective of healthcare system and insurers, but they acknowledged 
the low quality of original studies. The findings could not be generalised due to 
the heterogeneity of the studies reviewed, different settings in which the studies 
were conducted, and different patient groups and interventions. There was 
limited information on benefits, harms and costs of telehealth reported by 
individual study authors. It was likely that some of the costs were not fully 
accounted for in the reviews, especially those from carers’ and patients’ 
perspectives, which were also important. CASP scores are shown in Tables 4.6 
and 4.7; it was scored as being of low quality (17/30 or 57%). 
Polisena et al. (2009) recommended that future cost-effectiveness studies into 
telehealth should consider including (1) events rates; and (2) deaths from long-
term conditions. While for short-term programmes, they proposed including 
surrogate markers of clinical outcomes such as glycaemic control (HbA1c) for 
diabetes; forced expiratory volume in one second (FEV1) for COPD; and 
systolic blood pressure for heart failure patients; or quality of life of patients. 
Meanwhile, Udsen et al. (2014) conducted a systematic review of cost and cost-
effectiveness of telehealth for patients with COPD. They reviewed six articles, 
consisting of a combine total of 559 patients. The articles included in the review 
were assessed by the authors to be of poor quality: five of the six articles were 
assessed as poor and one was considered to be of moderate quality. All the six 
articles included in the review reported lower average cost per patient among 
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those on telehealth compared to the usual care. Given the poor quality of the 
systematic review (overall appraisal score of 40%) the findings were not 
generalisable to inform routine healthcare practice. 
4.3(2) Implementation of new technology 
This section assesses the evidence drawn from systematic reviews related to 
factors influencing successful implementation and embedding of new 
technologies in routine practice.  
A systematic review undertaken by Bartoli et al. (2009) investigated the types of 
telemedicine applications and the related organisational models used and their 
impacts in embedding telehealth service in routine practice. The review included 
40 studies (16 quantitative and 24 qualitative studies). The review had a clear 
aim but did not provide details of how data were analysed, nor gave explicit 
descriptions of the methods used in the studies included in the review. Despite 
the above limitations of the review, the key findings summarised below were 
valuable in this thesis, in understanding issues related to implementation of new 
technologies and why they succeed or fail to embed in routine clinical practice.  
The review identified three layers of organisational relationships which could 
impact on the implementation of telehealth, and these involved (1) hospital 
specialist and primary care physicians; (2) clinical teams and patients; and (3) 
nurses and hospital specialists. The key organisational factors influencing 
implementation were (Bartoli et al., 2009): 
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• Tension in agreeing a common goal  (shared vision) between 
collaborative partners, between primary and secondary care and the 
need for shared vision and inter-agency working; 
• The need to re-design work programme to adapt to patients’ needs in the 
new technology service; 
• The difficulties of ‘mainstreaming’ a new service; 
• The effect of new technology on relationships between nurses and 
doctors; 
• The attitudes of clinical staff to the new technology, including their 
concerns about the safety of the equipment, and general confidence in it; 
• Technology being perceived as a threat.  It was sometimes thought to 
undermine the credibility of nurses, and might take over nursing tasks, 
and threatened jobs.  
The authors’ main conclusion was that technology might be regarded 
simultaneously as an opportunity and a threat. There was a need to reconsider 
organisational structures in order to realise the benefits of new technologies.  
Bartoli et al. (2009) suggested that areas for future research in the 
implementation of telehealth should focus on (1) redistributions of staff roles, (2) 
change of work processes, and staff productivity; and (3) performance 
introduced by different telehealth services. 
A systematic review of reviews by Sheikh and colleagues identified at least 16 
systematic reviews related to implementation and adoption of new technology in 
healthcare. They acknowledged the limited theoretical frameworks in the field of 
implementation of new technology; however, they highlighted the importance of 
128 
 
 
technical, human, and organisational factors. Based on the body of literature 
from systematic reviews, they concluded that the key factors for success or 
failure of implementation of new technological service depended on: (1) user 
involvement; (2) showing early benefit of the technology; (3) close fit with 
organisation priorities and process; (4) training and support; and (5) effective 
leadership, and change management (Sheikh et al., 2011). They recommended 
that there was a need for further research where the above factors could be 
addressed in contexts of organisations. A number of future research questions 
and further practical issues for implementation of new technology were 
identified by the authors. These included potential dependency on cold 
technology versus warm human interaction; ease of operation of the technology 
by patients and staff; and the issues of data generated, including security and 
privacy. They also raised practical issues related to the need for major changes 
to roles and responsibilities and work flows in healthcare organisations if new 
technologies were to be successfully implemented. The fear by health 
professional, such as doctors, of being sued for medical negligent was also 
highlighted as potential barriers, as the British Medical Association placed 
obligations for doctors to undertake physical examinations of their patients 
(Sheikh et al., 2011). 
The Norwegian Centre of Telemedicine carried out a systematic review to 
determine characteristics of successfully implemented telemedicine 
programmes, and it identified six main categories of factors of interests 
(Obstfelder et al., 2007). These were: (1) defining health needs and challenges; 
(2) recognising the benefit of telemedicine; (3) seeing it as a solution to political 
and/or medical issues (e.g. equal access to healthcare); (4) collaboration 
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between promoters and users; (5) addressing the issues regarding 
organisational and technical arrangements; and (6) considering the future 
operation of the service, including future financing of telehealth (Obstfelder et 
al., 2007).  
Gorst et al. (2014) undertook a systematic review of the barriers and facilitators 
of telehealth service which determined why patients with heart failure and 
COPD refused or withdrew from telehealth service. They found three main 
themes that explained barriers to implementation of telehealth service: (1) 
technology related (technical problems such as equipment failure, technology 
anxiety, and technical support that patients needed); (2) telehealth process 
(believing telehealth to be unnecessary, difficulty remembering – the need to 
remind patients, and repetitive process that users found boring or monotonous); 
and (3) healthcare services (patients preferred in-person care). On the other 
hand, the main themes that summarised facilitation of implementation of 
telehealth were: (1) health management (improved self-care, improved health 
knowledge, effective health management when patients perceived telehealth to 
save lives); (2) health services (improved access to care, feeling happy and 
confident with health professional advice, telehealth perceived to be better than 
in-person care); (3) patient variables (convenient, and peace of mind); and (4) 
technology-related where the patients found the technology to be easy to use. 
4.3(3) Failed randomised controlled trials 
Research has shown that a third of trials managed to recruit less than 75% of 
planned subjects; and that reluctance of clinicians was a greater obstacle to 
successful completion of trial than reluctance of patients (Rendell et al., 2007). 
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Rendell et al. (2007) investigated factors that were considered as incentives or 
disincentives to clinicians to participate in recruiting patients into trial studies. 
They found that motivation was more important than simply being acquainted 
with the researchers.  The review identified concerns expressed by clinicians 
about randomisation process, which was not considered to be selecting the 
intervention they perceived to be beneficial for their patients. The other factors 
hindering recruitment into trials were having too stringent criteria. Participation 
of academic research group was viewed to be a positive factor in helping to 
increase recruitment to research studies (Rendell et al., 2007). The authors also 
identified concern about damage to doctor-patient relationship which was 
considered to be a potential disincentive to participation in research.  
Further evidence from the literature to help understand why some trials fail to 
recruit participants to expected level came from the findings of a report by 
Health Technology Assessment or HTA (Campbell et al., 2007). The report 
examined factors associated with good and poor recruitment into multicentre 
trials. The authors found that of the 114 trials reviewed, less than one third 
(31%) successfully recruited participants to their original target. Factors 
identified for successful recruitment into trial are outlined in Table 4.8 (Campbell 
et al., 2007).  
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Table 4.8: Factors influencing successful recruitment into trials  
Having dedicated trial manager 
Being a cancer or drug trial 
Having intervention only available inside the trial 
Using newsletters and mailshots to communicate about the trial 
Trials addressing clinically important questions 
Investigators were held in high esteem 
Trials were grounded in existing clinical practice 
Need of patients were considered to be well served in the trial 
Clear delineation of roles, which released the research collaborators from 
workload related to the trial participation. 
Feelings of pride in taking part in the trial. 
Good ground work and excellent communication 
Training about trial intervention and processes 
Team building 
Trial flexible and robust enough to adopt to changes 
Funders monitoring progress of the trials 
Use of business model (framework) to recruit participants into the research: 
(i) building brand value; (ii) product and market planning; (iii) making the sale; 
and (iv) maintaining engagement. 
Source: (Campbell et al., 2007) 
A similar review of trials funded by both Health Technology Assessment and the 
UK Medical Research Council (MRC) between 2002 and 2008, found that 55% 
of trials managed to recruit to their original target, and 78% managed to recruit 
to 80% of their set target (Sully et al., 2013). The authors suggested that trials 
with power of 80% were less likely to achieve their recruitment target compared 
with those with 90% of power. 
The importance of conducting a formal pilot before undertaking an RCT is 
highlighted in a systematic review by McDonald et al (2006). The researchers 
found that in 53% of trials that had undertaken formal pilots, they resulted in 
changes to trial design, recruitment strategy, written materials to patients and 
staff, inclusion criteria, and recruitment targets (McDonald et al., 2006). They 
suggested strategies for  improving recruitment into trials, such as sending out 
newsletters, making regular contacts, producing information leaflets, changing 
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inclusion criteria or amending the research protocol, and doing presentations to 
appropriate target audient, among others (McDonald et al., 2006), see Table 
4.9.  
Table 4.9: The most common strategies for improving recruitment 
(McDonald et al., 2006) 
Strategies 
1) Newsletters, mail shots, flyers (to clinical staff and/or patients) 
2) Regular visits / phone calls to wards / sites / practices 
3) Posters / information leaflets in clinics / wards / notes 
4) Amending inclusion criteria and protocol 
5) Presentations to appropriate groups e.g. at consultant meetings /  
community based physiotherapists etc. 
6) Resource manual for site staff / trained staff in disease area / procedures 
being investigated / role play exercises / study day / workshops for 
recruiters 
7) Advertisement / articles in newspapers / journals; radio interviews  
8) Presentations at national / international meetings  
9) Employed extra staff  
10) Investigators' / recruiting staff meetings 
11) Training / information videos 
12) Incentives for recruiters e.g. prize draw, chocolates etc. 
13) Trial material revised / simplified / customised for specific sites 
14) Visits to centres by Principal Investigators / senior members of study 
group 
15) Repeated contact by phone or letter to individuals / sites 
16) Increased or changed time points when information provided to potential 
participants 
17) Supportive statements from opinion leaders 
 
Meanwhile, systematic review by Fletcher et al. (2012) identified the following 
specific actions that clinicians could do to improve recruitment into trials: using 
qualitative methods embedded in trials; communicating trial methods; educating 
staff and patients to remove any misunderstanding about trial methods; and 
finally reinforcing the benefits of trials to both staff and patients (Fletcher et al., 
2012). 
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A Cochrane review of strategies to improve recruitment to RCTs found three 
strategies to be statistically significant: (1) having telephone reminders to non-
responders (odds ratio 1.95; 95%CI: 1.04, 3.66); (2) using opt-out rather than 
opt-in recruitment approach (relative risk [RR] 1.39; 95% CI: 1.06, 1.84); and (3) 
open design of trial where participants knew which arm of the trial they would be 
(RR 1.22; 95% CI: 1.09, 1.36) (Treweek et al., 2011).  There were ethical issues 
related to the use of opt-in approach for recruitment but it was considered by 
the authors to be more acceptable when used to contact participants in order to 
obtain their consent rather than use it as a means to consent participants into 
trials. Similarly, the authors acknowledged potential for bias in adopting open 
design trials due to lack of blinding. The Cochrane review was appraised as 
being of high quality (total score of 23/30 or 76.7%). It included 45 eligible trails 
with a total of 41,239 participants. 
Another review aimed at increasing recruitment of palliative care patients found 
cluster consent, opt-out consent, contact of participants before arrival, and 
memory aid for patients with dementia to be effective recruitment strategies into 
trials (Boland et al., 2015). However, this review was considered to be of a poor 
quality (total score of 13/30 or 43.3%). The review included 15 articles; 13 of 
which were RCTs. 
4.4 Conclusions 
The evidence from the systematic reviews shows that there is limited evidence 
of the effectiveness of telehealth services for patients with LTCs. However, for 
some specific disease areas such as COPD, heart failure, severe asthma and 
diabetes, there is evidence of modest effectiveness in reducing hospital 
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admissions and mortality. Patients seemed to be generally satisfied with 
telehealth services. Evidence of cost-effectiveness of telehealth was mixed, and 
the impact on quality of life was limited.  
Factors that determine success or failure of implementation of new technology 
included a combination of human, technical and organisational ones. Some of 
the organisational factors included having a common vision, redesign of work 
programmes, mainstreaming the service, enhancing relationship among 
professionals and their attitudes to new technology. The involvement of users in 
the implementation of new technology was considered to be important, along 
with provision of training for staff, and having effective leadership. Some of the 
main barriers and facilitators to implementation of telehealth were related to the 
technology and its processes, and the way in which health service was 
delivered to patients. 
Lessons from failed trials suggest that there are a number of factors that can 
influence successful recruitment into trials.  These factors include: having formal 
pilots of trials, communicating the trial methods, designing study sample size 
with 90% power to detect effects, improving clinician-patient relationship, 
educating staff and patients about the methods and benefits of the trial, 
adopting cluster consent and opt-in consent, having open trial design where 
participants knew before-hand the treatment they were going to receive, 
telephone reminders, and embedding qualitative methods into the study. 
Observing these factors and building them into trial designs and processes 
could improve recruitment into trials and reduce the likelihood of them failing to 
recruit to the expected target sample size. 
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Chapter 5: Effects of Telehealth on Patients with COPD in the 
Community (TELECCOM Study): A Pragmatic Randomised 
Controlled Trial 
5.1  Chapter introduction 
This chapter reports the trial conducted to evaluate the effectiveness of a 
telehealth service for chronic obstructive pulmonary disease (COPD) patients, 
living in the Doncaster community and at high risk of emergency hospital 
admission. 
Note that sub-section headings will reflect the numbering in the CONSORT 
(Consolidated Standards of Reporting Trials) 2010 checklist for reporting 
randomised controlled trial (RCT) in peer-review publications (CONSORT, 
2012).  This is to assist the reader and demonstrate that all guidelines for 
reporting of this trial have been adhered to. 
A flow chart summarising key actions undertaken, reasons for the key actions, 
and headline findings in Chapter 5 is shown in Figure 5.1. 
 
136 
 
 
Figure 5.1: Pragmatic trial assessing the effectiveness of telehealth: key 
actions and decisions (Chapter 5) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Practical question: Can telehealth ‘work’ in a real-life situation?  
Primary objective: To establish the effectiveness of telehealth for high-risk 
COPD patients.  
Literature review on 
effectiveness of telehealth 
• Original inclusion criteria: At least 2 previous hospital admissions 
from COPD; Sample size: 36. 
• Amended inclusion criteria: At least 1 previous hospital admission 
(after exhausting patients with 2 previous hospital admissions) from 
COPD. Sample size increased to 80. Reasons: difficulties in finding 
participants that met the original inclusion criteria, and availability of 
more telehealth equipment. 
Headline findings: 
Telehealth was neither effective nor cost-effective in reducing hospital 
admission rates among patients with COPD in the community.  
Pragmatic trial: Planned follow up for 12 months. Reason for doing a 
pragmatic trial: To undertake a robust assessment of effectiveness of 
telehealth. 
Headline findings 
(Chapter 4):  
1. Limited evidence 
of effectiveness 
2. Telehealth was 
not cost-effective 
Total recruited: n=37 (under original criteria: n=20; under amended 
criteria: n=16); 
Randomised and follow-up: n=36. One patient not assigned to treatment 
as randomisation block incomplete. 
Randomised, follow-up and analysed: n=36 
Followed up period: 9 months, trial stopped early; Reason for stoppage: 
staff absence to monitor patients on telehealth. 
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5.2  Introduction to the trial 
5.2.2a Background 
A review of the literature is provided in Chapter 4.  The trial reported in this 
chapter was initiated before the literature review was completed.  At the start of 
the trial however it was clear that there was insufficient good quality evidence to 
show the efficiency of telehealth for COPD patients in the community. 
The setting of the trial is Doncaster, which is described in Chapter 3.  Doncaster 
Primary Care Trust (PCT), the funder, wished to establish the effectiveness of 
telehealth for patients with COPD and in particular if the addition of a telehealth 
service could reduce the number of emergency admissions to hospital for those 
patients at highest risk.  The aim was to answer the practical question: “can 
telehealth ‘work’ in a real-life situation?”  The trial was a pragmatic one. 
It is noted, just as the trial was pragmatic; the running of the trial was much 
influenced by the needs of the PCT.  For example, the target sample size was 
increased when more funding became available, and the trial was stopped 
prematurely when staffing issues arose and the objectives from the PCT 
changed. 
5.2.2b Objectives and hypotheses 
At the start of the trial, the primary objective was to establish the effectiveness 
of telehealth for high-risk COPD patients.  A secondary objective was to 
establish cost-effectiveness of that telehealth service. 
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The null hypothesis was that the rate of emergency hospital admissions would 
not be affected by the telehealth service.  The alternative hypotheses were that, 
either the rate would be lower and consequently telehealth shown to be 
effective, or that the rate would be higher and thus harm associated with 
telehealth. 
5.3  Methods 
5.3.3a Trial design 
The initial design of the trial was a pragmatic randomised controlled trial with 
two arms: one active arm where patients received the telehealth service for 
monitoring COPD; and one control arm where monitoring was as usual. That is, 
where patients received routine primary care services (e.g., access to their 
general practitioners (GPs) and community nursing service) and hospital 
services (accident and emergency department, inpatient admissions, and 
outpatient departments). A more detail description of the intervention and usual 
care is provided in Chapter 3 (see Section 3.5.3, and Figure 3.15).  
The allocation ratio was 1:1 for selection of patients into the control and 
intervention arms of the trial, as this was the most efficient method.  As the trial 
was relatively small, block randomisation of four cases, allocating two to each 
arm randomly, was used to ensure a balance of participants to each arm of the 
study. The protocol stipulated that patients were free to withdraw from the study 
at any time. 
 It is important to note that a cluster randomised trial was considered.  A number 
of authors had highlighted advantages and disadvantages of cluster 
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randomised trial, which included costs, ethical issues and consents, risk of 
contaminations and external validity among others (Edwards et al., 1999, 
Sanson-Fisher et al., 2007, Mazar et al., 2007, Campbell et al., 2007).  There 
are many aspects of the cluster RCT that would have contributed to clearer 
evidence for or against a telehealth service.  For example, the clusters would 
have been the centres where all patients received telehealth or monitoring as 
usual.  This would have been easier to administer as all staff within a centre 
would deliver the same care model.  Also, staff would have been aware that 
telehealth was being implemented in other centres and this may have reduced 
staff resistance to the change of service.  Such a trial would have been far 
larger than the one implemented here as several centres would have been 
needed.  Randomisation would have been at the centre level and to provide 
convincing evidence around 20 centres would have needed to be involved.  
This size of trial was far beyond the resources available to Doncaster PCT and 
would have required collaboration with other PCTs.  In addition, before such a 
cluster RCT could have been proposed there would need to be extensive pilot 
work completed. 
At the trial design stage, an option for a cross-over trial was also considered, in 
which the intervention (Group 1) and control (Group 2) arms would be 
monitored for the first six months. With Group 1 receiving telehealth service and 
Group 2 receiving standard care. After the first six months, the intervention and 
control arms would be switched over (cross-over). This would mean that during 
the second six months, Group 1 would receive standard care while Group 2 
would receive the intervention (telehealth service). 
140 
 
 
The advantages of this option are that it would minimise variation between 
patients, as each patient would have been in both intervention and control arms 
of the trial; and there was an opportunity for analysing two sets of intervention 
and control groups. There are however a number of limitations of the cross-over 
trial. Firstly, the trial would take place during different time periods (seasons) of 
the year, since the trials would be for six months each.  It is known that the 
exacerbation of patients with COPD is worse in winter months. Therefore, the 
experiences of the trial groups during winter months would be adversely 
affected than those during other seasons of the year. Secondly, it is likely that, 
as telehealth service included elements of educating patients about self-care, 
some of the effects of intervention might persist beyond the first six months of 
the trial and into the second cross-over stage as control group. Thirdly, six 
months was not considered to be long enough to be able to determine the long-
term use of telehealth, as it was envisaged that patients would use telehealth 
services as long as they wished to support themselves with self-care. There 
was also the ethical dilemma of what to do if patients found the telehealth 
service helpful and consequently wanted to continue using it. Fourthly, unlike 
drug trials, the logistics of swapping intervention from one group to another 
would be potentially very challenging. The installation of the telehealth devices 
is time-consuming and this design would double the effort required in terms of 
staff capacity. 
 
 
 
141 
 
 
5.3.3b Changes to design 
There were a number of changes to the trial that occurred after it had been 
initiated.  Details of the changes are provided in the relevant sections below.  
The changes were: 
1. Change to the sample size and to the size of the effect that was to be 
detected.  When further funding became available, the sample size was 
increased so that the trial had better power to detect smaller effect sizes.   
2. There were changes to the telehealth equipment when a new model was 
developed by the suppliers. 
3. The inclusion criteria were modified (Table 5.1a) following difficulties in 
identifying eligible patients and recruitment. 
4. The proposed analysis was changed following the change in the 
distribution of the outcome variable, which arose from the relaxation of 
the inclusion criteria. 
5. The trial was stopped following staffing issues and a change of focus 
from Doncaster PCT, who funded the research. 
5.3.4a   Participants 
Potential participants for the trial were identified from hospital admission records 
or hospital episode statistics (HES) data that was available at Doncaster 
Primary Care Trust (PCT).  
The trial inclusion criteria focused on identifying patients with COPD who had 
two previous hospital admissions, were on general practice register, living in 
Doncaster and registered with a GP in Doncaster and were confirmed still alive 
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at the time of recruitment. These inclusion criteria were used for selecting 
patients who were recruited onto the trial from 24th October 2007 to 16th July 
2008. 
During the trial, it was planned to increase the sample size of the study to 80 
from the initial number of 36 participants, as funding for more telehealth 
machines became available. With the proposed changes in sample size, it also 
became necessary to consider relaxing the inclusion criteria related to the 
number of previous hospital admissions from COPD from the initial two previous 
hospital admissions to at least one previous hospital admission. The proposed 
change in inclusion criteria received ethical approval on the 5th March 2008. 
Based on the amended inclusion criteria, 16 participants were recruited (8 in the 
intervention, and 8 in the control arm of the trial). 
5.3.4a.1 Eligibility criteria 
In total, 37 participants consented to take part in the trial and 36 of them were 
randomised. One patient was recruited but not allocated to a treatment.  The 
trial was stopped when that one patient was the first of a block of four awaiting 
randomisation. The inclusion criteria (original and amended versions) are stated 
in Table 5.1a; and the number recruited under the two criteria can be found in 
Table 5.1b. 
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Table 5.1a: Amendments to original inclusion criteria into the trial 
 
Inclusion criteria Remarks 
1. The person has had 2 or more COPD 
emergency admissions (ICD-10 codes J40, 
J41, J42, J43, J44 or J47) to hospital in the last 
12 months from the day selection takes place.  
Original inclusion criteria 
2. The person has had a diagnosis of COPD as 
defined by NICE guidelines and had care 
optimised by an appropriate health care 
professional.  The person must be on a 
General Practitioners (GP) COPD Register. 
Original inclusion criteria 
3. The patient is confirmed as alive and residing 
in Doncaster. 
Original inclusion criteria 
4. The patient must have the capacity to use the 
equipment. 
Original inclusion criteria 
5. After exhausting cases from primary pool that 
meet inclusion criteria 1-4; cases will be 
included that had 1 previous COPD admission 
in the last 12 months. 
Amended inclusion criteria 
 
Table 5.1b: Recruitment into the trial according to original and amended criteria 
 Intervention Control Total 
Original criteria 10 10 20 
Amended criteria 8 8 16 
Total 18 18 36 
 
Patients were excluded if: (1) they did not have the physical or mental capability 
to operate telehealth machine or did not have carers that could enable them to 
operate the telehealth machine, this was determined by a community nurse at 
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the recruitment stage; (2) they were not on the GP COPD register; (3) they were 
registered with a Doncaster GP but were not living in Doncaster; and (4) they 
had no landline telephone.  An initial list of patients, obtained from hospital 
admission records, was checked against the primary care patient registration 
system (also referred to nationally as the Exeter System) to exclude those who 
had died between their last hospital admission and the time of screening for 
eligibility into the trial. 
5.3.4b Settings and locations 
The Chief Investigator (author) generated a list of eligible patients for the 
community matron to use in order to obtain consent.   
The setting of the study is the borough of Doncaster in the County of South 
Yorkshire, England (see Chapter 3). The sample was patients living in their own 
homes, who were registered with a GP in Doncaster, as well as being a resident 
of Doncaster. The telehealth service was monitored by staff from a central 
location, based at one community health centre in the Thorne area of Doncaster 
(England). A room at the health centre was used as a store for the telehealth 
machines that were not in use.  
Patients commenced telehealth as part of the trial on 24th October 2007, and 
the trial was stopped on the 8th August, 2009.  
5.3.5  Intervention 
The intervention is a telehealth service, consisting of a telehealth monitoring 
device (Genesis Monitor), supported by staff who monitor the readings of 
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patients.  A one-year contract for repair or replacement of any of the machines 
that were not working in the patients’ homes was established prior to the trial. 
The control group had access to standard healthcare (routine access to primary 
care services; and hospital services such as accident & emergency services) 
that was also available to the intervention group. A description of the local 
telehealth service is given in Chapter 3.  
Patients in the intervention group had a telehealth machine installed in their 
homes by a community nurse, after performing a demonstration of how to 
operate the machine. Patients then measured their vital signs (blood pressure, 
pulse rate using blood pressured cuff, temperature, and level of oxygen 
saturation using a pulse oximeter) and nine selected questions that patients 
answered by pressing a “yes” or “no” button on the telehealth device (Table 
5.2). The records of these readings were transmitted through the internet to a 
central location in a dedicated office based at the same health centre, described 
above; where nurses could access them, using special user name and 
password, and monitor them from a computer connected to the internet. 
146 
 
 
 
Table 5.2: Selected questions on telehealth device (Genesis Monitor) 
1. Are you experiencing more difficulty breathing today compared to a 
normal day? 
2. Have you been using your inhalers more than usual? 
3. Have you had to limit your activities more than usual? 
4. Have your ankles been swollen more than usual? 
5. Have you noticed a decrease in your appetite? 
6. Has your mood been more depressed this week compared to a normal 
week? 
7. Have you been to the Accident & Emergency this week? 
8. Has your doctor added, deleted, or changed any of your medications 
this week? 
9. Did you have an unexpected visit to your doctor this week? 
 
Measurements of vital signs (blood pressure, blood oxygen saturation or SpO2, 
heart rate, and temperature) and responses to selected questions were set to 
be taken twice a day; one in the morning when patients woke up and the other 
in the evening before patients went to bed. This was done at the same time 
every day, as agreed upon by the patients and the nurse. Each measurement 
usually took less than five minutes, but could take longer depending on 
individual circumstances and level of experience in using the equipment. 
Hospital admission records were obtained from hospital episode statistics 
(HES) through Doncaster PCT. Actual tariff cost of hospital admissions were 
obtained for each patient from the HES data. The cost of the telehealth 
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machine, as purchased in 2007, was used in performing cost-effectiveness 
analysis. Bed-days were obtained from the HES data. 
Information on mortality was obtained from three sources: (1) records on the 
telehealth system, as patients who died were noted by community nurses who 
monitored those on telehealth; (2) HES data, which indicated when patients 
died in hospital; (3) verification against public health mortality file data (all 
deaths that occurred in Doncaster up to the time of analysis), which was 
obtained from the Public Health Directorate of Doncaster Primary Care Trust.  
Quality of life questionnaires (St George’s Respiratory Questionnaire (SGRQ), 
and Karnofski Index) were completed at baseline and were planned to be 
undertaken subsequently after 6- and 12-month intervals. The 6- and 12-month 
quality of life questionnaires were not able to be followed up for all the patients 
as the study was prematurely stopped. Analysis was made based on the 
information collected at baseline for the quality of life questionnaire. Basic 
demographic information on patients was also collected at baseline.  
Interviews with patients were planned towards the end of the study. However, 
these did not take place because the RCT was prematurely stopped. However, 
interviews were subsequently carried out as part of observational study and the 
findings are reported in Chapter 7. The purpose of the interviews was to capture 
the views of patients and staff on their experience in relation to telehealth 
service. 
Patient compliance data related to telehealth was obtained from the telehealth 
system at the central computer that received all patients’ data. 
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5.3.6a Outcomes 
5.3.6a.1 Primary and secondary outcomes 
Primary outcome 
The main outcome measure of the trial was rates of hospital admission due to 
COPD measured in number per year of follow up.   
The follow-up period was calculated by using patient-years of follow up as the 
denominator. Those who were followed for 12 months or less were analysed 
based on hospital admission experience over the period of follow up (in years). 
Similarly, for those who used telehealth for over 12 months, the denominator 
was the patient-years of follow up. The end period was determined by the date 
when patients were discharged from telehealth service or when they refused to 
take part or when they died. For example, a patient who spent nine months on 
the trial was considered to have 0.75 person-years of follow up (9/12). 
Secondary outcomes 
Secondary outcomes of the study included:  
• whether or not participants were admitted to hospital; 
• mean hospital admission, length of hospital stay, and costs and their 
95% CI; 
• lengths of hospital stay per year of follow-up; 
• mortality rates; 
• costs (hospital admissions and telehealth machine) per year of follow-up; 
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• quality of life as measured by Karnofsky Index and SGRQ based on 
changes at six months and twelve months of follow-up; 
• compliance rate to telehealth monitoring measured against expected 
receipt of telehealth readings of twice per day per person or readings per 
week per person; 
• challenges encountered in the implementation of telehealth related to 
staff, technology, patients recruitment as the study progressed based on 
observation, and views from staff and patients; 
• safety of telehealth  as measured by mortality rates in both arms of the 
trial, equipment failure or malfunction leading to inaccurate 
measurements of health outcomes, and level of red alerts generated 
from the telehealth device and how they are responded to by community 
nurses; 
• patients’ experience of telehealth in the trial as measured by levels of 
satisfaction using structured questionnaires and semi-structured 
interviews.  
5.3.6b Changes to outcomes 
As the trial was discontinued, there were a number of changes; data collection 
was stopped prematurely and analysis was performed up to the time of 
discontinuation instead of the anticipated full 12 months of follow-up. This 
meant that quality of life was only measured fully at baseline, but the intended 
assessment using quality of life questionnaires at six months and twelve months 
of follow-up could not be completed. The rates of hospital admissions, length of 
hospital stays, and costs of hospital admissions were assessed at a shorter 
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time period, based on actual time of follow-up as a result of discontinuation 
(person-years of follow up), than it was originally anticipated. Level of 
satisfaction by patients by means of structured questionnaires and semi-
structured interviews could not be undertaken, as these were intended to be 
carried out towards the end of the study. 
5.3.7a Sample size estimation 
Initial sample size estimation 
The initial sample frame for calculating the sample size of the study was derived 
from all patients who had emergency hospital admission from COPD with 
primary diagnostic codes of International Classification of Diseases version 10 
(ICD 10: J40, J41, J42, J43, J44 or J47) and who were registered with a GP in 
Doncaster during the period of October 2005 to September 2006. A preliminary 
analysis showed that 73% of patients with COPD had only one previous 
hospital admission related to their disease, while the remainder (27%) had two 
or more previous hospital admissions (Table 5.3). 
Table 5.3: Number of emergency hospital admissions from COPD (ICD 10: J40, 
J41, J42, J43, J44 or J47) in Doncaster, October 2005 to September 2006; 
based on 549 patients. 
Number of hospital 
admissions Total Patients % 
1 401 73.0 
2 83 15.1 
3 30 5.5 
4 19 3.5 
5 or more 16 2.9 
Total Admissions 549 100.0 
Data source: Information Unit, Doncaster Primary Care Trust (PCT) 
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The evidence in Table 5.3 shows that there were a total of 148 (27.0%) patients 
that had two or more emergency hospital admissions from COPD during a one-
year period.  The proportions of male and female patients who were admitted to 
hospital from COPD were 49.3% (n=73) and 50.7% (n=75) respectively. For 
patients with two or more admissions in a twelve month period, the average 
hospital admission was 2.97, with a standard deviation of 1.55. 
Various models were proposed based on the potential average number of 
admissions per person that could be reduced (Table 5.4) in order to achieve a 
cost-effectiveness (value for money) threshold. The model estimated that in 
order to break even over a one-year period, the rate of COPD admissions that 
needed to be avoided was at least 1.33 (44.3%) average per person per year, a 
reduction from 3.0 to 1.67 admissions on average. Based on this assumption, 
three possible models were constructed, covering a five-year period. It was 
anticipated that the telehealth machine could be used beyond the 12 months of 
the study period. Assumptions of cost modelling were based on 2007 cost (in 
pounds sterling or £) of hospital admission from COPD of more than two days at 
£2,302; and the cost of telehealth machine at the time was £2,483 and its on-
going annual maintenance fees was £582 per machine (Table 5.4). 
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Table 5.4: Models of potential savings (£) from investment in telehealth 
Analysis per patient over a 5-year period 
Models Year 1 Year 2 Year 3 Year 4 Year 5 Total  
Model 1:       
Cumulative number 
of hospital 
admissions 
2.0 4.0 6.0 8.0 10.0 30.0 
Estimated costs: 3 to 
2 admissions 
£763 £97 -£1,998 -£5,522 -£10,475 -£17,135 
Model 2:       
Cumulative number 
of hospital 
admissions 
1.5  3.0  4.5  6.0  7.5  23  
Estimated costs: 3 to 
1.5 admissions 
-£388 -£3,356 -£8,904 -£17,032 -£27,740 -£57,420 
Model 3:       
Cumulative number 
of hospital 
admissions 
1.0  2.0  3.0  4.0  5.0  15.0  
3 to 1 admission -£1,539 -£6,809 -£15,810 -£28,542 -£45,005 -£97,705 
Note: Negative cost denote saving (cost-benefit); while positive cost denotes 
loss (cost of investment in telehealth is more than the cost from admissions 
prevented). 
Based on benefits realisation projection, shown above, it was estimated that if 
telehealth were to be cost-effective (break-even), the mean hospital admissions 
reduction to be achieved should be at least 1.5 (from 3.0 at baseline to 1.5 after 
telehealth intervention; 50% reduction in hospital admissions).  A minimum 
sample size to enable this effect to be achieved was determined to be 18 
patients in each arm of the study (Table 5.5, option 3). 
Table 5.5: Sample size calculations: mean hospital admissions rate per year 
Options mu1 mu2 Difference in 
Mean 
Sample size per 
study arm (n1=n2) 
1 3.0 2.0 1.0 38 
2 3.0 1.7 1.3 23 
3 3.0 1.5 1.5 18 
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Note: mu1 = mean of population 1 – mean admissions per year from COPD 
admissions in the control group; mu2 = mean of population 2 - mean 
admissions per year from COPD admissions in the intervention group. 
Note that, for this sample size, the outcome (rates of admission) was taken to 
be a continuous measure. This may not be normally distributed. The average of 
several measurements can be distributed close to a normal distribution and a t-
test is appropriate. It is worth noting that the mean is double the standard 
deviation which provides reassurance that a t-test is appropriate.  
Sample size for an unpaired two-sample student t-test was calculated (using 
StatsDirect computer software for calculating sample size) based on the 
following statistical variables: alpha = 0.05; power = 0.8; difference between 
means = 1.5; standard deviation = 1.55; control per experimental subject = 1; 
and degrees of freedom = 34. Therefore, the sample size for the trial was 
selected to be 36 patients, as shown in Option 3 of Table 5.5.  
A provision for recruiting additional 11% patients (n=4 or two extra participants 
in each arm of the trial) was planned in the study protocol (so that the trial was 
to have a total of 40 participants). The additional four participants were to cover 
for potential drop-out from the trial. However, this additional number was not 
recruited. 
Revised sample size estimation 
When further funding became available, the same assumptions described in 
Table 5.5 were still held, with the exception that patients with at least one 
previous hospital admission would be included at this time. Option 1 of Table 
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5.5 was chosen as the basis for the revised sample size with 38 participants in 
each arm of the trial (total of 76 participants). Allowance was made for drop-out, 
bringing the planned total number in the revised sample size estimation to 80. 
The inclusion criteria for the revised sample size estimation are shown in Table 
5.1a. 
5.3.7b  Stopping rules 
It was determined, in the study protocol, that the trial would be stopped if: (1) 
the equipment was found to be unsafe; (2) the integrity of the equipment and 
data was unreliable; and (3) a large number of patients withdrew from the study. 
The Steering Group would assess this, as and when the situation arose and it 
would take appropriate decisions and actions. No interim analyses of the trial 
were planned or performed.  
5.3.8a  Randomisation method 
The method used to generate the random allocation of participants was carried 
out by means of an excel software programme. A macro programme was used 
for the random allocation process of participants, which selected from a list of 
even numbers half of them into intervention group.  The randomisation into the 
intervention and control groups was carried out in blocks of four cases, based 
on the number of patients that consented at the time and were ready to be 
allocated into the trial. A list was created consisting of even numbers of patient 
identification numbers. The random allocation process using excel software was 
first tested on dummy numbers not related to the trial, and it was successful in 
randomly selecting half of the patients for the intervention arm of the trial. Using 
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similar process, random allocations were made from a list of even number, 
when randomisation command was activated, half of the cases were selected, 
and they were assigned as belonging to the intervention arm of the trial, while 
the remaining ones were assigned to the control group.  
5.3.8b  Randomisation type 
The trial was designed primarily to determine the effect of telehealth between 
the intervention and control groups, and simple random sampling in blocks of 
four was chosen to ensure good balance between the trial arms. Although the 
author was aware of the potential differences in patients’ characteristics, such 
as sex, age, ethnicity, and geographical location, these were not used for 
stratification: it was hoped that randomisation would balance these 
characteristics. Undertaking stratified random sampling would have increased 
the complexity of the study, and possibly the duration of recruitment. 
5.3.9 Allocation concealment 
Randomisation was concealed by carrying out central randomisation away from 
the community nurses who were responsible for implementing service delivery 
for the patients who might be allocated to control or intervention arms of the 
trial. The author undertook the central randomisation from a different site (at 
PCT headquarter), and informed the community nurses (based in the 
community setting) of the results of the allocation. The randomisation was 
therefore concealed from the clinical staff involved in the patients care. The staff 
who undertook randomisation did not know the patients. 
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5.3.10  Randomisation implementation 
Patients who met the eligibility criteria were contacted by a district nurse to 
obtain consent and those who consented were randomised by the Chief 
Investigator (the author of this thesis). The district nurses were informed by the 
Chief Investigator regarding which patients were to be assigned to the 
intervention arm (thus receiving telehealth service) and which ones were to 
continue receiving standard care (control group) after randomisation. The 
district nurses enrolled the patients onto telehealth by undertaking the 
installation of the machines, following consent by the patients. 
5.3.11 Blinding 
Blinding was not possible since it was not practical for staff and participants 
involved in the trial to be blinded as to who was, and was not, receiving the 
telehealth intervention after randomisation.  
After randomisation, patients were made aware that they could withdraw from 
the study at any time without giving any reason, as stipulated in the protocol. All 
cases that used telehealth for any duration were included in the analysis on the 
basis of intention to treat (ITT). 
5.3.12 Statistical methods 
Summary statistics (mean and rates) were calculated for intervention and 
control groups of the trial using STATA (statistical) software (version 11). The 
95% confidence intervals (CIs)  were calculated using Bootstrap resampling 
method using statistical computer programme called Statistics101 (Grosberg, 
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2014). Grosberg (2014) described Bootstrap as a statistical technique, used to 
derive unknown population parameters, such as mean or confidence interval by 
resampling from the original sample infinite number of times. Each time the 
resample is drawn, it is replaced and the process repeated as many times as 
required (Grosberg, 2014). In this way, Grosberg argued that the mean and 
95% CI of the unknown population could be derived. The advantage of using 
Bootstrap statistics to calculate 95% CI is that it does not  rely on the 
distribution of the data being normal (Grosberg, 2014). There was evidence 
from the trial’s data that the distribution of the data was skewed, thus justifying 
the use of Bootstrap for calculating 95% CI.  
The initial analysis was to undertake the hypothesis testing by applying a t-test 
for the difference in the mean rates of hospital admission between the two 
groups (intervention and control). This was amended when it was discovered 
that admission rates were much lower in both groups. There was the possibility 
that the assumption that the means were normally distributed might be violated. 
That is, with lower means the rates are more heavily skewed. To ensure validity 
of the test, the two-sample Wilcoxon rank-sum (Mann-Whitney) test was 
undertaken instead. There would be a small reduction in power compared to a t-
test should the normal assumption be valid but validity is ensured with a rank-
sum test. 
Secondary analyses were performed using Pearson’s chi-square test for 
statistically significant differences in binary outcomes between the study 
subgroups: participants admitted to hospital or not. All analyses were performed 
using intention to treat (ITT).  
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Why a non-parametric test was used  
As stated in the sample size calculation, the assumption of normality for the t-
test depended on the mean being relatively large compared to the standard 
deviation. With time, the mean number of hospital admission dropped.  
When the sample size calculation was carried out, a student t-test was 
assumed, since the distribution of the group means would be close to a normal 
distribution. Upon collecting data during the trial, it was revealed that the data 
were more skewed (asymmetric) and so the means were unlikely to be normally 
distributed (see Figures 5.2 and 5.3 under results).  An alternative non-
parametric test was considered to be the most appropriate one to use instead of 
the t-test. The alternative non-parametric test used was Wilcoxon rank-sum test 
(also called Mann-Whitney U test) for independent samples. This might have 
resulted in a minor loss of power. 
5.4 Results 
5.4.13a Participant flow 
A total of 243 cases were screened for eligibility into the trial. They were derived 
from hospital admission data held by Doncaster PCT. Of these, 206 were 
excluded because: (a) they did not meet the inclusion criteria (n=113); (b) were 
not reachable by phone in order to make contact for consent (n=50); and (c) 
other reasons (n=43). Consent was obtained from 37 patients. As 
randomisation was carried out in blocks, 36 cases were randomised. One 
patient could not be randomised because the study was stopped prematurely 
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and additional patients could not be recruited. A flow diagram, which describes 
the recruitment process, is found in Figure 5.2. 
For the 36 cases that were randomised into the trial: 18 were assigned to the 
control group and 18 to the intervention group. Of the 18 cases that were 
assigned to the intervention group, nine used telehealth for less than two 
weeks, while the remainder used telehealth for a duration ranging from two 
weeks to 1.3 years. The 18 cases assigned to the intervention group were 
followed up and analysed. Similarly, in the control group all the 18 cases were 
also followed up and analysed. 
A flow diagram, showing number of cases assessed for eligibility, to inclusion in 
the analysis, is shown in Figure 5.2 below, as recommended in the CONSORT 
2010 statement for reporting of randomised controlled trials. 
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 Figure 5.2: Flow diagram of the recruitment process into RCT 
Randomisation and analysis of the trial (CONSORT 2010 Flow Diagram)  
 
 
 
Assessed for eligibility (n=243) 
Excluded (n=206) 
♦ Not meeting inclusion 
criteria (n=113) 
♦ Not reachable by phone 
(n=50  ) 
♦ Other reasons: e.g. Not 
consented or died (n=43) 
 
♦ Analysed per intention to treat 
(n=18) 
♦ Excluded from analysis (n=0) 
 
Lost to follow-up (n=0) 
 
Allocated to intervention (n=18): 
• Received telehealth but 
withdrew within 2 weeks (n=9) 
• Received telehealth for more 
than 2 weeks: (n=9) 
Lost to follow-up (n=0) 
Allocated to control and 
received standard care 
(n=18) 
 
♦ Analysed per intention to 
treat (n=18) 
♦ Excluded from analysis 
(n=0) 
Allocation 
Analysis 
Follow-Up 
Randomised (n=36) 
Enrolment 
Total duration of follow-up: 
19.4 person-years 
Total duration of follow-up: 15.4 
person-years 
Follow-up time 
Consented 
(n=37) 
One patient not 
randomised 
before the trial 
concluded 
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5.4.13b Losses and exclusions 
All cases were accounted for in the follow-up process, hence there was no loss 
to follow up. Analysis was carried out based on period of follow up, using 
intention to treat (ITT). There was no exclusion from the analysis of those who 
were allocated to the trial. 
5.4.14a Recruitment period 
Recruitment into the telehealth trial commenced in August 2007 and the first 
patient recruited received the intervention in October 2007. Recruitment and 
follow-up continued until August 2009 when the trial was discontinued 
prematurely.  
5.4.14b Stopping the trial 
The immediate reason that led to the trial being halted was that the sole 
remaining nurse, out of the original two nurses, left the job. As a result, it was 
deemed unsafe to continue the service without a nurse to monitor the patients.  
After the trial was stopped, the telehealth service was re-started after staff 
issues were addressed, but the service was evaluated in a different way, see 
Chapters 6 and 7.  
Further details of stopping are provided in Section 5.7 below. 
5.4.15 Baseline data 
All 36 patients randomised and followed up were analysed. Of the 36 cases 
analysed, there were equal numbers; 18 (50.0%) in each arm of the trial. The 
162 
 
 
baseline characteristics of patients in the intervention and control groups were 
broadly similar in respect to age, sex, number of comorbidities, previous 
hospital admissions and length of stay in the previous 12 months; and also 
quality of life, as measured by Karnofski Index (KI) and St George’s Respiratory 
Questionnaire (SGRQ). The intervention group however was slightly older 
compared to the control group and the baseline mean hospital admission rate 
and length of hospital stay were also lower in the intervention than the control 
group (Table 5.6). The baseline mean score on KI was 49.2 in the intervention 
group compared with 38.0 in the control (the higher the Index the better was the 
quality of life); while the corresponding total scores on SGRQ were 71.9 
(intervention group) and 75.3 (control group); (the higher the score, the worse 
health outcome) respectively (Table 5.6).  
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Table 5.6: Baseline characteristics of intervention and control groups 
Variables Intervention Control 
Number of cases (%) 18 (50.0) 18 (50.0) 
Mean age in years (95% CI) 73.9 (70.3, 77.5) 67.7 (63.0, 72.4) 
Sex: 
Male: n (%) 10 (27.8) 8 (22.2) 
Female: n (%) 8 (22.2) 10 (27.8) 
Mean number of comorbidities 
(95% CI) 6 (3, 8) 7 (5, 9) 
Mean number of hospital 
admissions 12 months before the 
trial (95% CI) 1.11 (0.44, 1.94) 1.89 (1.11, 2.72) 
Mean length of hospital stay 
(days) 12 months before the trial 
(95% CI) 5.83 (2.00, 10.39) 15.11 (8.50, 22.78) 
Karnofski Index(KI): 
Number of cases 12 15 
Score: mean (95% CI) 49.2 (36.0, 62.3) 38.0 (26.7, 49.3) 
St Georges Respiratory 
Questionnaire (SGRQ): 
Number of cases: 13 13 
Symptoms score: mean (95% CI) 74.2 (63.7, 84.8) 79.2 (71.1, 86.6) 
Activity score: mean (95% CI)  87.2 (78.7, 95.8) 88.8 (83.3, 94.4) 
Impact score: mean (95% CI)  62.9 (48.9, 77.0) 66.4 (55.2, 77.6) 
Total score: mean (95% CI)  71.9 (61.5, 82.3) 75.3 (61.5, 82.3) 
Analysis of the data showed that 25 of 36 patients (69.4%) did not experience 
any hospital admission, and the frequency of those that had one to seven 
hospital admissions tailored off in single digits. This showed that hospital 
admissions were skewed, far more than initially anticipated (Figure 5.3), thus 
requiring the use of non-parametric tests e.g., Wilcoxon rank-sum test (Mann-
Whitney U test).  
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Figure 5.3: Distribution of hospital admissions among the study population 
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Similarly, the distribution of length of hospital stay (days) was also skewed 
(Figure 5.4). 
Figure 5.4: Histogram of length of hospital stay (days) during the trial  
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5.4.16 Numbers analysed 
There were 36 patients analysed, with 18 participants in each one of the 
intervention and control groups, as originally assigned.  
5.4.17 Outcomes 
5.4.17.1 Primary outcome: hospital admissions 
During the trial period, there were 16 (43.2%) hospital admissions in the 
intervention arm of the study in comparison with 21 (56.8%) in the control 
group. The total duration of follow-up was 15.4 years for the intervention group, 
while it was 19.4 year for the control group. The mean hospital admission rate 
per year of follow-up per person was 1.04 (95%CI: 0.59, 1.69) in the 
intervention group, and the equivalent rate for control group was 1.08 (95% CI: 
0.67, 1.65); p-value = 0.547 (p-value performed using Wilcoxon rank-sum test, 
while 95% CI was calculated using Bootstrap resampling method as described 
above). There was no statistically significant difference in hospital admission 
rates between the two arms of the trial (Table 5.7). 
Table 5.7: Outcome of hospital admission rate per year of follow-up 
Variables Intervention Control 
P-
value* 
Number of cases 18 18 
Years of follow-up 15.4 19.4 
Hospital admissions: 
Total number of 
admissions 16 21 
Admissions rate per 
year of follow up 
(95% CI) 1.04 (0.59, 1.69) 1.08 (0.67, 1.65) 0.55 
*P-value: derived from two-sample Wilcoxon rank sum (Mann-Whitney) test 
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A box plot of hospital admissions before and after the trial showed that hospital 
admissions appeared to be reduced in the intervention group compared to the 
control group (Figure 5.5). 
Figure 5.5: Hospital admissions before and after the trial (box plot) 
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Note: The box plot has a box with upper end (75th percentile) and lower end 
(25th percentile) with a median (line). The whisker represents upper adjacent 
value (there can also be lower adjacent value, which is not available in this 
figure). The dots represent outliers.  
During the trial the mean hospital admission rate per year reduced by only 6.3% 
(from 1.11 to 1.04) in the intervention group, while the control group 
experienced a reduction of 42.9% (from1.89 to 1.08). 
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5.4.17.2 Secondary outcomes 
Hospital admission as a binary outcome 
Analysis of participants admitted, or not admitted, to hospital (binary outcomes), 
using Pearson chi-squared test showed that there was no statistically significant 
difference in the two study arms (p=0.278). There were 7 cases (19.4%) 
admitted to hospital in the control group, while in the intervention group, the 
number was 4 (11.1%), (Table 5.8). 
Table 5.8: Pearson chi-squared test: admitted or not by study group 
Admitted to 
hospital 
 
Study groups 
  Total 
 
Control 
 
Intervention 
 
 
n % n % 
 
n % 
No 
 
11 30.6 
 
14 38.9 
 
25 69.4 
Yes 
 
7 19.4 
 
4 11.1 
 
11 30.6 
Total 
 
18 50.0 
 
18 50.0 
 
36 100.0 
Note: Pearson chi2 (1) = 1.1782, p = 0.278 
Hospital bed days 
The rate of mean hospital length of stay (bed-days) per year of follow-up per 
person was 5.99 (95% CI: 1.73, 11.32) in the intervention group, while the mean 
rate in the control group was 7.23 (95% CI: 2.27, 13.23), based on bootstrap 
statistical analysis described above in Section 5.3.12. There was no statistically 
significant difference in lengths of hospital stay rate between the control and 
intervention group (p-value = 0.57) (Table 5.8). 
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Costs 
The total cost (limited to hospital tariff cost and cost of telehealth machine and 
its communication) was £83,986 in the intervention group compared with 
£43,419 in the control group. The mean total cost per patient-year was three 
times more in the intervention group at £6706 (95% CI: £3595, £10,537), in 
comparison to £2,605 (95%CI: £807, £4805), in the control group; p-value 
0.005. 
Deaths 
There were a total of 15 deaths (41.7%) that occurred during the trial; which 
translated into 1.21 deaths per year of follow-up. Eight deaths (22.2%) occurred 
in the intervention group, and death rate per year of follow up was 0.52 (95%CI: 
0.22, 1.02). There were seven deaths in the control group (19.4%), which was 
equivalent to death rate of 0.36 (95% CI: 0.14, 0.74) per year of follow-up. 
There was no statistically significant mortality experience between the two arms 
of the trial (Table 5.9), although there was slightly higher mortality in the 
intervention group. 
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Table 5.9: Main health outcomes from the trial  
Lengths of hospital stay (bed-days), costs, and mortality rates 
Variables Intervention Control P-value* 
Number of cases 18 18 
Years of follow-up 15.4 19.4 
Lengths of hospital 
stay (days): 
Total number 98 127 
% 43.6 56.4 
Mean lengths of stay 
rate per person-year 
(95% CI) 5.99 (1.73, 11.32) 7.23 (2.27, 13.23) 0.5666 
Costs (GB £) 
[admission + 
telehealth machine]: 
Amount (£) 83,986  43,419  
Mean total cost (£) per 
person-year (95% CI) 6706  (3585, 10,537) 2,605  (807, 4805) 0.0050 
Mortality:  
Number (%) 8 (22.2) 7 (19.4) 
Rate of death per 
person-year of follow-
up (95% CI) 0.52 (0.22, 1.02) 0.36 (0.14, 0.74) 0.7389 
*Note: *P-value: derived from two-sample Wilcoxon rank-sum (Mann-Whitney) test
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Quality of life 
Since the trial was stopped before the planned completion time, the quality of 
life questionnaires were completed at baseline and no meaningful number of 
questionnaires was completed at 6th and 12th months’ interval as originally 
envisaged. Therefore, change in quality of life could not be performed, based on 
the tools selected: Karnofski Index, and St George’s Respiratory Questionnaire. 
Compliance with telehealth monitoring 
Records of nine cases (four females and five men) who received telehealth 
monitoring for a minimum period of 0.3 years (3.6 months) and a maximum of 
1.3 years (15.6 months) were examined for compliance. These nine cases 
encompassed all participants, for whom telehealth monitoring was used for a 
longer time period. Patients who only used telehealth monitoring for a brief 
period (for example 14 days) and gave it up were excluded from telehealth 
compliance data analysis, because they did not have any meaningful computer 
records of telehealth monitoring data to analyse for purpose of understanding 
compliance of patients with telehealth service. . However, they were included in 
other analysis on the basis of intention to treat. Fourteen days was agreed as a 
cooling period in which patients could try telehealth service to determine 
whether or not they wanted to continue 
The average age of users of telehealth home monitoring was 77 years old (72 
years old for females; and 81 years old for males). The combined time of 
patients data monitored was 9.1 years, or 3,309 days. Two readings were 
expected per day (from Monday – Friday), and a total of 6618 readings were 
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expected. A total of 5724 readings were actually transmitted and received, 
representing a compliance rate of 86.5%. The compliance rate per person was 
equivalent to 1.7 readings (consultations) per day; or 12.1 readings 
(consultations) per week. The proportion of red alerts was 82.6% (n=4,726) of 
the readings generated (Table 5.10). 
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Table 5.10: Compliance with telehealth home monitoring 
Experience of cases in Doncaster (note: cases with more readings received than was expected were considered to have 
complied fully, i.e. 100.0%, even though reading received was more than that expected) 
Sex Age 
(yrs.) 
Duration 
years of 
follow-up 
Actual 
days 
monitored 
Readings 
Received 
Red 
Alerts 
% of 
Red 
Alerts 
Expected 
readings 
calculated 
Compliance 
Rate% 
Consultation 
rate per day 
Consultation 
rate / person / 
week  
Female 69 0.8 285 629 382 60.7 570 100.0 2.2 15.4 
Female 78 1.2 423 328 203 61.9 846 38.8 0.8 5.4 
Female 80 1.3 478 950 814 85.7 956 99.4 2.0 13.9 
Female 63 1.1 384 715 564 78.9 768 93.1 1.9 13.0 
Male 79 0.3 113 209 164 78.5 226 92.5 1.8 12.9 
Male 108 1.1 407 821 777 94.6 814 100.0 2.0 14.1 
Male 75 1.1 409 589 513 87.1 818 72.0 1.4 10.1 
Male 66 1.1 416 755 752 99.6 832 90.7 1.8 12.7 
Male 76 1.1 394 728 557 76.5 788 92.4 1.8 12.9 
All 
Females 
72 4.3 1570 2622 1963 74.9 3140 83.5 1.7 11.7 
All Males 81 4.8 1739 3102 2763 89.1 3478 89.2 1.8 12.5 
All 
Persons 
77 9.1 3309 5724 4726 82.6 6618 86.5 1.7 12.1 
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5.19 Harms 
There were eight deaths (8/18) in the intervention group and seven deaths 
(7/18) in the control group, as shown in Table 5.9. Mortality rate per year of 
follow up was 0.52 (95% CI: 0.22, 1.02) in the intervention group, and the rate in 
the control group was 0.36 (95% CI: 0.14, 0.74). 
A major concern was related to the high rate of red alerts that were reported 
through the telehealth monitoring system, which was 82.6% of all the readings. 
This resulted in increased contacts with patients. Some of these contacts were 
necessary, while others were not. The potential harm from the red alerts was 
that they could be ignored since they were so frequent. Some of the red alerts 
arose from the fact that the questionnaires selected were not specific enough to 
detect deterioration in patients’ situation at the time of answering the questions. 
Consequently, patients often would return a response that yielded red alerts for 
a whole week (Table 5.2). Another reason for the red alerts was that staff did 
not have much experience in setting realistic red alerts that reflected the 
patients’ individual situations, but were guided more by national guidelines from 
the National Institute for Health and Care Excellence (NICE) for COPD. 
There were no harms directly reported as a result of using telehealth by 
patients. One patient reported concern around his readings not being picked up 
by the district nurse, when the latter was on leave.  
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5.5  Discussion 
5.5.20 Limitations 
The study had a number of challenges and limitations which became more 
evident as the trial progressed.  Ultimately the trial was stopped.  Details of 
these limitations are provided below. 
Some inconsistencies in the methods of recruitment are worth highlighting, 
although they did not affect the study arms differently due to the randomisation 
process undertaken. These inconsistencies related to: (1) differences in 
population frame used for the sample size estimation and for recruitment to the 
trial; and (2) different time frame between when study sample were identified 
and the baseline period before commencing on telehealth service. Hospital 
admissions at the time of sample size calculation proved to be different from 
when the actual study sample frame was derived. The data for calculating the 
sample size was much older (October 2005 to September 2006) than that used 
for recruiting participants into the trial, which captured patients during 2007.  
After participants were identified from the sample frame, there had been time 
lag of a couple of months before they were recruited into the study. This time 
lag was taken up for the necessary preparatory work, such as, undertaking staff 
training and consenting patients into the trial before recruiting participants into 
the trial. The time lag shifted the “baseline” period of the trial, which was taken 
as 12 months before starting on the trial from that when the study frame was 
identified. Therefore, participants with two or more hospital admission during the 
sample frame period when they were selected into the trial, might no longer 
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have similar level of previous hospital admission during the 12 months period 
when they actually started on the trial (baseline period). 
Since the actual baseline hospital admissions were lower than those originally 
anticipated, the economic model described in Table 5.4 is invalid. The cost-
benefit model (Table 5.4) relied on the assumption that the mean hospital 
admission per year per person was three, but the findings from the trial showed 
that the mean hospital admission per person per year was only 1.11 in the 
intervention group and 1.89 in the control, with no statistically significant 
difference between the study groups (Table 5.6). Evidence from different 
sample study frame showed that the average hospital admission reduced, even 
without any telehealth interventions, suggesting a possible regression to the 
mean. 
The change in inclusion criteria, from two previous hospital admissions from 
COPD to at least one previous hospital admission in the past 12 months, 
introduced some element of potential bias in the trial in detecting the effects of 
the intervention. However, through randomisation, the two arms of the trial were 
treated in the same way despite the change in inclusion criteria. The trial was 
originally planned to recruit 36 cases (Option 3, Table 5.5) and it achieved that 
number. The amended criteria were for a planned increase of study sample size 
to 80 participants, which did not come to fruition as the trial was halted 
prematurely. 
During the trial, the actual baseline mean hospital admissions were similar: 1.11 
(95% CI: 0.44, 1.94) for the intervention group and 1.89 (95% CI: 1.11, 2.72) for 
control groups. There was a large fall in the admission rates after recruitment in 
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both groups, thus suggesting that concerns about bias in randomisation process 
was false. The large reduction in admission rates observed is similar to a 
regression to the mean (RTTM) effect. This effect was very much larger than 
anticipated. The conditions during the trial were therefore very different to the 
conditions before the trial. This demonstrates the need for an RCT rather than a 
pre- and post-study design. The RTTM effect is also much larger than any 
anticipated treatment effect. As this is a source of considerable extra variation, 
the trial should be redesigned. Since the admission rate was lower and much of 
the variation in rate was further reduced due to the RTTM effect, the outcome 
measure had very different properties to that anticipated at trial design.  If 
circumstances arise where another trial of telehealth is appropriate, then these 
influences should be factored into the redesign. 
The change in statistical test used (non-parametric test instead of student t-test) 
might have resulted in lower power of the study and the potential for benefit was 
reduced. Therefore, the trial was less likely to detect an effect.  
Given the option, some of the staff would have expectation and preference to 
give telehealth to their selected patients. From a research point of view, no one 
was at equipoise (including staff and patients); there was inherent belief that 
telehealth was effective, thus holding a biased position in favour of telehealth. 
Patients on telehealth might have reassurance that they were being monitored 
and therefore could down-grade their symptoms and not seek hospital care, 
unlike those receiving standard care. This assurance might be false for some 
patients, as there were a lot of red alerts generated from the telehealth 
monitoring system and their validity was uncertain. It was made clear to patients 
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however, that if they felt the need for emergency health care (Accident & 
Emergency or A&E in the hospital), they should make that contact, as the 
telehealth service was not an emergency service.  
From a healthcare organisation point of view, Doncaster PCT was willing to 
invest in piloting telehealth because it believed in its potential health benefit. To 
minimise bias in allocation of participants, randomisation was carried out by 
different administrative staff to those who were not part of the clinical nursing 
team. Hence, the nursing staff did not influence in the selection of who should 
be allocated to the intervention arm of the trial to receive telehealth.  
It was possible, that some staff might have carried out compensatory work with 
controlled arm of the trial, especially drawing on lessons learned from the 
intervention group. Nursing staff also considered their primary role as 
preventing hospital admission, and they perceived telehealth as a threat to their 
job. Therefore, some of the nursing staff may have preferred it to fail in showing 
any potential health benefit. It was also possible, that healthcare professionals 
interacting with trial participants could have influenced patients’ behaviour, for 
example, they might have influenced when the patients sought hospital 
admissions. There was little firm evidence obtained that potential compensatory 
behaviour took place among the clinical staff, in the form of trying harder with 
control group participants. On the contrary, it was felt that the high rates of red 
alerts might have diverted the attention of nurses away from providing routine 
care, including care to those in the control arm of the trial. For participants in the 
control group, it was likely that enrolment into the trial might have increased 
their awareness about telehealth, but there was no evidence that it resulted in 
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modification of their behaviour to improve their health. Although the trial was 
small with only 36 patients, it would have been greatly preferable to run a pilot 
trial before embarking on the main trial.  Looking back, the conditions for a fair 
pragmatic trial were not in place at the time; a good pilot with process 
evaluations would have uncovered the limitations encountered in this trial. This 
would have identified lessons learned by others related to failed trials (Rendell 
et al., 2007) and factors influencing the conduct of successful trials (Campbell et 
al., 2007), as summarised in Table 5.11, which would have enhanced the 
quality of the trial. 
The premature discontinuation of the trial meant that the full outcomes initially 
planned could not be realised as part of the trial findings, including effects of 
telehealth on hospital admission, quality of life, and patients’ satisfaction. 
The timeline of this PhD, which commenced after the trial began, meant that 
there were additional secondary analyses introduced, such as, Wilcoxon 
ranked-sum test, including logistic regression. Before enrolment onto the PhD, 
this was not clearly determined. With the commencement of PhD study, 
additional knowledge was gained in how to analyse the findings of the trial, 
using Stata software (version 11). The pragmatic trial helped to address the 
question of whether telehealth is effective in the real world of routine healthcare 
delivery, (Roland and Torgerson, 1998) that is, in a Primary Health Care Trust 
in Doncaster (England), where policy makers wanted to implement telehealth. 
Analysis was carried out based on intention to treat (ITT). This meant that 
participants who were allocated into the two arms of the trial, during any time 
period, were included in the final analysis. This included participants who were 
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assigned to the intervention arm of the trial and used telehealth for less than 
two weeks.  
The fact that half of the intervention participants (9/18) withdrew within two 
weeks of commencing on telehealth, weakened the validity of the trial. This 
shows that, for patients recruited through the RCT, adherence to telehealth was 
poor.  
The scale of red alerts generated was too high; 82% in this study. The high 
level of red alerts could be a reflection of lack of confidence by practitioners in 
setting the right vital sign parameters; and the problem of the selected 
questions that were initially thought to be relevant for patients with COPD. Most 
clinicians relied on guidelines, which did not reflect the conditions of individual 
patients. A red alert meant that healthcare professionals had to make contact 
with the patients, thus generating more work. With limited capacity in the 
workforce, the increased workload might be additional source of frustration for 
staff, and a possible reason why they ended up leaving work on the telehealth 
service. The nurses were not fully released to do the telehealth service work, 
they were doing it in addition to their main district nursing duties. With the high 
rate of red alerts (82%), this suggests that the level of contacts between 
patients using telehealth service and their healthcare professionals was also 
more frequent than patients in the control arm of the study. The increased 
contacts with the intervention group could potentially divert attention from 
control groups, thus raising potential safety concerns to those receiving 
standard care. As the red alert rate was so high, staff could become complacent 
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and might ignore the red alerts, thus posing a potential safety concern too 
among those using the telehealth service. 
There was some concern that telehealth might have provided a false sense of 
security to some patients, who felt they were being monitored by healthcare 
staff when in fact the staff concerned were actually not actively monitoring 
patients. However, this concern was not substantiated. Apart from rare 
occasions, the nurses appeared to be dedicated in ensuring that the alerts were 
monitored during office hours and they took appropriate action. It was identified 
as a key gap, as part of risk in the service to have a sole nurse running the 
service, as oppose to a team to provide assurance of business continuity of 
telehealth service. This lesson was translated into the future development of 
service, which is reported in the observational study (Chapters 6 and 7). 
It was also found that hospital episode statistics (HES) was a poor source for 
recruiting participants into a trial due to out-of-date records or cases that could 
not be easily contacted. Recruiting patients while they were in hospital would 
have been a more efficient method. 
The costs of telehealth service were recognised to be much greater than that of 
the machine and hospital admissions alone. Other costs not featured in the 
analysis could include staff cost and costs to patients and carers. What the 
findings show is that the actual cost of delivering telehealth service would have 
been much higher than that found in the trial, making telehealth service even 
less cost-effective in the form it was used during the trial. 
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The strength of the trial was that it assessed the effectiveness of telehealth in a 
real world situation at the time when there was limited, good quality evaluation 
on the subject (Chapter 4). RCTs are regarded as the gold standard in 
hierarchy of evidence (SIGN, 2011). On this basis, it was considered justifiable 
to conduct a pragmatic RCT to determine the effectiveness of telehealth. The 
aim and objectives of the trial were clear. 
5.5.21 Generalisability 
The main findings of the study show that there is little evidence for effectiveness 
of telehealth in reducing hospital admission rates; significance tests did not 
show any difference between hospital admissions experience between control 
and intervention groups despite the admission rates being lower in the 
intervention arm of the trial.  
The trial showed that, even without considering the cost of staff time, telehealth 
was already not cost-effective. The mean cost (pounds sterling or GBP-£) for 
the intervention group was £7,544 compared to £2,604 in the control group 
(three times higher in the intervention than the control group). If the real cost of 
telehealth service (machines plus all the service around it, including staff costs) 
were considered, telehealth as used in this trial, would have been even less 
cost-effective. 
The study also adds to our understanding of (1) how patients complied in using 
telehealth, including the fact that nine of the 18 patients only used telehealth for 
less than two weeks suggesting that patients might have disliked the machine; 
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and (2) the dynamics between patients and staff in relation to remote home 
monitoring, and in particular the concerns about the high rate of red alerts. 
It is often a challenge to try and translate the findings from research studies into 
the real world, as acknowledged in the literature.  Complex interventions are 
often difficult to replicate due to difficulties in identifying the actual ‘ingredients’ 
that were responsible for the outcomes achieved (Campbell et al., 2000).  
5.5.22 Interpretation 
The findings from the trial show that there is little evidence of reduced hospital 
admission rates among patients with COPD, who were living in the community. 
The null hypothesis was accepted, which stipulated that telehealth made no 
difference in hospital admission rates among patients with COPD. Similarly, 
there was no impact of telehealth usage on lengths of hospital stay among 
participants in the trial. Mortality rates were similar in both arms of the trial, 
while the results showed that telehealth was not cost-effective. The findings of 
the trial, which demonstrated that telehealth had no effects on hospital 
admission rates, mortality rates, and  was not cost-effectiveness are similar to 
some of the literature review findings reported in Chapter 4. 
The Whole System Demonstrator (WSD), one of the world’s largest RCTs on 
telehealth to-date, found an odds ratio (OR) from hospital admission to be 0.82 
(95% CI: 0.70 to 0.97), only marginally protective for telehealth (Steventon et 
al., 2012). The findings of the WSD was heavily influenced by admissions 
records in the first three months of the trial, if this initial three months were 
excluded  the study would not have been able to claim any positive findings 
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reported. A separate economic evaluation of the WSD showed that the cost per 
quality adjusted life years (QALY) for patients on telehealth was £92,000; three 
times more than the upper limit recommended by NICE (Henderson et al., 
2013). The WSD also showed that telehealth was not cost-effective. In this 
pragmatic trial, it was found that the cost per year of follow-up in the telehealth 
group was three times more expensive than that in the control group. If all 
relevant costs were taken into account, telehealth would be even less cost-
effective. 
There were no consistencies in the published literature on mortality outcomes. 
Although the WSD appeared to find significant difference in mortality in favour 
of the telehealth group (Steventon et al., 2012), other studies showed no 
significant difference in mortality between the intervention and control groups 
(McLean et al., 2011, de Toledo et al., 2006, Vitacca et al., 2009). 
On the other hand some positive findings were reported from a number of 
systematic reviews on telehealth among COPD patients, including hospital 
admissions odds ratio of 0.46 (95% CI: 0.33 to 0.65) (McLean et al., 2011); and 
Sorknaes and colleagues  found hospital admissions hazard ratio (HR) of 0.25 
(95% CI: 0.09, 0.69) among COPD patients (Sorknaes et al., 2011). 
This chapter has provided a platform for work reported in the next two chapters, 
which focus on exploring why new technology embeds or not in routine practice, 
drawing on the experience from this chapter.  
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5.6  Other information 
5.6.23 Registration 
The trial received ethical approval from South Humber Local Research Ethics 
Committee, reference number 06/Q1105/64 (details in Annex 2.1).  
At the time of conducting the trial, information about registration with the Trial 
Register of Promoting Health Interventions (TRoPHI) was unknown to the 
author (even though the register was in place then) and therefore it was not 
considered at the time of the trial; as a result the trial was not registered on 
TRoPHI. The requirement of registration of the trial was not mandatory, and no 
recommendation was made by the Research Ethics Committee for the trial 
registration, which could have prompted the author to register the trial.  
5.6.24 Protocol 
A copy of the trial protocol was submitted as part of NHS Research and 
Development application online on 24 January 2007. A copy of the application 
submitted is available from the author. 
5.6.25 Funding 
Funding for this study was secured from Neighbourhood Renewal Fund (NRF), 
totalling £65,000 (sixty-five thousand pounds), which comprised of £30,000 for 
capital costs (to purchase the telehealth machines) and £35,000 was allocated 
for revenue costs (including connection / communication fees and staff costs). 
185 
 
 
Following a competitive tender process (described in Chapter 3 on telehealth), a 
successful supplier (Tunstall) was chosen from among eight suppliers (Docobo, 
RSL Steeper, Initial Attendoo, Tunstall, Fold Telecare, Philips Medical, Pro-
wellness, and TSB GB Telematic). 
The telehealth machine did not change during the trial. There was a plan in 
2009 to replace the initial machines but this did not happen until 2010, when the 
trial had stopped. The rapid development of technology can be seen to be one 
of the challenges in evaluating telehealth but was not the case here. The wider 
roll out of telehealth service was funded by Doncaster PCT. 
5.7 Lessons from other failed trial: the pragmatic trial in context 
The trial planned to recruit 36 participants and it achieved that target. However, 
the trial could not be followed up for the anticipated 12 months’ period and had 
to be stopped. The immediate reason that led to the stoppage of the trial was 
that the only remaining nurse left the job and there was no nurse to monitor the 
telehealth service. It was therefore deemed unsafe to continue with the service 
as it was. The underlying reason was that the trial was considered to be 
premature; it should have been preceded by a pilot to assess the process 
outcomes. This would have uncovered a lot of the issues related to staff, 
technology, and patients. Lessons learnt from the pilot could have strengthened 
the conduct of the pragmatic trial. 
It was the plan to increase the sample size of the trial from 36 to 80 participants, 
but this did not happened due to factors related to recruitments, and changes to 
the technologies, among others. 
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Research has shown that a third of trials managed to recruit less than 75% of 
planned subjects; and that reluctance of clinicians was a greater obstacle to 
successful completion of trial, than reluctance of patients (Rendell et al., 2007). 
A review by Rendell et al. (2007) investigated factors that were considered as 
incentives or disincentives to clinicians to participate in recruiting patients into 
studies. They found that motivation was more important than simply being 
acquainted with the researchers (Rendell et al., 2007). In this pragmatic trial, 
the clinicians involved were largely not acquainted with the researcher; instead, 
some of the nurses who were considered to be more acquainted with the 
researcher resisted participating in telehealth. The reason they gave, included 
the view that some patients were not suitable as they were end-of-life or 
palliative patients. They also considered that any funds available could be used 
for alternative causes such as recruiting more nurses rather than for procuring 
telehealth devices. There were fears also expressed by community nurses that 
telehealth, if shown to be successful, might replace nursing jobs. There was 
similarity in the findings in this trial to that of the review by Rendell et al. (2007) 
related to potential increased workload to clinicians resulting from recruitment of 
participants. The potential increase in workload during the trial could be from 
red alerts generated from telehealth. Rendell et al. (2007) review also identified 
the same concern expressed by clinicians about randomisation process, which 
was not considered to be selecting the intervention clinicians perceived to be 
beneficial for their patients selected for the trial. This was one of the reasons for 
local resistance to participate in this pragmatic trial on telehealth. The other 
factors that were also experienced in this trial, also reported in the review 
(Rendell et al., 2007), were related to too stringent criteria. There was lack of 
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availability of dedicated staff in recruitment of participants. Participation of an 
academic research group was viewed to be a positive factor in helping to 
increase recruitment to research studies (Rendell et al., 2007). However, this 
trial did not have participation of an academic research group as such, but it 
was linked to an academic institution through PhD supervised study programme 
at the University of Leeds, Institute of Health Sciences being undertaken by this 
author. Another concern identified by Rendell and colleagues was about 
damage to doctor-patient relationship which was considered to be a potential 
disincentive to participation in research. In this trial, it was found that where 
doctors (GPs) were not fully aware of the telehealth service and they did not 
know what to do in case they were contacted by a community matron; they 
were less likely to engage positively with the patients. Some patients withdrew 
from the trial for fear of not damaging their relationship with their doctor, when 
they found that the GP were negative about telehealth service.  
Another review evidence from the literature to contextualise findings of the trial 
came from the findings of a report by Health Technology Assessment 
(Campbell et al., 2007), which examined factors associated with good and poor 
recruitment into multicentre trials. The authors found that of the 114 trials 
reviewed, less than one third (31%) successfully recruited participants to their 
original target. The pragmatic trial reported in this chapter managed to recruit to 
the original target. However, it did not recruit to the amended protocol target of 
80 participants due to stoppage of the trial. Factors identified for successful 
recruitment into a trial included those summarised in Table 5.11, and these 
were contextualised for the pragmatic trial into factors met and unmet in the 
course of the trial (Campbell et al., 2007).  
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Table 5.11: Factors influencing successful recruitment into trials  
Source: (Campbell et al., 2007) 
Factors met in this trial (TELECCOM study) 
• Having intervention only available inside the trial 
• Trials addressing clinically important questions 
• Need of patients were considered to be well served in the trial 
• Trials were grounded in existing clinical practice 
• Funders monitoring progress of the trials 
• Feelings of pride in taking part in the trial.  
• Investigators were held in high esteem 
Factors not met or limited evidence in this trial (TELECCOM study) 
• Trial flexible and robust enough to adopt to changes 
• Having dedicated trial manager 
• Being a cancer or drug trial  
• Using newsletters and mailshots to communicate about the trial 
• Clear delineation of roles, which released the research collaborators 
from workload related to the trial participation. 
• Team building 
• Training about trial intervention and processes 
• Good ground work and excellent communication  
• Use of business model (framework) to recruit participants into the 
research: (i) building brand value; (ii) product and market planning; (iii) 
making the sale; and (iv) maintaining engagement. 
A lot of the factors identified in Table 5.11 were lacking in the trial. Although 
there was Assistive Technology Manager recruited to post at the beginning of 
the trial, this was only temporary. The employment contract ended and the 
individual left the job before all participants were recruited into the trial. 
Telehealth service, as an intervention, was available for those inside the trial. 
The trial was neither for cancer nor drug trial. Communication could have been 
189 
 
 
improved, and there was no arrangement made for neither newsletter nor 
mailshots to communicate with clinicians, including GPs, to inform them about 
the trial. However, there was a GP represented in a steering group for the 
project.  
The investigators were local clinicians / public health leaders in their respective 
fields, and the initiative of the trial was considered to be in the best interest of 
patients. Despite efforts to agree roles of collaborators in the trial, to ensure 
workloads were not unnecessarily increased, this was not realised; as line 
managers of the community nurses maintained normal duty in addition to that of 
the trial. No qualitative data was gathered at this stage of the trial in order to 
determine participants’ feelings towards the project, because the trial was 
stopped prematurely. Some training was delivered to staff but this was 
considered to be inadequate. An update of the project progress was provided to 
the organisation management of Doncaster Primary Care Trust, including 
mitigation measures being considered at the time. The original inclusion criteria 
offered little flexibility in carrying out the trial. No business model approach was 
used to try to recruit participants into the trial. It is possible that this would have 
improved recruitment and identified resource gaps early, to allow them to be 
addressed. From the above analysis, it appears that the performance of the 
pragmatic trial, in terms of staff factors, recruitment of participants, and factors 
related to the technology, could have been improved if some of the factors 
above were considered and addressed, within the limitation of the resources 
available at the time. 
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5.8 Clarification of methods and findings in a separate 
publication  
This section provides clarification on why logistic model was used by the author 
in a separate publication and the ethical implications of post-hoc outcomes. 
The findings of the trial and that of a separate observational study had been 
published in a book chapter (Joseph, 2013). The article concluded that 
telehealth was effective in reducing hospital admissions among patients with 
COPD, heart failure and diabetes. The analysis of the trial, which focused on 
patients with COPD, was performed using hospital admission and logistic 
regression modelling. Since the trial was small, randomisation may not have 
balanced all factors between the two arms.  Thus, an analysis with adjustment 
for baseline factors, using logistic regression modelling, would be reasonable 
and might also give further understanding of the impact of factors on the 
outcome.  For the book chapter, the RCT protocol, which is usually preferred for 
reporting in the academic literature, had been adhered to. The results show a 
non-statistical significant reduction in hospital admission rates, while logistic 
regression analysis showed a statistically significant reduction in hospital 
admissions (odds ratio of 0.80; 95%CI: 0.01, 0.81; p-value 0.03). The logistic 
regression model performed could be considered as a post-hoc analysis, in 
view of the fact that it was not explicitly stated in the study protocol. The use of 
post-hoc outcome analysis had been recognised as an important analytical tool 
in research (Elliott, 1996). There are however limitations of the use of post-hoc 
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analysis (Elliott, 1996, Stefansdottir et al., 2013), as well as its associated 
ethical implications (Leung, 2011). 
Logistic regression analysis could have been included at the design stage of the 
trial, but this was considered after registration for the PhD programme (see PhD 
study line in Chapter 1, Figure 1.3). Following expert statistical advice and 
further training received in handling statistical analyses for the trial, as part of 
PhD study, this was able to be undertaken. 
The justification for the use of logistic regression, as post-hoc analysis, includes 
the fact that it focuses on hospital admissions as categorical variables, viewing 
analysis from the angle of whether or not patients with COPD were admitted to 
hospital. It was considered to be an appropriate and important analysis to 
perform. Future research in this area should include this analysis as part of the 
hypothesis (a priori hypothesis – pre-specified). 
The limitation of the use of logistic regression analysis, as a post-hoc analysis, 
is that it can be criticised for attempting to find particular outcomes or 
relationship, which had been referred to as data fishing, mining or dredging 
(Smith and Shah, 2002). In the case of the trial, the post-hoc analysis could be 
accused of actively trying to find evidence of reduction in hospital admissions in 
relation to the use of telehealth. The chance of finding false statistical significant 
results is increased where multiple tests are carried out. It is possible that the 
logistic regression findings of the trial could uncover false statistically significant 
results, especially given the small sample size. The post-hoc findings from the 
trial using logistic regression model should be considered as exploratory only: 
as providing potential associations, rather than testing whether telehealth is 
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effective. The overall conclusion of the article (Joseph, 2013), is based not only 
on the findings of the trial, but also on the findings from the observational study, 
which was conducted separately and included different patients population 
(patients with COPD, heart failure and diabetes). In the observational study, the 
regression model was pre-specified as an analysis tool to predict the effects of 
the intervention on hospital admissions and other secondary health outcomes. 
The ethical implication of post-hoc outcomes is that presenting the finding as 
though they are a priori (pre-specified) is likely to breach the ethical conduct of 
research (Leung, 2011). Leung (2011) suggested two options to remedy the 
challenge, either researchers could delete the rejected hypotheses or modify 
the hypotheses based on empirical findings. In this chapter, the number of 
hospital admissions is a pre-specified outcome, and there are multiple 
approaches used in performing the analyses. 
5.9 Chapter conclusions 
Telehealth, as used in the trial, was neither effective nor cost-effective in 
reducing hospital admission rates among high risk patients with COPD living in 
the community. Compliance with telehealth home monitoring was high among 
patients with COPD. However, the rates of red alerts generated from telehealth 
were also very high, which could increase workload of staff and posed safety 
concerns. 
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Chapter 6: Assessing Embeddedness of Telehealth Service in 
Routine Practice: A Service Evaluation 
6.1 Introduction 
The previous two chapters of this thesis addressed the effectiveness of a 
telehealth service in reducing hospital admissions among other health 
outcomes. This was achieved by reviewing the literature, and conducting a 
pragmatic randomised controlled trial (RCT). The current chapter is dedicated to 
assessing embeddedness of a telehealth service in routine healthcare practice. 
Embeddedness is defined as the process of “making practices routine elements 
of everyday life” (May and Finch, 2009). Along with social organisation of work 
(implementation), and sustainability of embedded practices in social context 
(integration); embeddedness forms part of Normalisation Process Theory (NPT) 
(May and Finch, 2009), which was described in Chapter 2.  
Implementation of innovation, such as new technology, involves a range of 
activities, from making adoption commitment to when an innovation either 
became routine in an organisation, or when it ceased to be new or was 
abandoned (Linton, 2002). Linton (2002) further noted similar attitudes among 
staff involved in implementation of innovation, which were characterised by 
avoidance, compliance, or skilled use of a new technology. 
Embeddedness is important in helping to understand why innovation, such as 
implementation of new technologies, fails or succeeds in routine health 
services. The factors, which determined embeddedness of new practices in 
relation to NPT were described previously, in Chapter 2. 
194 
 
 
6.1.1 Backgrounds and rationale 
The pragmatic trial on telehealth was stopped prior to its planned completion. 
The reasons for stoppage were outlined in Chapter 5. Fundamentally, it became 
apparent that there were many factors in the trial that were contributing to 
making it less likely to achieve valid results. These factors were not fully 
anticipated at the time, including the challenges related to staff, recruitment of 
participants, and the technology, among others. Analysis following the trial 
revealed little evidence that the telehealth service made any difference in 
hospital admission rates among community-dwelling patients with COPD, and 
there was also little evidence regarding its cost-effectiveness.  
The service evaluation (observational study) was a new phase of 
implementation of telehealth following the stoppage of the pragmatic trial. The 
strict eligibility criteria and randomisation process associated with the trial were 
removed. Less onerous eligibility criteria for inclusion in the study and follow-up 
of patients were adopted as part of the service evaluation. 
The main purpose of the current chapter is to understand why new technologies 
embed or not in routine practice, rather than to assess the effectiveness of 
telehealth. At this stage, lessons were learned from the pragmatic trial that 
could be transferred to the service evaluation, to improve the implementation of 
telehealth. There was also the need to observe how telehealth operated rather 
than to impose an artificial environment similar to that of the trial for the staff 
and patients in particular. A simpler and faster means of evaluation based on a 
greater number of patients receiving telehealth was needed, and the service 
evaluation offered this flexibility. 
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There is no accepted quantitative measure of embeddedness in the published 
literature. It has been identified that acceptance of telehealth by users is an 
important factor in the implementation of a telehealth service (Broens et al., 
2007, Joseph et al., 2011). A systematic review by Gorst et al. (2014) used 
acceptance rate as a measure of uptake rate of telehealth service. They found 
that the uptake of telehealth among patients with heart failure and COPD was 
67.9% (640/942) (Gorst et al., 2014). Therefore, it was decided to use the 
uptake rate of telehealth as a quantitative measure of this aspect of 
embeddedness for the service evaluation study. The overall uptake rate 
(67.9%) found by Gorst et al. (2014) was used as the standard to judge 
embeddedness and to pose hypotheses tests. 
6.1.2 Objectives 
The main objective of this chapter is to assess the embeddedness of a 
telehealth service in routine healthcare practice.  
Other secondary objectives are to assess compliance of patients with telehealth 
home monitoring and the associated levels of red alerts; and to assess patients’ 
levels of satisfaction with the service.  
The primary difference between Chapter 5 and Chapter 6 are in the following 
areas: (1) Chapter 5 assessed the effectiveness of telehealth service, while 
Chapter 6 assesses uptake of a telehealth service; (2) the evaluation designs of 
the service are different, along with selection of participants; and (3) patient 
groups are also different.  The evaluation design in Chapter 5 was a pragmatic 
trial focusing on patients with COPD, while Chapter 6 is a service evaluation 
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involving patients with long-term conditions (e.g. COPD, heart failures, and 
diabetes, among others).  
6.1.3 Hypotheses 
The null hypothesis was that the uptake rate of the telehealth service would be 
67.9%; similar to that observed in the systematic review (Gorst et al., 2014).  
The alternative hypothesis is that the uptake of the telehealth service would 
differ from 67.9%; with a lower rate suggesting the lack of uptake and therefore 
embeddedness of the telehealth service; and a higher uptake of telehealth 
service would support the case for embeddedness. 
It was hypothesised that the telehealth service would embed in routine health 
service in this service design. Embeddedness of telehealth service would be 
demonstrated if:  
Primary outcome 
1. There is a statistically significant increase in the proportion accepting 
telehealth service over the whole study period. 
Secondary outcomes 
2. Generalised linear modelling shows a high acceptance rate of the telehealth 
service over time. 
3. Compliance rates (percentage of readings received versus expected) with 
the telehealth service are the same or better than that observed in the 
pragmatic trial (86.5%). 
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4. The rates of red alerts generated from the telehealth service during the 
service evaluation study are significantly lower than 82.6%; the rate of red 
alerts observed in the pragmatic trial. 
6.2 Methods 
6.2.1 Study design 
The study is a service evaluation, which may be regarded as a cohort study in 
terms of telehealth home monitoring, including compliance to the telehealth 
service and red alerts. A cohort study is a specific type of an observational 
study where patients are followed up over time. Selected patients with long-term 
conditions (COPD, heart failure, and diabetes) and under the care of community 
nurses were offered telehealth service and followed up over a 24-month time 
period.  
6.2.2 Setting 
The study was conducted in Doncaster, a district in England, involving patients 
with long-term conditions who were under the care of community nurses 
(community matrons or heart failure nurse) and living in the community. A 
detailed description of Doncaster, as the study setting, was reported in Chapter 
3, this contains population profile, geographical location and deprivation status. 
6.2.3 Participants: eligibility criteria, selection and follow up 
The main criteria for participants recruited onto the telehealth service were that 
they had long-term conditions and were under the case-load of community 
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nurses. Cases that made up community matron workload were selected based 
on patients who were considered to have intense health needs; often with 
multiple hospitalisations in the previous year and therefore regarded as most 
complex; they were also referred to as Level 3 long-term condition patients 
(Department of Health, 2006). Long-term condition cases that were considered 
to be under Level 1 and 2 were not part of community matron caseload, as they 
could be managed under disease specific protocol or by self-care. Cases on 
community matron workload were identified with the help of the English 
Department of Health risk prediction tool, which was referred to as “Patients at 
Risk of Re-hospitalisation” or PARR. The tool predicted the likelihood of a 
patient being admitted to hospital in subsequent 12 month period (Department 
of Health, 2006). 
Recruitment into the study was undertaken by community nurses; who were 
either community matrons or heart failure specialist nurses. The community 
nurses had a number of patients under their care, with each nurse expected to 
manage up to 50 patients. The patients were considered to be in stable 
conditions. The community nurses had freedom to choose from among the 
patients on their caseload those patients whom they considered to be suitable 
for telehealth. These patients were then referred to the telehealth service under 
the coordination of a Telehealth Coordinator. 
Consents from patients were obtained by community nurses before being 
offered the telehealth service. After obtaining consents from patients, the 
Telehealth Coordinator then installed telehealth device for the patients. Patients 
were free to withdraw from the service at any time of the telehealth service. 
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The author worked with the nurses and involved them in agreeing the new 
approach for selecting patients. This contrasted with the pragmatic trial, where 
nurses had no choice of which patients would get telehealth service. In this 
study, nurses were in control of selecting the appropriate patients for telehealth 
service, based on their own clinical assessment.  
The recruitment of patients onto the telehealth service and their subsequent 
follow-up and analyses were on-going during the period from March 2010 to 
June 2012 for uptake of the telehealth service. A number of sub-analyses were 
undertaken over different shorter time-scales, but within the above broad time-
frame. This was to investigate a number of outcome variables, for example 
compliance rate, acceptance of telehealth service, satisfaction with the service, 
etc. 
6.2.4 Variables 
The case definition was based on patients diagnosed with long-term conditions 
considered as requiring intensive use of health care (Level 3) see above; and 
patients had to be under the care of a community matron or specialist heart 
failure nurse. Referral to telehealth service was only received from community 
matron or heart failure nursing teams. The selected participants were offered 
the telehealth service (see description in Chapter 3).  
(1) The primary outcome measure for embeddedness of telehealth was the 
proportions of users accepting telehealth service over the whole study 
period. This was compared with an acceptance rate of 67.9% (640/942) in 
the previous systematic review (Gorst et al., 2014). 
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The secondary outcomes were: 
(2) Generalised linear modelling for binomial family of acceptance rate of 
telehealth service by month. 
(3) Compliance rate with telehealth service: percentage of readings received 
versus expected; and rate of readings received per day and per week 
(4) Proportion of red alerts generated from the telehealth service.  
6.2.5 Data sources / measurement 
The measures of embeddedness were based on uptake of telehealth under 
natural healthcare condition. Acceptance of the telehealth service was defined 
as proportion of patients who were referred to telehealth service and who 
subsequently used the service. 
Compliance rate during the study period was calculated as percentage of actual 
readings in relation to the expected readings; while rates of red alerts were 
calculated as a proportion of all alerts received. Two readings were expected 
per day, one in the morning and the other in the afternoon, taken at specified 
time suitable for patients and agreed with the community nurse. A three-month 
sample was taken in order to assess compliance by patients’ characteristics, 
including sex, age groups, diagnoses, and current or ex-users of telehealth 
service. 
The telehealth Integrated Care Platform (ICP) Triage Manager (Tunstall online 
database for monitoring patients’ vital signs) was accessed using a secure 
username and password. A compliance report was obtained from the ICP 
Triage Manager, which detailed the compliance status for each patient to 
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telehealth home monitoring. The telehealth readings were manually extracted 
and transferred onto an excel spread sheet for further analysis. The following 
colour codes were used to interpret the readings on patients’ online home 
telehealth monitoring record (Table 6.1).  
Table 6.1: Severity legend of telehealth readings 
Colour Classification Meaning 
 Red High risk answers or vital alerts (outside parameters 
set) 
 Amber Medium risk answers, no vital alerts 
 Blue Reading not submitted when expected (patient 
incompliance) 
 Grey Lost contact (no response from patient’s equipment) 
 Yellow Incomplete data (reading submitted with missing 
data) 
 Green Low risk answers, no vital alerts (vitals within limits, 
questions with no or low risk) 
 
A monthly trend of all active cases on telehealth between April 2010 and June 
2012 was produced from Tunstall online database of patients’ records of 
telehealth users. 
6.2.6 Study size 
The findings from Gorst et al. (2014) on proportion of patients accepting a 
telehealth service was used as comparison of proportion accepting the 
telehealth service in the observational study. The power of the study to detect 
embeddedness of the telehealth service was calculated using Stata version 
11.1 Software.  
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The report from Gorst et al. (2014) can be summarised, as would be done with 
meta-analysis, as an uptake by 640 of 942 patients, giving a rate of 0.679.  For 
the service evaluation, it was anticipated that 147 patients would be offered 
telehealth during the study period.  To provide a guide to the power that would 
arise from a test of proportions, the following calculation was undertaken.  Using 
the following Stata command: sampsi 0.679 0.810, n1(942) n2(147); where: 
Test Ho: p1 = p2, where p1 is the proportion in population 1;                 
and p2 is the proportion in population 2;  
Assumptions: alpha = 0.0500 (two-sided); p1 = 0.6790; p2 =   0.8100; 
sample size n1 = 942; n2 = 147; n2/n1 = 0.16; 
This determined the power of the study to be 0.9065 (or 90.7%). Therefore, a 
difference in uptake of +/-13% can be detected with a power of at least 90%. 
6.2.7 Quantitative variables: statistical analyses 
Statistical analyses were performed using Z-test for proportions (as outlined in 
the sample size calculation above) or equivalently a chi-squared test and 
Generalised Linear Modelling Binomial Regression, using Stata version 11. 
Chi-square test was performed using Chi-square Calculator (Stangroom, 2015) 
to detect difference in proportion of existing users of the telehealth service in the 
systematic review by Gorst et al (2014) and the current observational study.  
Monthly numbers of existing users of telehealth was presented graphically.  
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Summary statistics were produced in a tabular format for compliance rates and 
rates of red alerts to telehealth service. Test of two proportions and Chi-squared 
test were undertaken to assess difference in acceptance of the telehealth 
service. The monthly uptake data and the compliance data were generated from 
Tunstall online database for telehealth; the Integrated Care Platform (ICP). This 
was analysed using an Excel spread sheet to calculate summary statistics, such 
as compliance per person per week. A structured satisfaction questionnaire was 
analysed, which represented a sample of existing users of telehealth service 
during the period April 2012 and June 2012.  
6.3 Results 
6.3.1 Participants at each stage of the study 
There were 204 paper referrals made to the telehealth service during the period 
from March 2010 to August 2011, from 147 patients. Some patients were 
referred more than once to the service. Referrals were linked with patients on 
telehealth service using their NHS number. One hundred and nineteen patients 
(81.0%) that were referred to the telehealth service were able to use the 
service, while 28 (19.0%) patients referred for the service did not use it.  
The reasons for not using the telehealth for the 28 patients who were referred to 
the service included: 11 (12.2%) patients were awaiting installation of the 
telehealth device; 6 (4.1%) patients were declined telehealth by professionals 
because they were deemed unsuitable for telehealth service; and 4 (2.7%) 
patients had their referral withdrawn by referring health professional. 
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All 119 patients who used the service were followed up and analysed. They 
included 33 (22.4%) ex-users of telehealth service. There were also 25 deaths 
(17.0%) during the study period.  
6.3.2 Flow chart 
Figure 6.2 shows referral of patients to the telehealth service, and those who 
subsequently used the service, were followed up. It also shows patients who 
were referred but did not use telehealth service. 
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Figure 6.2: Flow chart showing referral to telehealth service: March 2010 to August 2011 
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6.3.3 Descriptive data: study participants 
There were a total of 119 users of telehealth during the study period, from 
March 2010 to August 2011. An analysis of users of the telehealth service 
revealed that the majority of them (49%) were patients who were issued with 
devices for congestive heart failure (CHF). A total of 41% of patients were 
issued telehealth devices for patients with COPD; 9% of patients were given 
devices, which were referred to as Chronic Disease Management (CDM), for 
patients with both COPD and heart failure; and 1% of patients received device 
for those with diabetes. The 9% of patients who received telehealth devices 
designed for CDM was given to patients with COPD and heart failure, based on 
the clinical judgement of the community nurses at the time. The 9% of patients 
did not represent all patients in the study with multiple comorbidities. Most of the 
patients with heart failures and COPD were likely to have multiple conditions 
even though they were not explicitly identified.  
The sex profile was 58% males and 42% female, while the age distribution 
varied with majority patients concentrated in the age group of 70-79 years old 
(Table 6.2), with average age being 70.6 years old. 
Table 6.2: Age and sex profile of patients on telehealth service 
Age groups 
(years) 
 SEX  
All persons  Male  Female  
 n %  n %  n % 
Less than 50   4 3.4   3 2.5   7 5.9 
50-69  6 5.0  7 5.9  13 10.9 
60-69  20 16.8  11 9.2  31 26.1 
70-79  22 18.5  14 11.8  36 30.3 
80-89  15 12.6  14 11.8  29 24.4 
90 and over  2 1.7  1 0.8  3 2.5 
All ages   69 58.0   50 42.0   119 100.0 
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6.3.4 Descriptive data: follow-up time 
Embedding of telehealth was analysed based on active users of telehealth 
service per month between April 2010 and June 2012, see Figure 6.3. The 
compliance to telehealth home monitoring was analysed over 17 months during 
the period from April 2010 and 31 August 2011 based on readings received, 
expected number of readings, and alerts generated.  
A sub analysis of compliance by sex, age groups, diagnoses, and discharge 
from telehealth service or active users was performed for a cohort of patients 
over a 3-month follow-up period between 1 July 2010 and 30 September 2010. 
This analysis was to gain an in-depth understanding of compliance to telehealth 
service by various patients’ characteristics.  
6.3.5 Outcome data on embeddedness of telehealth service 
6.3.5.1 Uptake of telehealth service 
It was found that uptake of the telehealth service increased steadily over time 
between April 2010 and June 2012 (Figures 6.3). Evidence of the importance of 
the role played by staff in recruitment and implementation of the telehealth 
service is illustrated by uptake of telehealth when the Telehealth Coordinator 
was in post from February 2010, until when she left the job in October 2011. 
After this period, recruitment of patients into the service not only stopped, but 
started to decline when there was no dedicated Telehealth Coordinator in post. 
Tunstall was contracted to monitor the existing patients during the period 
following the departure of Telehealth Coordinator from October 2011 and 
February 2012. However, it did not recruit new patients during this time. A new 
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Telehealth Coordinator was recruited in February 2012, after which, uptake of 
telehealth began to rise again (Figure 6.3). 
Figure 6.3: Existing number of patients on telehealth in Doncaster per month 
April 2010 to 26 June 2012 
 
Statistical tests 
Compared to telehealth service acceptance rate of 67.9% (95% CI: 64.9%, 
70.9%) found in the systematic review by Gorst et al. (2014), the findings on 
acceptance rate in the whole observational study period was statistically higher 
at 81.0% (95% CI: 74.7%, 87.3%); p = 0.001 (Table 6.3). The Chi-square 
statistic (10.1934) also showed statistically significant difference in acceptance 
rates between Gorst et al. (2014) and the current study, (p = 0.001) (Table 6.4).   
The Chi-squared test is almost equivalent to the z-test for proportions and both 
tests are presented here to enable comparison with the approaches taken by 
other authors.  Either test could have been selected. 
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Table 6.3: Two-sample test of proportion of users accepting telehealth service 
Variables Mean Std. Err. z P>|z|      [95% Conf. Interval] 
x .679 .0152111                      .6491867    .7088133 
y .81 .0323564                      .7465826    .8734174 
diff -.131 .0357536                  -.2010757   -.0609243 
 under Ho:   .0407658     -3.21    0.001  
Note: Where x is the number of observations in Gorst et al (2014) = 942; y is 
the number of observation in current work = 147. Stata command used in the 
analysis was: prtesti 942 0.679 147 0.810                                                     
 
Table 6.4: Chi-squared test: refusal and acceptance of telehealth between 
Gorst et al. (2014) and the observational study  
  Gorst et al. (2014)  Observational Study  Totals  
Refused 
telehealth  
302   (285.45)   [0.96]  28   (44.55)   [6.15]  330  
Accepted 
telehealth  
640   (656.55)   [0.42]  119   (102.45)   [2.67]  759  
Totals  942  147  1089    (Total)  
Chi-square statistics = 10.1934; p=0.001409 
Sub analyses of telehealth service uptake: statistical tests 
A sub-analysis of the uptake of the telehealth service, based on those accepting 
referral to the service, indicated that acceptance rate of the telehealth service 
over time remained high. The average acceptance rate of the telehealth service 
for the first five months was 91.1% (ranging from 66.7% to 100.0%). While the 
average uptake of telehealth service for the three months towards the end of 
the service was 90.0% (range 83.3% to 100.00%). The uptake rate by months 
for the sample period for undertaking binomial regression analysis is shown in 
Table 6.5. 
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Table 6.5: Acceptance rate of telehealth over time 
Month No. Referred No. Accepted 
Percentage 
accepted 
01/04/2010 20 16 80.0 
01/05/2010 3 2 66.7 
01/06/2010 6 6 100.0 
01/07/2010 14 14 100.0 
01/08/2010 13 13 100.0 
01/03/2012 6 6 100.0 
01/04/2012 8 7 87.5 
01/05/2012 6 5 83.3 
 
A binomial regression analysis showed that there was no statistically significant 
difference in uptake of telehealth service over time (p = 0.864; OR= 1.000 per 
month 95% CI: 0.998, 1.003), (Table 6.6).   
Table 6.6: Acceptance of telehealth service among those referred to the 
service: binomial regression analysis 
Accepted Odds Ratio   EIM* 
Std. Err. 
z P>|z|     [95% Conf. Interval] 
Month 1.000235   .0013688 0.17 0.864 .9975557    
1.002921 
_cons .1255659 3.191612 -0.08 0.935 2.91e-23    
5.43e+20 
*EIM = Expected Information Matrix 
Stata command: binreg Accepted Month, or n(Referred) 
 
6.3.5.2 Compliance with telehealth service 
During the period covered in the analysis of telehealth compliance (1 April 2010 
to 31 August 2011), a total of 28,873 telehealth readings were received from 
telehealth monitoring system (ICP Triage Manager, Doncaster). The compliance 
rate of telehealth home monitoring was 87.6% (95% CI: 87.2, 88.0). This 
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represented 25,258 actual readings received from both vital signs and 
individually tailored questions from the telehealth home monitoring service.  A 
third of the total readings (32.4%; n=9,341) were classified as low risk (green); 
while 43.9% (n=12,687) were considered as high risk, generating red alerts on 
the telehealth home monitoring system (Table 6.7). 
The mean number of readings per person was 166, and the mean compliance 
was 84 readings. The corresponding mean readings for red alerts was 73 per 
person; and that for low risk (green) was 54 (Table 6.7). 
Therefore, the main finding from the telehealth monitoring was that it generated 
12,687 readings, which was an equivalent of 43.9% of all the readings. This 
amount of red alerts required assessments and appropriate interventions by a 
nurse, and consequently they generated additional workload. 
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Table 6.7: Compliance to telehealth in Doncaster by alert categories 
Between 1 April 2010 to 31 August 2011 
Variables  Total  Mean per person 
  n % (95% CI)  n (95% CI) 
      
Readings  
         
28,873  100.0 (100.0, 100.0)  165.9 (145.6, 186.3) 
Alerts  
         
19,026  65.9 (65.3, 66.4)  109.3 (88.1, 130.6) 
SEVERITY:      
High (Red alert)  
         
12,687  43.9 (43.4, 44.5)  72.9 (60.9, 85.0) 
Moderate (Amber)  
                 
28  0.1 (0.1, 0.1)  0.1 (0.00, 0.04) 
Low (Green)  
           
9,341  32.4 (31.8, 32.9)  53.7 (44.7, 62.7) 
Missed  
           
3,202  11.1 (10.7, 11.5)  18.4 (13.5, 23.3) 
Compliance  
         
25,258  87.6 (87.2, 88.0)  84.4 (82.3, 86.5) 
Note: based on reading from verified number of 119 patients. Compliance = 
(High + Moderate + Low + Missed)/Readings x 100).  Missed reading = vital 
signs and questions reading received with some missing readings.  
6.3.5.3 Compliance with telehealth service: 3-month audit 
Compliance rate to telehealth service by age group was categorised in five age 
bands and the results are shown in Table 6.8. A more detailed analysis of 
compliance was carried out on a sample of data covering a three-month time 
period. The three-month compliance data (July 2010 to September 2010) 
revealed a compliance rate of 90.1% (95% CI: 89.2, 91.1) with telehealth home 
monitoring. There was variation in compliance rate by sex, age-group, 
diagnoses, and discharge status from telehealth monitoring. There was a 
slightly better compliance among females than males, and older patients aged 
70 years old and over complied better than those below the age of 70 (Table 
6.7). 
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Based on utilisation of telehealth consultations per person per week (c/p/w), the 
average consultation per week per person was 6.8 (95% CI: 6.2, 7.4) or the 
equivalent of at least one telehealth reading per person per day. 
There were 3489 readings, which contained vital signs or responses to 
questions. Of these, 2669 readings (68.8%) were considered as alerts. The 
main finding of the compliance was that sixty-two per cent (62.1%, n=1658) of 
all the alerts were rated as severe (red alerts).
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Table 6.8: Patients compliance to telehealth service by sex, age-groups and diagnoses 
Telehealth home monitoring in Doncaster: 1 July 2010 to 30 September 2010 
Variables 
Actual Readings 
(Vital signs and 
questions)  Missed Reading  Total Readings  Compliance 
 n %  n %  n %  % (95% CI) 
Total 3498 90.1  383 9.9  3881 100.0  90.1 (89.2, 91.1) 
Sex:           
Male 1996 88.8  251 11.2  2247 100.0  88.8 (87.5, 90.1) 
Female 1502 91.9  132 8.1  1634 100.0  91.9 (90.5, 93.2) 
Age-groups:           
<50 307 84.8  55 15.2  362 100.0  84.8 (80.7, 88.3) 
50-59 242 79.9  61 20.1  303 100.0  79.9 (74.9, 84.2) 
60-69 1128 90.8  114 9.2  1242 100.0  90.8 (89.1, 92.4) 
70-79 1095 92.5  89 7.5  1184 100.0  92.5 (90.8, 93.9) 
80+ 726 91.9  64 8.1  790 100.0  91.9 (89.8, 93.7) 
Diagnoses:           
CDM* 235 84.8  42 15.2  277 100.0  84.8 (80.1, 88.8) 
CHF** 1661 86.5  260 13.5  1921 100.0  86.9 (84.9, 88.0) 
COPD*** 1602 95.2  81 4.8  1683 100.0  95.2 (94.1, 96.2) 
Discharged from 
telehealth:           
No 2980 90.9  299 9.1  3279 100.0  90.8 (89.8, 91.8) 
Yes 518 86.0  84 14.0  602 100.0  86.0 (83.0, 88.7) 
Note: CDM*=Chronic Disease Management Telehealth units or multiple co-morbidity; CHF** = Patients with congestive heart failure machine; 
COPD*** = Patients with chronic obstructive pulmonary disease telehealth units.
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6.3.5.4 Levels of satisfaction and experience with telehealth service 
A self-completion satisfaction survey, on a sample of 52 (44.8%) active users of the 
telehealth service during a three-month period between April to June 2012, yielded a 
completion rate of 69.2% (n=36). There was a 100% satisfaction rate with the 
telehealth service among those surveyed. The different perspectives of patients on 
various aspects of the telehealth service are presented in Table 6.9, which suggest 
favourable experiences with telehealth service. 
Table 6.9: Experience of patients in relation to telehealth service 
Variables 
Strongly 
agree Agree No opinion Disagree 
Strongly 
Disagree 
n (%) n (%) n (%) n (%) n (%) 
I received an explanation of 
how to use the monitor, in 
terms I could understand. 23 (63.9) 13 (36.1) - - - 
The monitoring system is 
easy to use. 25 (69.4) 11 (30.6) - - - 
The monitoring system 
is/was useful in assisting me 
to manage my health. 24 (66.7) 9 (25.0) 3 (8.3) - - 
I felt more involved in my 
care by participating in the 
telemonitoring programme. 24 (66.7) 11 (30.6) 1 (2.8) - - 
I believe daily monitoring 
assisted the clinicians in 
understanding changes in 
my condition.  25 (69.4) 11 (30.6) - - - 
Home monitoring provided 
me with a sense of security 
and peace of mind. 27 (75.0) 7 (19.4) 2 (5.6) - - 
I would recommend the use 
of daily home monitoring to 
my family and friends. 29 (80.6) 3 (8.3) 4 (11.1) - - 
Note: Total (n) = 36 respondents
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6.4 Discussion 
6.4.1 Summary of key results with reference to study objectives 
The main objective of the study was to determine embeddedness of the 
telehealth service in routine practice based on uptake of the service. The null 
hypotheses stated that the uptake rate of the telehealth service would be 
67.9%, similar to that observed in the systematic review by Gorst et al. (2014). 
The findings of the current study showed that the uptake of telehealth was in 
fact significantly higher in the observational study, at 81.0% (95% CI: 74.7%, 
87.3%); p = 0.001. 
Acceptance of telehealth remained high from the beginning through towards the 
end of the assessment period. The null hypothesis was rejected in favour of the 
alternative hypothesis, that is, the evidence supports embeddedness of 
telehealth service in routine healthcare practice. There was however high rates 
of red alerts, and extra workload created in dealing with them. Compliance rate 
to telehealth home monitoring was 87.6%, and satisfaction with telehealth 
service was 100.0%. Acceptance of the telehealth service following referral 
remained high at around 90.0%, and there was no statistically significant 
difference over time, based on binomial regression modelling; (p =0.864; 95% 
CI: 0.998, 1.00). 
6.4.2 Limitations of the study 
The main limitation of the study was that of selection bias by community 
matrons, as the eligibility criteria for the study was left to their clinical 
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judgements. As a result, it remained uncertain as to which group of patients 
were most suitable for telehealth service, since recruitment was undertaken 
based on the subjective views of clinicians. This was the compromise that was 
accepted in view of the challenges faced during the conduct of the pragmatic 
trial in order to observe uptake of telehealth service in routine practice. 
There were also challenges of reconciling information sent to the telehealth 
service, such as referrals, to ensure that they were related to individual patients, 
rather than duplicate referrals of the same patients. Linkages were made using 
NHS number to ensure that duplicate referrals were identified. 
The high rates of red alerts represented a major limitation to implementation of 
telehealth service. This could be due to technical issues related accuracy of 
vital sign readings or how staff set the alert parameters. 
6.4.3 Interpretation of findings 
The findings suggest that telehealth service was starting to embed in routine 
healthcare practice. The study shows a sustained increase in telehealth uptake 
over more than a year. The acceptance rate for the early months of 
implementation of the telehealth service was very high and, as such, it was 
difficult to improve on that.  Patients appeared to accept the telehealth service 
and they were satisfied with it. Since the increase was sustained over a year, 
then the telehealth service in Doncaster could be described as having met the 
criteria for success advocated by Heeks (1999); where the major goals of 
stakeholders were met (Heeks et al., 1999).  
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Unfortunately, embeddedness was undermined by high rates of red alerts, 
which increased workload of staff. If a telehealth service is to embed in routine 
practice in the future, mechanisms to reduce the level of red alerts will need to 
be addressed in order make it more attractive for healthcare practitioners.  
Telehealth service was more acceptable to patients in this study because of a 
number of factors, including improved features of the telehealth technology, 
which generated fewer red alerts compared to the pragmatic trial and the fact 
that community nurses had more control in recruiting patients. A fuller 
understanding of why and how new technologies fail or succeed to embed in 
routine practice is further explored in Chapters 7 and 8, using the NPT 
framework. 
The uptake of telehealth service in the study was higher compared with some of 
the telehealth projects in England (Joseph et al., 2011), and in systematic 
review undertaken to assess acceptance and refusal of telehealth service 
(Gorst et al., 2014). The current study has produced a compliance rate for 
telehealth; evidence on compliance rate is limited in the published literature. 
Contrary to expectation, older people over 60 years of age appeared to comply 
better than those aged 50 years old and below. This suggests that older people, 
once trained, can engage effectively with new technology in health. 
Between the pragmatic trial and observational study, there were significant 
changes in the physical structure and operation of telehealth technology, as 
shown in Table 6.10 below. At least five software changes were observed within 
a period of five years, which averaged at one software change per year. 
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Table 6.10: Key changes of versions of telehealth software/machines over time 
Software version Key operational features 
RCT: 
Genesis (2007) 
a) Patients’ data could be accessible from only one base 
where computer was installed in a health centre by 
means of user name and password.  
b) Output could be produced in PDF and printed off or 
saved. It was not compatibility with excel spread sheet. 
c) Lots of wires connecting the peripherals 
d) No wireless machines; people without phone lines were 
excluded. 
e) Dedicated British Telecom phone line to operate the base 
unit. 
Observational 
study: 
Lifestream – 
Honeywell HomMed 
(2009) 
a) Patients’ data could be accessed from multiple sites, but 
the computers from where access could be gained need 
installation of specific software.  
b) Output documents included PDF, which could be printed 
or saved. Output was compatible with excel spread sheet. 
c) Fewer wires;  
d) Options for wireless machine; patients without phone line 
could be given one. 
Tunstall CSO 
(Clinical Systems 
Organiser)/ 
Telehealth (June 
2010) 
 
Tunstall icp 
(Integrated Care 
Platform), 2011 
a) Patients’ data could be accessed from multiple sites, 
without the need for installing special software on them; 
all what was required was user name and password. 
b) Output document include PDF, which could be printed 
and saved. 
c) Compatibility of outputs with excel spread sheet. 
d) Fewer wires to be connected to electric sockets; blue 
tooth technology, which allowed for peripherals vital signs 
records to be transmitted to base machine without the 
need for physical connection by wires. 
e) Options of wireless machine for patients without phone 
line. 
f) Ownership of company also changed from Honeywell to a 
separate entity. 
Mymedic (Tunstall, 
2013) 
a) Tailored vital signs and questions; large colour display; 
blue tooth; and secure N3 data storage. 
Docobo Care Portal 
(Docobo, 2015) – a 
new provider of 
telehealth service in 
Doncaster 
a) Can measure a range of vital signs, and ability to select 
tailored questions, camera for wound care. Mobile units 
that can be taken around the house, central docking 
station, all wireless. Patients can access own data. 
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6.4.4 Generalisability of the study results 
The study shows that it is possible to implement and embed telehealth service 
in routine healthcare practice. 
Overall, the telehealth service was acceptable to users, and they were satisfied 
with it. Older people (aged 60 and over), had been shown to comply very well 
with telehealth home monitoring once shown how to use it.  
The study presents original contributions to knowledge on telehealth and its 
implementation in a routine healthcare setting. Specifically, the study 
contributes to understanding of embeddedness of telehealth in routine 
healthcare practice. 
6.4.5 Conclusions 
The telehealth service appeared to be embedding in routine healthcare practice 
in an observational study context. The service had high acceptance rate over 
time and patients were satisfied with it. The high uptake rate however was 
undermined by high rates of red alerts, which was lower than that found in the 
pragmatic trial. The compliance rate to telehealth monitoring was higher than 
that found in the pragmatic trial.  
6.4.6 Funding 
Funding for rolling out telehealth widely in Doncaster came from Doncaster 
Primary Care Trust (PCT), the responsible commissioner for health service in 
the area at the time of this study. The original study (pragmatic trial) was funded 
through Neighbourhood Renewal Fund and administered by Doncaster 
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Metropolitan Borough Council, as part of assistive technology grant by the 
Government in England (described in Chapter 3). The PCT commissioned 
telehealth service to be rolled out widely in Doncaster for patients with long-term 
conditions. It did not influence the evaluation design, analyses, outcomes and 
publication of the study findings. 
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Chapter 7: Interviews with Stakeholders on Why and How New 
Technologies Fail or Succeed to Embed in Routine Health 
Services: A Qualitative Study 
7.1 Introduction 
This chapter addresses the research question related to why telehealth, as an 
example of new technology, embedded or not in routine healthcare practice. 
The reason for the focus on embedding was to understand why uptake of 
telehealth failed to embed in the trial, while it appeared to have embedded in 
the observational study. Understanding the reasons for this will help to increase 
future uptake of new technologies being introduced in routine health services. 
The ultimate purpose of this knowledge is to improve health and to save lives of 
people suffering from long-term conditions. 
The original protocol of the pragmatic randomised controlled trial (RCT) 
included conducting a qualitative study in order to determine the views of 
patients, and staff who were involved in telehealth service. Since the RCT was 
stopped, the qualitative study was not carried out. When the observational study 
was designed, conducting a qualitative study parallel to it was planned.  
This chapter presents the views of stakeholders in relation to telehealth 
implementation. It uses a qualitative evaluation approach. The chapter 
contributes towards understanding of why and how telehealth service performs 
in routine healthcare practice. The objectives of the chapter are (1) to identify 
and describe a theoretical framework to help with interpretations of findings of 
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the study; (2) to determine how telehealth performed in routine practice, from 
qualitative perspective; and (3) to investigate factors that influenced the uptake 
of telehealth service in the observational study.  
This chapter will contribute to answering the research questions stated in 
Chapter 1. The specific research sub-questions that are relevant include the 
following: 
1. Technology: Are there factors associated with the new technology used 
in the randomised controlled trial (RCT) versus the ones used in the 
observational study that made a difference in uptake of the new 
technology? 
2. Patient group: Are there factors related to the patient group recruited for 
the RCT as opposed to the observational study that made the difference 
in uptake of new technology?   
3. Staff: Are there factors associated with staff involved in the RCT, as 
opposed to the observational study that made a difference in uptake of 
new technology? 
4. Evaluation: Are there factors associated with RCT methodology 
approach, as opposed to observational study that made a difference in 
uptake of new technology?  
This study is reported in line with recommended standard for qualitative study: 
consolidated criteria for reporting qualitative studies (COREQ): 32 items 
checklist (Tong et al., 2007). 
The remainder of this chapter is structured as follows: 
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• A brief overview of Normalisation Process Theory (NPT), the main 
theoretical framework used in the thesis. 
• Methods: a description of qualitative research methods used in this 
study; staff involved and reflexivity, study design (tools, data collection, 
and participants), and analyses. 
• Results: four themes where identified that explained why and how 
telehealth performed in the observational study. The four themes 
covered factors related to (1) service design, (2) the technology, (3) staff 
and (4) patients and carers. The findings from the study showed that 
there were mixed picture regarding performance of telehealth in routine 
practice, with both positive and negative views expressed by staff and 
patients. The benefits of telehealth appeared to outweigh its negatives as 
reported by patients and staff. The evidence also suggests that 
telehealth was starting to embed in routine practice but was not yet fully 
embedded. 
A full discussion of the findings from this chapter is presented in Chapter 8. 
7.2  Normalisation Process Theory  
The theoretical framework used in this study is Normalisation Process Theory 
(NPT). It has been described in detail in Chapter 2. In brief, NPT helps to 
explain why and how new technology embeds in routine use through:  (1) 
accommodation of new practice into social and organisation structures; (2) four 
stages of implementation: understanding the usefulness of a practice, decision 
to take part, collective actions, and collective efforts in evaluating the practice 
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as worthwhile; and (3) continuous investment of efforts of people involved in the 
implementation of a practice (May and Finch, 2009). 
7.3 Qualitative case study methods  
The methods used in this qualitative evaluation of the study are represented in 
Figure 7.1 below. The choice of method used for the qualitative evaluation was 
a pragmatic one, guided by NPT, and utilising interview questions relevant to 
the evaluation of telehealth service.  
Figure 7.1: Summary of research methodology used 
 
The research received favourable ethical approvals, and the details of ethical 
opinions are shown in Annex 2. 
7.3.1 Qualitative research methods 
Integrating quantitative and qualitative research methods in complex 
interventions had been recognised as best practice in understanding 
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implementation of complex interventions (Campbell et al., 2000). Further 
evidence of the importance of embedding qualitative study in the evaluation of 
telehealth is described in the literature review (Chapter 4).  
There are several approaches to qualitative research (Creswell, 2007, Willig, 
2008, Glaser and Strauss, 1967). Five main approaches to qualitative research 
had been described in the literature, which were described as follows: narrative 
research; phenomenology; grounded theory; ethnography; and case study 
(Creswell, 2007). According to Creswell (2007), a narrative research was best 
suited for understanding detail stories of a single individual or a small number of 
individuals; phenomenology research enabled understanding of several 
individuals’ shared experiences of a phenomenon; grounded theory was helpful 
for generation of theory to explain a phenomenon, where there was no or 
incomplete theoretical basis; ethnographic studies was appropriate in describing 
how cultural groups operated and to explore their cultural behaviours; and case 
study research was used where there was clear identified cases with 
boundaries and an in-depth understanding of cases or where their comparison 
was needed (Creswell, 2007). 
This study employed case study research methods, in enabling an in-depth 
understanding of telehealth implementation in a routine health care setting. 
7.3.2 Staff involved in research and reflexivity? 
The author interviewed the Telehealth Coordinator, and facilitated a group 
discussion involving stakeholders’ event held on 29th March 2011 and analysed 
the results. The author is male, and he undertook qualitative evaluation as part 
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of his degree of Master of Public Health (MPH), which he held and he received 
appropriate training in research methods. At the time of the study, the author 
was employed with Doncaster Primary Care Trust (PCT) as a Consultant and 
Assistant Director of Public Health. 
The service contract between the PCT and the provider organisation required 
that the provider would collect patient satisfaction feedback on regular basis. 
This was part of standard quality assurance requirements included in a range of 
services commissioned by the PCT, and telehealth service was one of them. 
The telehealth contract was written by the author and a Commissioning 
Manager for Long-term Condition, and it was approved by Programme Director 
for Long-term Condition at Doncaster PCT.  
On behalf of the provider, the Telehealth Coordinator interviewed staff and 
patients on the experience related to telehealth service. This also enabled the 
process of collecting feedback from patients and staff to be seen as part of 
embedded routine delivery of health service, rather than as a separate initiative. 
The role played by the Telehealth Coordinator in interviewing both patients and 
some frontline staff, was in line with the service contract. The Telehealth 
Coordinator was a female, and she had experience of undertaking similar 
interviews, and possessed a bachelor degree. The Telehealth Coordinator had 
established some relationship with the patients and staff in that she installed 
telehealth machine in the homes of the patients, and she also trained the staff 
and helped them with any on-going problems at the time related to telehealth in 
use by patients. The author provided the Telehealth Coordinator with interview 
schedules (questions containing the guide) for interviewing patients and staff 
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(Annex 3), as well as a tape recorder for recording the interviews, as part of 
collecting patients’ feedback. She undertook the interviews with community 
matrons, heart failure nurse, administrative staff, and healthcare assistants and 
recorded them. She transcribed the interviews and gave them to the author for 
analyses. 
There was potential area of bias in the role of Telehealth Coordinator as being 
involved in implementing telehealth service as well as interviewing 
stakeholders. This bias was minimised by the fact that the Telehealth 
Coordinator had no direct healthcare responsibility for the patients, but this role 
rested with the community nurses; and the role that the Telehealth Coordinator 
played with the community nurses was that of coordination of the service. Most 
community matron involved in telehealth service would have known the 
Telehealth Coordinator. However, her involvement with patients was minimum 
and it related to installation and trouble-shooting if there was any problem with 
the telehealth equipment. Hence, many patients would not have known the 
Telehealth Coordinator as well as the nursing staff did.  
At the start of the roll out of telehealth service, some of the patients were 
introduced to telehealth as part of the pragmatic trial, however, when the trial 
was formally stopped, the community nurses introduced telehealth to anyone of 
their patients that they considered to be appropriate, including those who were 
previously part of the trial.  
The author approved the change in methodology from RCT design to service 
evaluation. In the service evaluation, the community nurses did not need to 
have patients whom they considered suitable for telehealth service to be 
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randomised into intervention and control groups. The author led the evaluation 
of the telehealth service, including the analyses of the results, and engaging 
with the local delivery and strategic groups on telehealth service. The author 
was the public health lead for respiratory disease, and COPD was part of this. 
He was responsible for delivery of health improvement strategy for people with 
respiratory diseases in Doncaster on behalf of the PCT. 
7.3.3 Study design: tools, data collection and participants 
The study adopts qualitative research approach, using case study research 
method, which allows for triangulation of data from both qualitative and 
quantitative sources and an in-depth understanding of the phenomena 
(Creswell, 2007). A further description of case study research method is outline 
in Chapter 8). 
Interview schedules (semi-structured questionnaires) were developed and used 
to guide interviews with selected patients and staff (Annex 3.1 questionnaire for 
patients; and Annex 3.2 questionnaire for staff). The questions were formulated 
taking into account evidence from the literature review and further described in 
Chapters 4 (Robson, 2002, May et al., 2007, May, 2006). The interviews with 
staff and patients were carried out by the Telehealth Coordinator; tape 
recorded, transcribed and handed to the author for analyses. Three one-to-one 
(repeat) interviews, over an 18-months’ period, were conducted by the author 
with Telehealth Coordinator that was tape-recorded and transcribed. The 
interview duration lasted between 40 minutes to 1 hour, and the transcripts 
were shared between the author and Telehealth Coordinator to confirm their 
accuracy.  
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Information from the author’s reflective log was used. The reflective log 
contained key issues encountered and information which was considered to be 
important in the implementation of telehealth service in both the trial and 
observational study.  
7.3.3.1 How participants were selected 
The purpose of selection of participants was to cover a range of informants; 
hence a convenience sampling method was used. Participants for the 
interviews were selected to include views of (1) patients, (2) community nurses 
and healthcare staff, and (3) group meeting, consisting of multi-disciplinary and 
multi-agency staff.  
(1) Patients 
The selection was designed to include sample of patients who had used 
telehealth service and had chronic obstructive pulmonary disease (COPD), and 
heart disease. These were the two main patient groups represented in the 
telehealth project. These groups of patients were specified by the author in the 
service contract. The community nurses identified the patients, while the 
Telehealth Coordinator carried out the interview with patients. Interviews with 
patients were conducted in patients’ own homes. The interviews were 
conducted face-to-face, and prior arrangements were made by telephone and / 
or face-to-face. There were no other participants present besides the 
participants and interviewer. The interviews were conducted between June 
2010 and October 2011. 
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(2) Community nurses and healthcare staff 
Community nursing staff selected for the interview included community matrons 
(nurses), healthcare assistants, administrative staff and heart failure specialist 
nurses. There was only one heart failure team in Doncaster and the Team 
leader was interviewed by Telehealth Coordinator. On the other hand, there 
were several community matrons teams in Doncaster, and two of the teams 
were selected for interview with the respective community matrons. The 
Telehealth Coordinator interviewed the community nurses, as per 
commissioning service level agreement, using interview scheduled developed 
by the author.  Interviews with staff were conducted at work and over the period 
from June 2010 and October 2011. 
(3) Multi-stakeholders’ group meeting 
The views of stakeholders at a specially convened event on telehealth on 29th 
March 2011 were obtained using group discussion facilitated by the author who 
carried out the interview. The author also analysed all the results of the 
interviews.  
7.2.3.2 Analyses 
Analyses of qualitative (interview) data were carried out manually, identifying 
key themes and patterns emerging from interviews, as recommended by a 
number of authors (Boyatzis, 1998, Robson, 2002, Braun and Clarke, 2006). 
The author coded the data for the analysis. The key steps recommended by 
Boyatzis (1998) were followed, which consisted of reducing the data, identifying 
themes within sub-samples, comparing themes across sub-samples, and 
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creating codes. Guidance for creating a good code was used, as outlined by 
Boyatzis (1998), where each code was assigned a label, and it was defined, 
giving a description of what it meant. Examples of the codes were given, by 
identifying the most relevant quotations by individuals interviewed; and 
exclusion and inclusion criteria of items were used. 
Analyses were conducted by drawing on key themes.  The author was guided 
by data in the thematic analysis; hence the method was considered to be a 
bottom up approach (Boyatzis, 1998). The four research questions posed at the 
beginning of this chapter were referred to in the analyses of the qualitative 
interviews. 
7.4 Results 
The results sections are structured covering qualitative interview with staffs and 
patients, exploring why and how telehealth performed the way it did, as part of 
the observational study. 
The views of 49 participants were obtained in the course of the evaluation; of 
which 29 were on one-to-one or small team basis; and 20 participants were part 
of a time-out session with key players at an event for telehealth and telecare. 
The individual or small team feedback involved 29 participants (16 patients and 
13 staff). This included 13 in-depth interviews that were tape recorded and 
transcribed (6 with staff and 7 with patients) and 16 satisfaction questionnaires 
(7 staff; and 9 patients). 
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7.4.1 Qualitative interviews with patients and staff 
The results reported in this chapter relate to observational study (also reported 
in Chapter 6) in Doncaster, using semi-structured qualitative interviews with 
patients and staff. 
A thematic analysis revealed four main themes on how and why telehealth 
performed in Doncaster. These themes were categorised as follows; indicating 
that the findings of the study were explained by factors related to (1) service 
design (2) technology; (3) staff; and (4) patients and carers (Figure 7.2). The 
quotes provided are representative of the themes.
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Figure 7.2: Explanation of why and how telehealth performed 
 
  7.4.2 Theme 1: Service design: The findings of the study were 
explained by how the service was designed 
Successful model of telehealth service delivery 
The local model of telehealth delivery was described as being successful 
during the observational study period.  Key characteristics of this success 
included the following: staggered service, expanded bit by bit, team by team; 
removing strict eligibility criteria; having a coordinator; and flexibility of the 
service to adapt to changes. This is illustrated by the quote below: 
“They [Tunstall] think that having a coordinator has been essential to 
the success of the project in Doncaster as a whole. They also think 
that the way in which we have done it, sort of bit by bit, a team at a 
time, has helped us to be able to cope with any problems; adapt to 
the way we do things and build it to a stage where we are now. It has 
gradually got bigger and there is no reason that it is not going to 
continue to do that. And basically, what has been said to me is that as 
supposed to somewhere buying; investing in 2000 kits, and planning 
this big major roll out, actually it’s far more sensible to do things in a 
much staggered way of doing it. And it’s proved successful that we 
have done it and so they approached other organisations with that 
model” Staff 4; Telehealth Coordinator, 7/10/2011 
Recognising the drivers of telehealth for relevant stakeholders 
This sub-theme was scored when individuals specified the drivers for 
adoption of telehealth. To qualify for coding this theme, individuals 
mentioned any of the following: competition among health service providers; 
recognising the drivers (and threats) to professional practice of clinicians; 
preventing hospital admissions; achieving financial savings from hospital 
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activities; and reducing admissions into residential care homes. The 
following examples further showed the drivers for health professional in 
relation to their practice: 
 “I think the way you overcome that cultural barrier is you get them to 
do one consultation. If we are talking about telemedicine you need to 
get them to do one consultation. And they walked out from that and 
they’ve all said: ‘I get what you are saying; I can see where it will work 
in my specialty; it will work in that area, it won’t work for those 
patients but will work over there.’ And then they say one of two things; 
they either say, ‘I am happy to do this whenever you want me to or I’ll 
never do another one.’ And I’ll say, ‘why would you not do another 
one?’ When you get under the skin, because it is a threat, and it is a 
threat to their independent practice.” Staff 6, Consultant Physician, 
29/03/2011 
Another example of driver for telehealth implementation related to 
competition among health service providers: 
“And then there is the argument, if you don’t do this, another hospital 
is going to do it to you. And that hospital maybe the Mayo Clinic or it 
might be the Hammersmith, or might be UCL [University College 
London]. You know, you have got to really stand your corner against 
those guys because they bring very heavy weight clout to 
commissioning. So this is coming; join us or the bus is over there.” 
Staff 6, Consultant Physician, 29/03/2011 
Service design barriers 
This sub-theme was coded if individuals identified negative factors that were 
related to service design. To qualify for coding this category, individuals 
must have mentioned any of the following factors: lack of integration of 
telehealth into existing health system (e.g. IT, and care pathways); logistical 
237 
 
 
problems (coordinating sites, office, and storage); randomised controlled trial 
service design as a barrier; purchasing telehealth machine from suppliers 
(rather than renting them), as local experience showed that a lot of 
telehealth machines were not used when purchased by the organisation. 
This sub-theme is illustrated by the following quote below, about the need 
for embedding telehealth to be part of standard operating system of 
delivering healthcare service: 
“I think it needs documenting somewhere on the SAF [Single 
Assessment Framework – information system] when we see a new 
patient, but also maybe on the community matron admission analysis 
forms that we fill in because it is making you think of it twice and you 
are having to justify why or why not. The problem with that though is 
that it is TPP [computer software system used in primary care] and it 
takes ages to change a form. It has got to go through all sorts of 
governance.” Staff 3, Community Matron, 21/12/2010 
7.4.3 Theme 2: Technology: The findings of the study were 
explained by the use of a particular technology (telehealth) 
Patients’ satisfaction with telehealth 
 
In this sub-theme, individuals described telehealth in the following ways: 
smashing, fantastic, amazing, happy with telehealth, a good thing, good 
idea, honoured using it, good feedback, and patients being on board with it. 
This is illustrated by the following quotes: 
 “I thought it was a good idea. Yes, I did. I didn’t understand it…. I 
mean technology, I don’t understand anyway, but I think it’s been a 
really fantastic thing.” Patient 3, COPD, 12/11/2011 
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“I thought it was smashing. It put everybody’s mind at rest here, and it 
went through to the doctors [care team] and they got in touch with me 
if anything was wrong.” Patient 2, COPD, 25/11/2010 
Staff satisfaction with telehealth 
 
This category was scored when healthcare staff indicated satisfaction with 
telehealth; or if they expressed readiness to recommend telehealth to other 
healthcare professional colleagues or patients; or if they identified the 
benefits of telehealth to themselves. This is shown by the examples below: 
“I have started saying to people [colleagues], now that it is just a trial 
for a month and we’ll see how it goes, so we can take it out if needs 
be. I’m feeling ok with it at the moment.” Staff 3, Community Matron, 
21/12/2010 
 “So you know that if they are not looking good on screen, it may pre-
empt a visit there and then. You think that their oxygen level don’t 
look great, so maybe I should go out. So, it does have a benefit that 
way with us.” Staff 3, Community Matron, 21/12/2010 
Technological barriers 
Under this sub-theme, individuals mentioned any of the following points: 
breakdown of telehealth machine; difficulties of differentiating between true 
and false red alerts generated by telehealth; and installation issues (e.g. lack 
of backup of telehealth during installation, including wireless ones, where 
there were problems with telephone lines). The example below illustrates 
this point: 
“The extent of the problem is quite evident in that we have had at 
least three patients that have had the equipment (telehealth) removed 
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for the specific reason that the case manager does not believe that 
the readings from the blood pressure [machine] is accurate. It was 
constantly causing red alert because, obviously the nurses feel that 
they have to put limits, which were within guidelines, which they have 
been advised; the NICE Guidelines, etc. And the nurse believes that 
those red alerts are not necessary, and therefore believes that the 
equipment is causing work that is not necessary.” Staff 4, Telehealth 
Coordinator, 9/11/2011 
7.4.4 Theme 3: Staff: The findings of the study were explained by 
how the new technology (telehealth) service was implemented 
Telehealth increased workload of staff 
This sub-theme was scored if individual mentioned that telehealth increased 
the workload of staff. To qualify for this code, individuals must have 
acknowledged increased workload in their responses; this included visits to 
patients and/or increase telephone contacts to support patients in their own 
homes. This is shown by the example below from a community nurse: 
“In some ways, I would say that it [telehealth] does increase 
workload, but not tremendously. Having said that, I probably haven’t 
got that many patients on it. You do have more telephone contact 
with patients, which is fine if you are saving [hospital] admissions. I 
think that’s the point. You are having more contact but you are 
nipping things in the bud. I can change medication and advise 
patients over the phone, I can advise them to increase antibiotics or 
whatever. So though there are more consultations, they are generally 
telephone consultations and not visits. I think for the patients that I 
have on it, it is appropriate and it is saving admissions.” Staff 3, 
Community Matron, 21/12/2010 
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Participants talked about telehealth as introducing new ways of working 
This sub-theme was coded if individuals identified telehealth as introducing a 
new way of working. Any of the following points mentioned qualified to be 
coded: references made to new roles for healthcare assistants or 
administrative support staff in monitoring telehealth readings; and enhancing 
their career development; the role of community nurses identified as making 
referral of patients onto telehealth and responding to red alerts; the role of 
Telehealth Coordinator in overall coordination of the service; telehealth was 
seen as enhancing team working among professional teams that was made 
up of community nurses and administrative support staff. 
The above position is best illustrated by the example below in relation to 
investigating problems identified with patients: 
“I think it’s different and maybe changes some things that you would 
do slightly. You might see a patient more often because actually you 
have picked something really appropriate up and you have 
investigated it deeper and you have highlighted a new problem. I 
think it’s a different way of working really and we are still getting to 
grips with that and in terms of long term monitoring for some of our 
patients, we are looking at how we might use it further.” Staff 2, Heart 
Failure Specialist Nurse, 11/11/2010  
Another example shows the importance of having a coordinator in order to 
coordinate the service and to maintain standard: 
“I think that having at least a person to coordinate the service is 
essential. I think the idea that it can be maintained without somebody 
with an overview is a very unlikely scenario to be honest. I think as 
with a lot of things, unless it has got somebody constantly keeping 
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things in check, things crumble you know, and what will also happen 
is this person will start doing things different to this person, and 
before you know it, you haven’t got a standard, and it is not 
functioning as a proper service should.” Staff 4, Telehealth 
Coordinator, 7/10/2011 
Staff barriers and enabling factors, including staff attitudes to telehealth 
Barriers to uptake of telehealth by staff were identified as described below. 
These were identified from the interviews with staff and from observations, 
and meetings attended by the author: 
1. Fear among clinicians for a number reasons, including the effects of 
telehealth on patients, potential increase in staff workload, and threat 
to professional independent practice; 
2. Training for telehealth was not made mandatory, giving rise in some 
occasions to poor attendance at telehealth training sessions set up 
for staff; 
3. Lack of clinical network on telehealth to discuss clinical aspects of 
telehealth e.g. setting the right alert parameters; 
4. Lack of staff capacity; and  
5. Lack of acceptance of telehealth by some health professional 
colleagues. Timeline was recognised to be associated with 
acceptance of telehealth by professionals (as time went by, 
resistance by staff gradually reduced to telehealth as it got embedded 
into routine service delivery). 
The following example of resistance of professional colleagues illustrates 
this sub-theme: 
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“The biggest difficulty is colleagues’ acceptance, and there is timeline 
to it. You struggle and struggle and struggle and suddenly it seems to 
be the norm. Today, our consultants have all got telemedicine in their 
job plans and they are all completely cool with doing it apart from two 
orthopaedic surgeons who have refused. We have not gone against 
them. We’ve said, that’s fine, your colleagues can do them.” Staff 6, 
Consultant Physician, 29/03/2011 
Another example related to making training on telehealth mandatory to staff 
who might be involved in telehealth service provision: 
 “…We got to January [2011] and I was getting no response to my 
invitation, and in hindsight, there has been a lot going on over the last 
few months, a lot of transferring issues [transfer of staff employment 
contract from one organisation to another]; a lot of issues with 
mandatory training – obviously telehealth is not mandatory ….”  
“….so I would hope that in the future they would attempt to make the 
training mandatory, that would mean there would be no way we would 
have an empty training session..…”  Staff 4, Telehealth Coordinator, 
08/04/2011 
Attitude of staff towards telehealth 
Staff attitude towards implementation of telehealth was an important factor 
that explained why patients’ were offered telehealth or not by their case 
manager. Any of the following evidence was coded:  positive attitude of staff 
towards trying telehealth on patients, and not being held back by pre-
conceived prejudice; selection of patients; and overcoming fear of unknown 
potential effects of telehealth on both the patients and its effects on staff 
workload. 
Examples of quotes that illustrate the above theme are shown below: 
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“And I think sometimes, and this may be why we are not getting a lot 
of people on it, that there is a fear of putting people on because you 
are not sure how they are going to respond to it and how it is going to 
work for them really.” Staff 4, Telehealth Coordinator, 9/11/2010 
“If you think somebody might not be suitable, you are probably more 
likely not to try it because you know it’s going to be hard work and 
very intensive. They are going to be anxious and you are going to be 
ringing and visiting and all the rest, and that kind of puts you off a bit.” 
Staff 3, Community Matron, 9/11/2010 
A prevailing view (assumption) among respiratory specialist nurses in 
Doncaster at the time was that patients who were considered to be “end of 
life” (palliative care) patients, such as patients with severe chronic 
obstructive pulmonary disease (COPD), were not considered suitable for 
telehealth. The respiratory specialist nurses had not been involved in 
telehealth at the time. This view was not held by one community matron, 
who looked after respiratory patients as well, including those with severe 
COPD, and she found that not all “end of life” patients were unsuitable for 
telehealth, but some could benefit from it. This view is illustrated by the 
quote below: 
“So, sometimes I think with the community matrons, a lot of our 
patients possibly are coming towards end of life. But for some, it may 
be appropriate because although they are coming to the end of life, 
they are still bobbling in and out of hospital. It may be that you can 
avoid those types of situations. But I think patient selection is a biggy 
[big issue] really.” Staff 3, Community Matron, 9/11/2010 
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7.4.5 Theme 4: Patients and carers: The findings of the study 
were explained by the experiences of patients and carers 
Positive impacts of telehealth on patient 
 
Impacts of telehealth on patients are described as positives and negatives. 
Positive experiences are first described in this sub-theme; while negative 
impacts are described separately under sub-theme entitled as patients’ 
barrier (negative experience). 
This sub-theme was coded if individuals indicated positive impacts of 
telehealth on patients. Anyone of the following descriptions below applied for 
inclusion into this sub-theme: a description that patients felt more confident, 
supported, and in control of their conditions, patients felt reassured, their 
minds were put at rest, anxiety relieved and they were more independent; 
patients described a feeling of being monitored; not suffering in silence, or 
not being neglected by health professionals, a description of the care 
received as being similar to that of being in a hospital; individuals described 
some of the impacts of telehealth as improved health (felt better), reduction 
in visits to the doctors (GPs), reduction in number of visits by community 
nurses to the patients at home; prioritising home visit to patients;  face-to-
face visits to patients in their own homes were still regarded by community 
nurses as being important; impacts of telehealth were also described as 
saving hospital admissions; changing medication; enabling easy decision-
making on patients’ care; and telehealth was described as having embedded 
and its uptake was steadily increasing. 
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Example of this is shown by the quote below from staff in relation to patients 
feeling in control of their condition: 
“I think that they [patients] feel more supported. I think it [telehealth] 
gives them a lot of control. They feel a bit more in control of what’s 
happening because a lot of it is educating them as well. A fella I have 
put on it recently keeps asking me ‘what should my Sats [SpO2] be? 
What’s normal?’ So he is learning about it and you can see that he is 
interested and he wants to learn about it so it is giving him a bit of 
autonomy and control I suppose. I think the patients get more care, 
more contact and I am not visiting those patients any less than I was 
before because of the telehealth but I am contacting them more.” 
Staff 3, Community Matron, 9/11/2010 
Two further examples from patients’ perspective of the impact of telehealth 
on their confidence are illustrated by the quotes below: 
“You know that you are using it and people are watching you all the 
time. It gives you that bit of confidence if you know what I mean. You 
know you are not being neglected because there is always somebody 
at the other end keeping a check on you.” Patient 4, COPD, 
26/11/2010. 
“Very high [impact of telehealth]. It has made me feel better and more 
confident and everything. Because I was scared a lot you know; I 
was. Sometimes, I had really bad days and that [telehealth] has put 
my mind at rest.” Patient 2, COPD, 25/11/2010 
Patient barriers 
This category was coded if individuals identified any of the following 
negative factors related to patient’s experience of telehealth: discrepancies 
between telehealth readings and case manager’s own (manual) readings for 
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blood pressure; alert parameters, as recommended by NICE, was 
considered to be a barrier; lack of consensus on selecting the right patients 
for telehealth; and some possible unknown factors in patients that was the 
cause of inaccurate vital signs reading (see examples below). 
Issues related to accuracy of telehealth device are shown by the quote 
below: 
“I need to have someone [a clinician at Tunstall] to tell me what is 
happening because technically it’s [machine] fine, the nurse [in 
Doncaster] is saying it’s not and we need to know what the reason is. 
Not only that, we need to pre-empt it for when we are installing it 
because actually it is a waste of time to install it for certain people….” 
Staff 4, Telehealth Coordinator, 8/04/2011 
Issues to do with the right vital signs parameters are illustrated by the 
following quote: 
“And the other thing is if the red alert is coming up every day, then I 
would say to them they need to start reviewing whether that is a 
normal parameter for that patient. If the patient says they are fine, but 
for a number of weeks, every day they have been on red alert, then 
the parameters are obviously not right. And so what I advise them is 
that they set parameters based on what’s helpful to them and not 
what they think should be guidelines. That’s a sensible way of using 
the equipment.” Staff 4, Telehealth Coordinator, 7/10/2011 
Impacts of telehealth on carers 
This sub-theme was coded if references were made about the impacts of 
telehealth on carers. The following references qualified for inclusion: 
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reassurance of carers, and happiness with telehealth by carers. This is 
illustrated in the example below: 
“A big impact. Like I said, my husband mind is at rest. He doesn’t 
worry half as much about me. He sees my temperature is alright, my 
blood pressure.…. He sees my Sats [SpO2] aren’t bad. Sometimes, 
they are 90, but sometimes, like today, they are 94. They might be 89 
tomorrow, it depends you know.” Patient 2, COPD, 25/11/2010 
Relationship between patients and healthcare staff 
In scoring this sub-theme, individuals described the relationship between 
patients and staff. Patients used the following form of words to describe 
such a relationship with healthcare professionals: marvellous, lovely ladies, 
nurses were smashing, wonderful, great, and same as face-face visit. 
Nurses on the other hand, described their relationship with patients as 
enhanced, anxieties of patients were alleviated, and they felt supported. This 
is captured in the following examples: 
“Well, they have rung me to make sure I am ok; if everything is going 
a bit ‘upsy-daisy’ you know. But they are smashing women; the 
nurses.” Patient 2, COPD, 25/11/2010 
“Oh! Great. Great yeah.” [In response to relationship with staff]; 
Patient 4, Heart Failure, 26/11/2010 
There was trust by patients in their community nurses that explained why 
patients enrolled onto telehealth, even though they were not quite sure 
about it at the beginning: 
“Yes, I recall her just saying about this telehealth, which I didn’t really 
know what she was talking about. She asked if I was willing to 
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participate and I just said yes, that’s fine. We’ll give it a whirl.” Patient 
3, COPD Patient, 12/11/2010  
A discussion of the findings from this qualitative study is found in Chapter 8. 
7.5 Conclusions 
The performance of telehealth was explained by a combination of factors 
related to service design, technology, staff, and patients and carers. There 
was mixed evidence regarding performance of telehealth in routine practice, 
with positive views from staff and patients, but there were also a number of 
challenges identified that needed to be overcome. The benefits of telehealth, 
from the interviews, appeared to be greater than its negatives. The evidence 
suggests that telehealth was starting to embed in routine practice but was 
not yet fully embedded.  
7.6  Summary 
This chapter investigated how and why telehealth performed in routine 
health care setting. It also investigated factors associated with the uptake of 
telehealth in observational study and how telehealth performed in routine 
healthcare practice. The methods used were semi-structured interviews 
guided by Normalisation Process Theory (NPT). The study uncovered four 
main themes that explained why and how telehealth performed in routine 
healthcare practice; factors related to: (1) service design; (2) telehealth 
devise; (3) staff; and (4) patients and carers. The findings suggest that 
telehealth was embedding in routine healthcare use. 
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Chapter 8: Synthesis 
8.1 Introduction 
This thesis aims to investigate why new technologies fail or succeed to 
embed in routine healthcare practice. Chapter 1 outlined the research aims 
and objectives. The theoretical framework underpinning the research, 
normalisation process theory (NPT), was described in Chapter 2. This was 
followed by background information relevant to the study, which described 
the study setting, the health status of the local population, and a description 
of telehealth (Chapter 3). A literature review on effectiveness and cost-
effectiveness of telehealth was presented in Chapter 4, along with literature 
on factors influencing successful implementation of new technologies and 
why trials failed to recruit to their intended targets. The effectiveness of 
telehealth was assessed using a pragmatic randomised controlled trial (RCT 
or referred to here as pragmatic trial) and it was reported in Chapter 5, while 
Chapter 6 (referred to here as service evaluation) assessed the uptake of 
telehealth using quantitative outcome measures to determine 
embeddedness of telehealth service. A qualitative study examining why new 
technologies embedded or not was explored in Chapter 7 (qualitative study), 
where factors related to staff, technology, service design, and patients’ 
groups were found to be possible explanations. The current chapter 
synthesizes all the evidence from the thesis to answer the research question 
posed in Chapter 1, in line with Yin’s (2009) case study research method 
(Yin, 2009). NPT presented earlier in Chapter 2 is used as the theoretical 
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framework in the synthesis of the findings, using the propositions stipulated 
in the theory.  
This chapter is structured as follows:  
1. Each of the five research sub-questions are addressed in order to 
understand why new technologies embed or not in routine practice. 
The findings from all the chapters thus far were synthesised.  
2. The way forward to help new technologies embed in routine practice 
is discussed.  
3. Recommendations on practice, policy, and research are made in 
order to promote new technologies embed in routine healthcare 
practice.   
8.2 Synthesis of why new technologies fail or succeed to 
embed or not in routine healthcare practice 
In the sub-sections below, evidence is drawn from previous chapters of the 
thesis, using Yin’s case study research methods to address each of the five 
research sub-questions outline in Chapter 1. NPT was used in order to make 
sense of what happened in relation to the findings. 
8.2.1 Setting 
The following research question was posed in relation to setting: “Is there 
something about Doncaster that made it more difficult to operate a 
randomised controlled trial (RCT) versus a service evaluation?”    
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Using Yin’s case study research approach (Yin, 2009), the evidence to 
address this question was derived from the following sources: (1) research 
experience of Doncaster in relation to other districts in England (Chapter 3); 
(2) experience of uptake of telehealth service in Doncaster during the 
pragmatic trial (Chapter 5), (3) the service evaluation (Chapters 6) and the 
qualitative study (Chapter 7).  
Factors related to recruitment into research studies and uptake of telehealth 
service in Doncaster 
Evidence from Chapter 3 showed that recruitments into observational and 
interventional studies in Doncaster were comparable to other districts in 
South Yorkshire. The same chapter showed that recruitments into national 
portfolio studies were higher in Doncaster than the average for primary care 
trust organisations in England.  
Experience of implementation of telehealth service from the published 
literature (Chapter 4) showed that it was possible to implement telehealth in 
various settings from around the world. From the literature review reported in 
Chapter 4, no evidence was found relating to setting as being a barrier to 
successful implementation of telehealth. On the other hand, comparison of 
uptake rates of telehealth service in Doncaster was higher than in some 
districts in England (Joseph et al., 2011).  
In Chapters 5 and 6, comparison of uptake of telehealth service during the 
pragmatic trial versus the service evaluation showed that within Doncaster, it 
was possible to increase the uptake of the service. If uptake rates of 
telehealth service could be low and later increase in the same setting, then 
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setting can be eliminated as the possible reason for the performance 
observed in both the pragmatic trial and the service evaluation.  
There was no evidence that Doncaster, as a setting, was the reason why the 
uptake of telehealth service was low in the pragmatic trial and higher in 
service evaluation. Therefore, the hypothesis that Doncaster was 
significantly different in its experience of uptake of telehealth service 
compared to other districts in England was rejected. 
8.2.2  Technology 
The research question posed was: “Are there factors associated with the 
new technology used in the RCT versus the ones used in the service 
evaluation that made a difference in uptake of the new technology?” The 
following evidence was used to answer the research question:  
(1) Changes in relation to telehealth device: physical and software 
(Chapters 3, 5 and 6);  
(2) Compliance rate and level of red alerts (Chapters 5 and 6);  
(3) Uptake of telehealth and withdrawal of cases from its usage 
(Chapters 5 and 6); 
(4) Views of patients and staff from the qualitative study (Chapter 7), and 
NPT to make sense of the findings (Chapter 2). 
Factors related to physical features of telehealth technology 
The physical structure of telehealth machines used during the trial and 
service evaluation had changed over time (Chapters 5-7). Changes were 
observed in base units of telehealth machines, and there were fewer wires in 
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the newer versions of the machines than the older ones (Chapter 3: Figures 
3.15a and 3.15b). However, features of the telehealth devices for measuring 
blood oxygen saturation (SpO2) and blood pressure cuff remained the same. 
As shown in Chapter 6, between 2007 and 2013 there had been 5 versions 
of telehealth technologies that were released by the same company, 
Tunstall. This meant that on average, a new version of telehealth technology 
was released into the market per year. Features of these new technologies 
also differed. There were operational differences in transmission of data and 
access to information for nurses who monitored the readings from telehealth 
monitoring system.  The software used in the pragmatic trial was different 
from that used in the service evaluation. Software used in the latter study 
enabled easy remote access via internet by safe and secure username and 
password.  
Senior managers within Tunstall acknowledged that in 2009, there were 
some technical changes in telehealth between 2007 and 2009. They advised 
Doncaster PCT at the time that if it was considering rolling out telehealth 
service in Doncaster, it was appropriate for the organisation to wait and use 
the newer version of telehealth technology, which they considered to be 
more user-friendly, for both patients and staff. The new version of the 
technology was about to be released at the time. In the contract with 
Tunstall during the service evaluation, the PCT therefore, replaced the older 
machines with the newer ones for existing and new patients who were on 
telehealth in Doncaster at the time. This act acknowledged the significant 
changes in the technology and the fact that it was better to use a newer 
version of the technology for the population of Doncaster. 
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Telehealth Co-ordinator and community nurses in Doncaster reported that 
there were a lot of changes in the machine between those used during the 
trial and service evaluation; the more recent machines were smaller and 
neater, and represented an improved version (Chapter 7). The evidence of 
the difference in the performance of telehealth during the trial and service 
evaluation can be observed in the rates of red alerts that were reported in 
Chapters 5 and 6. 
Factors related to symptom questions in the machines 
Some questions chosen from a bank of questions on the telehealth machine 
for COPD patients during the pragmatic trial had some inherent limitations in 
the way how they were framed, as a result it was inevitable that 
unnecessary red alerts were generated. For example, questions such as the 
one below meant that patients would return similar answers in the same 
week even though their daily situation might have changed for that week: 
“Did you have an unexpected visit to your doctor this week?”  
During the service evaluation, such questions were changed or omitted 
altogether for some groups of patients at the discretion of community nurse. 
Factors related to remote access to telehealth readings of patients by staff  
The pragmatic trial had records of patients accessed only from a central 
location, while in the service evaluation, patient records were accessed from 
multiple sites where community nursing teams were located using the 
internet. This made it more acceptable and accessible for staff. 
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Factors related to technical accuracy and red alerts 
In the pragmatic trial and the service evaluation, the red alerts were serious 
challenge to the implementation of telehealth service, as some patients were 
withdrawn from the service due to high levels of red alerts. In addition, the 
red alerts also created workload for staff, which was regarded as 
unnecessary by some of the staff. Some of the red alerts were attributed to 
lack of training and experience (practical guidance) in setting realistic alert 
parameters. In an attempt to follow NICE clinical guidance 12 on the 
management of COPD in adults in primary and secondary care (NICE, 
2004), this appeared to cause confusions, anxiety and uncertainty for the 
inexperience staff that were new to telehealth service. Tunstall constructed a 
decision-tree (pathway) for use during the period of the pragmatic trial, 
which included specific reference to NICE guidance CG 12. Although the 
evidence reported in the qualitative study showed that staff workload did 
increase, staff also indicated that they needed to know some of the 
information so that they could prioritise their workload and see appropriate 
patients at the right time; hence telehealth helped in introducing a new way 
of working. 
Interviews with Telehealth Coordinator showed that telehealth performance 
suggested that the uptake of the service was increasing steadily and it was 
embedding (Chapter 7). This pattern was supported by evidence from the 
service evaluation on embeddedness of telehealth (Chapter 6). Problems 
were uncovered and resolved, where possible in the course of the 
implementation of telehealth service. However, there remained some 
unanswered questions for further research, policy makers and 
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manufacturers, for example, “why does telehealth machine appear to work 
for some patients and not others?” Such question arose from observation 
made during the course of the implementation of service evaluation where 
vital sign readings from telehealth machines for some patients appeared to 
be consistently different from those obtained using traditional tools such as 
sphygmomanometer (blood pressure measure). The differences observed 
by the clinicians resulted in less trust in telehealth machines, and they 
trusted their own tools more. Without independent assessment of the 
accuracy of these machines, it was difficult to know whether the telehealth 
vital sign measurements were inaccurate or the problem rested with 
clinicians’ traditional tools that they routinely use in their practice. 
NPT highlighted the importance of understanding the meaning of a new 
practice by staff in order for them to embed it in their routine practice. The 
theory also stipulated that implementation of new practice had to fit in the 
social contexts and organisational structures in order for it to embed. 
Proposition 1.1 of NPT (Chapter 2, Table 2.1) stated that: “Embedding is 
dependent on work that defines and organizes a practice as a cognitive and 
behavioural ensemble” (May and Finch, 2009). At the beginning of the 
implementation of telehealth service during the trial, fewer people, especially 
among healthcare staff, saw the meaning and uses of the new technology. 
Some staff even proposed that the available funds for telehealth be used to 
employ more nurses. At the time of introduction of telehealth service in 
Doncaster, as part of the pragmatic trial, there was limited evidence on 
effectiveness and cost-effectiveness of telehealth from the literature. The 
current evidence of literature review presented in Chapter 4 had been 
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updated after the studies were undertaken. As the new technology was 
being rolled-out in the service evaluation, the understanding of telehealth 
technology in the delivery of healthcare was better among healthcare 
professionals, especially among community nurses. However, not all 
healthcare professionals had a common understanding of the usefulness of 
telehealth service.  Appreciating the usefulness of telehealth is what 
constitutes proposition 1.1 of NPT. It is the first step for a new practice to be 
taken up by practitioners. 
Proposition 1.2 of NPT asserted that: “Embedding work is shaped by factors 
that promote or inhibit actors’ apprehension of a practice as meaningful” 
(May and Finch, 2009). Factors related to differences in technologies that 
might have contributed to the performance of telehealth are described 
above. These factors included the physical features of telehealth technology, 
symptom questions used, remote access to patients’ data by staff, technical 
accuracy and the issue of red alerts.  
Proposition 1.3 of NPT stated that: “The production and reproduction of 
coherence in a practice requires that actors collectively invest meaning in it” 
(May and Finch, 2009). At the time of implementation of telehealth during 
the service evaluation, lessons were learned from new evidence in the field 
of telehealth. The new evidence came from the experience of implementing 
the pragmatic trial. In addition, some lessons were drawn from key 
challenges encountered in the implementation of telehealth as reported in 
the literature in Chapter 4. The key factors for successful implementation of 
telehealth service were used to inform the implementation of the service 
evaluation (Joseph et al., 2011). In the service evaluation, there was a broad 
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understanding among the various stakeholders that there was a place for 
telehealth in professional practice by community nurses, as described in 
Chapter 7. Hence, there was a much better collective investment in meaning 
of telehealth service in the service evaluation, than it was in the trial. The 
qualitative study showed that a stakeholders’ workshop was held to try to get 
a shared understanding of the value of telehealth service that had been 
implemented. The stakeholders’ workshop aimed to establish how the 
knowledge and experience gained could inform future roll-out of telehealth 
service. This was consistent with proposition 1.3 of NPT stated above. The 
usefulness and place of telehealth was affirmed by professionals in 
Doncaster, and the organisations involved, from both commissioners and 
providers of health and social care services. 
From NPT perspective, there was organisational commitment to 
implementation of telehealth service in Doncaster when it was first 
introduced. However, initially during the pragmatic trial, telehealth service 
did not appear to fit in with the prevailing social norm and practices of 
community healthcare staff. During the service evaluation, there was a much 
better understanding of the usefulness of telehealth service, and the service 
appeared to be more acceptable to community healthcare professionals.  
In summary, it had been found that there were changes in the physical 
characteristics of the telehealth device, and the network it was linked to. 
Similarly, changes were observed in the rates of red alerts, and uptake rate 
of telehealth service between the pragmatic trial and the service evaluation. 
The changes might have reflected in the technical accuracy or how staff 
became more experienced in interpreting the readings from telehealth 
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service. Experience from the qualitative study also confirmed that the 
technology had changed over time, as noticed by staff involved in the 
implementation process. All these resulted in a better uptake of telehealth 
service in the service evaluation study. Therefore, it was not possible to 
reject the hypothesis that “there were factors associated with the new 
technology used in the RCT versus the ones used in the service evaluation 
that made a difference in uptake of the new technology”. 
8.2.3  Patients’ group 
This section tackles the following research question: “Are there factors 
related to patients’ group recruited for the RCT as opposed to the service 
evaluation that made the difference in uptake of the new technology?”   
The following evidence was considered in order to answer the above 
research question:  
(1) The primary types of diseases of patients who used telehealth service in 
both the pragmatic trial and the service evaluation;  
(2) The evidence from the literature, including Chapter 4; 
(3) Uptake rates of telehealth service in both the pragmatic trial and the 
service evaluation.  
Factors related to types of disease of patients involved in telehealth service 
Patients in the pragmatic trial and the service evaluation study on telehealth 
implementation were different in that the pragmatic trial focused on COPD 
patients. While in the service evaluation, there were patients with various 
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types of diseases that used telehealth service, including those with COPD, 
heart failure, and diabetes.  
Evidence presented in Chapter 4 from the published literature indicates that 
there were a number of studies that reported on various long-term 
conditions, including heart disease, diabetes, stroke, and COPD. One of the 
largest telehealth programme in the United States of America, the Veteran 
Health Administration (VHA), had also various groups of patients with 
different long-term conditions, including heart failure, hypertension, COPD, 
diabetes, and mental illness (Darkins et al., 2008). While in the UK, the 
Whole System Demonstrator (WSD) telehealth project had patients with 
COPD, heart failure and diabetes on telehealth (Steventon et al., 2012). 
Based on evidence from the literature, it can be argued that the uptake of 
home telehealth monitoring was possible by various patients groups.  
Factors related to uptake rate of telehealth from the pragmatic trial and the 
service evaluation  
The findings from the pragmatic trial and the service evaluation showed that 
it was possible for patients with COPD to be recruited in the studies. 
Although recruitment into the pragmatic trial was limited (Chapter 5), it 
increased during the service evaluation (Chapter 6). 
There was limited evidence to accept that the uptake of telehealth service in 
both studies was explained by differences in types of diseases of patients. 
Therefore, the hypothesis that “there were factors related to the patients’ 
group recruited for the RCT as opposed to the service evaluation that made 
the difference in uptake of new technology” was rejected.  
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8.2.4  Staff 
The research question addressed in relation to staff was: “Are there factors 
associated with staff involved in the RCT, as opposed to the service 
evaluation that made a difference in uptake of the new technology?” The 
objective here was to determine whether the implementation of telehealth 
was better managed in the service evaluation than in the trial. Evidence was 
drawn from the thesis (the pragmatic trial, service evaluation and the 
qualitative study) by examining the following factors:  
1) Capacity of staff and team involved in the management of telehealth  
2) Project management,  
3) Staff resistance, and 
4) Training for staff.  
Factors related to capacity of staff and team involved 
When the pragmatic trial was being planned, there was a concern expressed 
by some members of the Respiratory Working Group (RWG) in Doncaster 
around lack of capacity among the respiratory nurse specialist team, as a 
member of the team had left for a job as a community matron. It was feared 
that the introduction of telehealth service would deprive staff capacity from 
existing service. Subsequently, the telehealth service was conducted with 
the district nursing team, who had COPD patients on their case workload, in 
the East side of Doncaster, with the support of clinical nurse manager. The 
telehealth service involved only one district nursing team located physically 
in one health centre where the telehealth monitoring base unit was hosted. 
Two district nurses were tasked with the responsibilities of recruiting patients 
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into the telehealth service and monitoring them. They visited the site on daily 
basis to check patients’ readings on one computer installed in an office at 
the health centre.  The telehealth office was in a different location from the 
usual health centre where the two district nurses usually worked from. This 
made it operationally difficult, as they struggled to find time to travel from 
their usual base to the telehealth office to view patients’ readings that were 
transmitted online (detail description can be found in Chapter 5). This 
contrasted with the service evaluation (Chapters 6) where several teams of 
community matrons, based in different health centres across Doncaster had 
access to their patients’ record online by means of special user names and 
passwords from computers within the health centres where they worked 
from. The teams comprised of healthcare assistants, as well as 
administrative support staff who checked the telehealth readings and they let 
the community matrons know when to follow up further cases with red alerts. 
The implementation of telehealth during the pragmatic trial lacked dedicated 
administrative support. 
In the service evaluation, it was planned that the system was going to 
operate as part of an integrated community care pathway (ICCP). An ICCP 
was defined as one where patient care was provided by a team of multi-
disciplinary staff within the right time-frame in order to achieve the best 
outcomes for the patient with a specific condition (Middleton et al., 2001). 
The ICCP in Doncaster was led by a steering group in the PCT to oversee 
the implementation of community matrons programme in Doncaster and 
telehealth service was seen as an integral part of the process for these 
healthcare workers.  
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In the pragmatic trial, there were only two district nurses responsible for the 
implementation of telehealth service and they did not have protected time for 
telehealth work. Doncaster PCT had made financial provision for employing 
two full time nurses to support the delivery of the telehealth service. 
Although, two district nurses were identified, arrangement was not made by 
their manager for them to deliver telehealth service on full time basis. The 
two nurses were required by their managers to continue to discharge their 
district nursing duties as well as that of telehealth service. As a result, the 
delivery of telehealth service did not happen as envisaged and there was 
limited staff capacity for the service. There was also a high turnout of staff 
observed during the pragmatic trial, which suggested a lack of satisfaction 
among the staff with the service. 
Although further efforts were made to increase the recruitment of 
participants in the pragmatic trial, it did not yield expected results. It was 
agreed that a Tunstall Nurse Consultant would undertake recruitment into 
the pragmatic trial, as part of contract arrangement with Tunstall, this did not 
happen. The reason given by the Tunstall nurse was that she was not an 
employee of NHS Doncaster and therefore she was not legally protected to 
go and meet patients in their homes for recruitment unless she was 
accompanied by another PCT employer. There was no administrative 
support available for the telehealth project to accompany the Tunstall nurse 
to visit patients for recruitments at home (Chapter 5).  
The service evaluation benefited from a full-time dedicated Telehealth 
Coordinator in terms of uptake of telehealth, in addition to several 
community matrons and their teams across Doncaster who were supported 
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by administrative staff, including healthcare assistants. This improved the 
efficiency of the delivery of telehealth service; with the healthcare assistants 
taking the initial reading and flagging up any issues such as red alerts with 
community matrons or heart failure specialist nurses, as described in 
Chapters 6 and 7.  
Factors related to project management 
During the service evaluation, a project implementation plan was agreed by 
a steering group, the Telehealth Delivery Group. Lessons learned during the 
trial were built into the plan during the service evaluation period. Most 
importantly, there was a full-time Telehealth Coordinator in place, 
community matrons were on board, along with other activities agreed by the 
delivery group. Two GP champions were also enlisted.  In the pragmatic 
trial, there was a protocol in place to guide the delivery of telehealth service, 
however, implementation was hampered by the end of employment contract 
of the Project Manager who subsequently left and there was neither a 
replacement to the post nor any dedicated project manager. Other 
healthcare professionals who were previously involved in the implementation 
of telehealth were busy with other work duties; telehealth was not in their 
main job. The pragmatic trial had only one GP champion on board, as part of 
a steering group. These were a number of critical factors identified in failed 
trials (Chapter 4) that were not addressed in the pragmatic trial. 
Factors related to staff resistance 
Before the start of the trial in 2006, there was some resistance even among 
some members of the professional groups in Doncaster, for example, the 
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Respiratory Working Group (RWG). Some members of the RWG expressed 
alternative views for using the money for telehealth for other purposes, for 
example, employing more nurses or purchasing other equipment, other than 
telehealth. They did not see the usefulness of telehealth at the time. 
Although there was professional resistance during the trial, the situation was 
different in the service evaluation where the attitude of staff appeared to 
have softened with time in favour of telehealth. More staff began to accept 
that there was a role for telehealth service for certain groups of patients. The 
experience of nurses in the service evaluation showed that even some of the 
patients on community matron’s workload who were regarded as end-of-life 
care, including those with respiratory diseases (severe COPD), were thought 
to benefit from telehealth service. 
Earlier views of community matrons showed resistance to telehealth, as it 
was considered by them to be a potential risk to their job security if the 
service was to show effectiveness in reducing hospital admissions (Chapter 
5 and Chapter 7). Their perception was that fewer community matron nurses 
would be needed if telehealth service were to prove successful, as fewer 
face-to-face visits would be needed. Some of those professionals who were 
still resistant to telehealth service were willing to accept that there was a 
place for telehealth for some patients. Telehealth service did not result in the 
loss of jobs of the community nurses after all. The acceptance of telehealth 
service also extended to secondary care where the local clinicians were 
keen to engage with telehealth activities and they wanted hospital business 
managers to be on board, as part of the local planning process. 
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Factors related to training 
Training was better organised in the service evaluation than in the pragmatic 
trial. In the pragmatic trial, a total of six staff had been trained, which 
consisted of four district nurses, one Project Manager and the Chief 
Investigator of the pragmatic trial. While in the service evaluation, during the 
first 6 months of implementation, there was a total of 48 staff trained. The 
training, however, needed to have been continuous and increased. The 
scope of staff trained increased over time in the service evaluation, and the 
training was better organised and delivered initially by Tunstall staff and 
subsequently all the training in the service evaluation was delivered in-house 
by the Telehealth Coordinator (Chapters 6 and 7).  
The training activities provided during the pragmatic trial and at the service 
evaluation were limited to how to operate the telehealth equipment, access 
patients’ readings from online monitoring system (database), interpret them, 
and manage the information recorded such as entering information on 
patients’ record regarding observation or intervention done. However, the 
training did not cover change management, and process re-designs. This 
would have improved the understanding of all those involved in the 
implementation to see the bigger challenges involved in embedding 
telehealth in routine practice. However, issues related to change 
management, and service re-design were considered by policy makers and 
managers at the PCT and the local authority. 
Findings from the published literature showed that the implementation of 
telehealth service was related to staff input and workload, as shown by 
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examples of the VHA telehealth programme in the US where over 6000 staff 
were trained (Darkins et al., 2008); and examples of staff role in telehealth 
projects elsewhere in Scotland (Roberts et al., 2010) and in Italy (Vitacca et 
al., 2010). Although the service evaluation achieved a high level of staff 
trained in telehealth service, lessons from the VHA indicated that there 
needed to be a continuous programme of training of staff involved in 
telehealth service and a much higher number of staff needed to be trained. 
The level of training of staff in telehealth service during the service 
evaluation study was considered to be still limited in light of the work that 
needed to be done. 
In Chapter 3, it was also shown how hospital trusts that had a dedicated 
staff nurse for managing recruitment of participants into portfolio research 
studies, did better than those where there was no dedicated research nurse. 
Having a dedicated staff had been recognised as one of the important 
factors for successful recruitments of participants into research studies, as 
shown from the literature review (Campbell et al., 2007). The pragmatic trial 
did not have dedicated staff, from nursing and managerial perspectives. 
Normalisation process theory (NPT) stipulated that for practices to embed in 
routine practice, it was necessary that those responsible for implementation 
needed to fully understand the usefulness of a practice, be engaged in it 
(cognitive participation), and collectively take action in implementing the 
change (May and Finch, 2009). The extent to which the work on 
implementation of telehealth service related to the propositions 2.1-3.3 of 
NPT is synthesised below. 
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Proposition 2.1 of NPT stated that: “embedding is dependent on work that 
defines and organises the actors implicated in a practice”.  The qualitative 
study showed that there was evidence in support of the fact that some 
health professionals (community nurses) were finding telehealth to be useful 
in their practice, however, this was not across the board, and there were 
some staff that needed to be convinced of the usefulness of telehealth. Staff 
involved in telehealth, found that telehealth was compatible with their work 
practice and it was introducing some new ways of working, as evidenced 
from the interviews. Community nurses and healthcare support staff were 
beginning to identify how telehealth could fit into their job roles and the wider 
potential for telehealth in enhancing their practice. This was consistent with 
NPT proposition 2.1 stated above. 
NPT proposition 2.2 stipulated that: “embedding work is shaped by factors 
that promote or inhibit actors’ participation” (May and Finch, 2009). In the 
context of telehealth service in the qualitative study (Chapter 7), there were 
concerns also around workload of staff arising from telehealth, and lack of 
training for staff. Although there had been training provided, this was not 
given priority by the relevant staff as it was not considered to be mandatory 
by the organisation. There were some barriers that were identified and 
drivers to be recognised if progress for embedding telehealth was to be 
realised.  
An important issue highlighted in the service evaluation was related to the 
attitude of staff. While healthcare staff needed to know the evidence of 
effectiveness of interventions to inform their actions, barriers such as staff 
resistance and negative assumptions posed a significant problem for 
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implementation of telehealth. As shown in the qualitative study, such 
resistance appeared to be overcome when staff tried to use telehealth in 
some of their patients. This approach seemed to be a reasonable way 
forward for clinical staff that are in doubt about the role of telehealth service 
in their clinical practice. 
Unlike in the pragmatic trial where there was lack of protected work time for 
staff undertaking telehealth implementation, in the service evaluation there 
was agreement by senior managers at Assistant Director level of healthcare 
provider organisation to oversee the implementation of telehealth service. In 
the pragmatic trial, implementation was overseen by a clinical manager who 
did not have direct power to influence some of the changes required by front 
line nursing staff. Therefore, the above factors that shaped implementation 
of telehealth service were consistent with NPT proposition 2.2: “Embedding 
work is shaped by factors that promote or inhibit actors’ participation” (May 
and Finch, 2009). 
Proposition 2.3 of NPT stated that: “The production and reproduction of a 
practice requires that actors collectively invest commitment in it” (May and 
Finch, 2009). Stakeholders on the Long-term Condition Steering Group in 
Doncaster accepted telehealth as the future means of delivery of healthcare 
for patients with long-term conditions and the group considered its 
implementation to be in the best interest of patients, thus legitimising the use 
of telehealth. There was also organisational commitment to the 
implementation of telehealth, in terms of financial resource investments. The 
level of commitments in telehealth was greater in the service evaluation than 
it was in the pragmatic trial. Without such financial investment in telehealth 
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service, the work on implementation would not have been realised. The 
investment of efforts was therefore consistent with above the proposition. 
NPT propositions 3.1-3.3 related to collective actions by actors to implement 
a practice. Proposition 3.1 of NPT stipulated that: “Embedding is dependent 
on work that defines and operationalizes a practice” (May and Finch, 2009). 
The interaction between professionals and patients (interactional workability) 
in the pragmatic trial was poor, as evidenced by higher rate of red alerts and 
limited number of staff (2 nurses) to respond to the alerts. On the other 
hand, staff-patient relationship improved in the service evaluation (Chapter 
7). Similarly, the relationship among community nursing teams also 
improved in the service evaluation compared with the situation during the 
observed in the pragmatic trial. For example, healthcare assistants played 
an important role in screening alerts for the nurses to look at (Chapter 7), 
thus improving the skills for the work that needed to be done in the service 
evaluation. While in the pragmatic trial, the community nurses did both the 
administrative job of reading the alerts and responding to the technical 
issues (malfunctions of the machines), and their role extended to performing 
clinical duties of interpreting the alerts, thus displaying poor skill-set 
workability. All these added to the workload of the community nurses, and 
coupled with time constrain, they made the job more difficult to undertake for 
the limited nurse capacity available at the time. The key challenges 
encountered in implementing telehealth in healthcare settings as reported in 
service evaluation (Chapter 7), were consistent with propositions 3.1 of NPT. 
Propositions 3.2 of NPT stated that “Embedding work is shaped by factors 
that promote or inhibit actors’ enacting it.” (May and Finch, 2009). These 
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factors in relation to implementation of telehealth service are described 
above, and they included capacity of staff, project management, staff 
resistance, and training. 
Proposition 3.3 of NPT: “The production and reproduction of a practice 
requires that actors collectively invest efforts in it” (May and Finch, 2009). 
This proposition was demonstrated by implementation of both the pragmatic 
trial and the service evaluation. As implementation of telehealth progressed 
in both the pragmatic trial and the service evaluation, there was a realisation 
of the role of telehealth service in the delivery of healthcare, and the 
collective investment of efforts made by various players: the Telesolution 
Delivery Group, Telesolution Programme Board, the community nurses and 
other staff involved in the implementation of telehealth. This collective 
investment of efforts by health professionals in the implementation of 
telehealth service was consistent with proposition 3.3 of NPT. 
In summary, the implementation of telehealth in the service evaluation was 
better managed than it was in the pragmatic trial. There was dedicated staff 
and team to manage telehealth service in the service evaluation, whereas 
the pragmatic trial lacked both dedicated coordinator and team. Lessons 
learned from the pragmatic trial were used to improve implementation of 
telehealth service in the service evaluation. The way staff capacity was used 
to manage telehealth service helped to explain the reason for better uptake 
of telehealth in the service evaluation compared to the pragmatic trial. The 
implementation of telehealth was better managed in the service evaluation 
than in the trial, based on a number of factors considered, which included 
levels of team organisation, staff capacity, project management, professional 
272 
 
 
resistance, and training. Therefore it was not possible to reject the 
hypothesis that “there were factors associated with staff involved in the RCT, 
as opposed to the service evaluation that made a difference in uptake of 
new technology”. 
8.2.5  Evaluation 
The research question to address the evaluation design of the service was: 
“Are there factors associated with the methodological approach used within 
a randomised controlled trial (RCT), as opposed to service evaluation that 
made a difference in uptake of the new technology?” It was hypothesised 
that the methodological approach used within the RCT hindered the uptake 
of telehealth service, while service evaluation method enhanced the uptake 
of telehealth service. 
The evidence was drawn from the pragmatic trial, the service evaluation, 
and the literature review (Chapter 4) to answer the research questions. 
Factors examined related to methodological approach were: (1) the inclusion 
criteria; (2) the randomisation process, and (3) sources of data for recruiting 
participants. 
The key features of an RCT were that patients with similar baseline 
characteristics (e.g. disease characteristics, age, sex, etc.) were selected 
and they were randomly allocated into an intervention group and a control 
group, as described in Chapter 3. This approach was considered to 
minimise bias in assessing the effects of an intervention. The RCT operated 
on strict participant inclusion and exclusion criteria.  
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The following factors were identified, as possible explanations for the 
difference in uptake of telehealth service in the pragmatic trial and the 
service evaluation:  
Factors related to sources of data for recruiting participants 
The pragmatic trial encountered difficulty in identifying eligible cases based 
on the inclusion criteria from hospital admission records as most of the 
cases were not easily reached or some had already died after they were last 
discharged from hospital. While the service evaluation participants were 
recruited from among community matron caseload, which had live patients. 
Factors related to randomisation process 
The random allocation of eligible participants into the pragmatic trial was not 
under the control of community nurses, but a third party. Community nurses 
were uneasy with having to randomise their patients, when they had 
identified them initially as being eligible for telehealth service, but were 
subsequently allocated to the control arm of the trial. They preferred patients 
whom they identified for the telehealth service to be allocated telehealth 
machines. On this basis, the nurses considered the randomisation process 
of the trial as being unfair (Chapter 7). On the other hand, the service 
evaluation enabled the community matrons to offer telehealth service to the 
patients whom they considered to be appropriate, and they were in control of 
the process. Another possible reason for the difficulty in recruiting 
participants onto telehealth service under RCT design by healthcare staff 
might be related to the fact that RCT was outside the comfort zone of most 
frontline healthcare practitioners.   
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A Cochrane systematic review of strategies to improve recruitment to RCTs 
found that open design of trial, where participants knew in which arm of the 
trial they would be, was significantly associated with higher uptake of 
participants  into trials (RR 1.22; 95% CI: 1.09, 1.36) (Treweek et al., 2011). 
However, the pragmatic trial was not an open design, but one where 
participants did not know before-hand which of the two arms of the trial they 
would be allocated to.  
Factors related to inclusion criteria 
The strict eligibility criteria for the pragmatic trial, was viewed as a barrier by 
community nurses. The community nurses welcomed the fact that the strict 
eligibility criteria were removed for the service evaluation. The only eligibility 
requirement left in the service evaluation was for patients with long-term 
conditions being on the case-load of community matron or heart failure 
nurses. The nurses were much comfortable with these changes (Chapters 6 
and 7). 
Evidence from the published literature on how telehealth service was 
implemented indicated a flexible system of provision of home telehealth 
monitoring had better uptake, like that observed at the Veteran Health 
Administration (VHA) system in the United States based on observational 
study (Darkins et al., 2008). It had been shown that where an RCT was 
inflexible in its inclusion criteria, there was an associated high drop-out rate 
and lower uptake rate of the service (Shea et al., 2009).  
NPT enables researchers to understand how practices get understood and 
assessed (reflexive monitoring); these were captured in propositions 4.1-4.3 
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(May and Finch, 2009). The authors of NPT described how embedding was 
dependent on work that defined and operationalized every day practice 
(proposition 4.1); factors that shaped or inhibit appraisal (proposition 4.2); 
and the need for actors to collectively invest in understanding of a practice 
(proposition 4.3).  
In the pragmatic trial, the methodology that was used made it difficult to 
enrol participants into the telehealth service. As a result, some community 
matron staff showed reluctant to put forward the names of their patients to 
be randomised for fear of unknown effects of telehealth service. A system of 
appraisal of the work on telehealth was established in both the pragmatic 
trial and service evaluation. However, in the pragmatic trial, this was limited 
to a steering group with a few members of stakeholders, which did not 
include patients’ representatives. While in the service evaluation, there was 
a wider representation of stakeholders, including patients and staff from both 
the local authority and the health service sector. The steering group 
assessed how telehealth service was being implemented, with updates 
received at its regular meetings, often held on monthly basis or bi-monthly. 
This was consistent with proposition 4.1 of NPT: “Embedding is dependent 
on work that defines and organizes the everyday understanding of a 
practice.”  
Proposition 4.2 of NPT stated: “Embedding work is shaped by factors that 
promote or inhibit appraisal” (May and Finch, 2009). The specific factors that 
promoted or inhibited the uptake of telehealth service under pragmatic trial 
and service evaluation have been described above, consisting of difference 
276 
 
 
in inclusion criteria, randomisation process, and sources of data for 
recruiting participants. 
Proposition 4.3 stated that “The production and reproduction of a practice 
requires that actors collectively invest in its understanding” (May and Finch, 
2009). The steering groups in both the pragmatic trial and the service 
evaluation provided a forum to appraise the development of telehealth 
implementation and institute appropriate remedial actions, where 
appropriate. In the service evaluation, there were additional layers of 
committees, such as Telesolution Programme Board with membership from 
both the PCT and the local authority, and senior management team in the 
PCT with decision-making power of allocating resources to programme 
areas. The experiences on appraising local practices in the implementation 
of telehealth were captured in both studies. 
Therefore, it was not possible to reject the hypothesis that “there were 
factors associated with randomised controlled trial (RCT) methodology 
approach, as opposed to service evaluation that made a difference in uptake 
of new technology”. 
8.2.6 Strengths and limitations of the research 
The strengths and limitations of the pragmatic trial and the service 
evaluation had been discussed in the respective chapters (Chapters 5 and 
6). The strengths of the qualitative study (Chapter 7) was that it covered a 
range of stakeholders (staff, and patients with COPD and heart failure), and 
a number of methods and data sources were used.  The use of Telehealth 
Coordinator in undertaking interviews with patients and staff could be 
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considered as strength on the one hand, and a limitation on the other. The 
strength of using the Telehealth Coordinator in undertaking the interviews 
was that the role was consistent with routine delivery of telehealth service 
expected, as per service contract for the provider to obtain patients 
satisfaction feedback on their experience of using telehealth service. The 
potential limitation of the use of Telehealth Coordinator in undertaking the 
interview was that certain important observations of interviewees during the 
interview process might not have been captured. Such clues were 
considered to be an important part of undertaking qualitative interviews 
(Boyatzis, 1998). 
Another strength of the qualitative study was that it had been reported 
according to accepted standard, consolidated criteria for reporting qualitative 
studies (COREQ) (Tong et al., 2007). Further strength of the qualitative 
study was also that the views on telehealth service were from patients who 
used telehealth service, which reflected a true assessment of what the 
service in use was. This contrasted with the Whole System Demonstrator 
(WSD) qualitative study that explored barriers to participation and adoption 
of telehealth among patients who declined to participate or withdrew from 
the study before actually taking part in the telehealth service (Sanders et al., 
2012). The authors of the WSD project found that potential participants for 
the pragmatic trial had initial fears about telehealth service. Some of them 
thought that they needed some technical competencies in order to operate 
telehealth equipment effectively. The qualitative study in Doncaster had 
shown that some users held negative views about telehealth prior to using it, 
and some even did not possess any prior technical knowledge of using 
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technology, yet after using it, they liked it. These experiences were similar 
for staff; those initially sceptical about telehealth became comfortable with 
using it after they tried it. 
Taken together, the pragmatic trial, service evaluation, and the qualitative 
study provided a rounded evaluation of telehealth service using mixed 
methods advocated by researchers in the field of complex interventions 
(Campbell et al., 2000, Ekeland et al., 2012). The qualitative study confirmed 
that the difference between telehealth care and standard care was due to 
increased contacts (interactions) between patients and healthcare staff, and 
the associated care needed as a result of those contacts. 
Despite the limitation of having too many propositions (n = 12), some of 
which appeared to be overlapping, NPT was found to be a useful theoretical 
framework in this work to organise and explain the findings of the studies. 
NPT was able to provide explanations as to why and how telehealth failed to 
embed in practice in the pragmatic trial, while it appeared to have 
succeeded in the service evaluation.  The differences in the technologies 
used, factors related to staff, and evaluation methodologies appeared to 
have explained why and how telehealth performed in the pragmatic trial and 
the service evaluation. 
8.3.7 Overall conclusions 
This chapter used a range of evidence drawn from previous chapters of the 
thesis to address five research questions on why new technologies failed or 
succeeded to embed in routine healthcare practice. This approach was 
consistent with that advocated by Yin for case study research (Yin, 2009). 
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The better uptake of telehealth service in the service evaluation, in 
comparison with the pragmatic trial, were likely to be explained by a 
combination of factors including differences in approach to evaluation of the 
service, changes in the technologies, and better use of staff capacity in the 
management of telehealth service in the service evaluation. Geographical 
setting, such as Doncaster, was not considered to be the reason for failure 
or success of new technologies embedding in routine practice. Both studies 
had patient group with similar disease (COPD) but their uptake of the 
service were better in the service evaluation than in the trial; thus showing 
that difference in patients’ groups could not explain the uptake of telehealth 
service.  
Therefore, on the basis of the evidence presented, the following hypotheses 
could not be rejected as possible reasons why new technology embeds or 
not in routine practice: 
1. There were factors associated with the new technology used in the 
RCT versus the ones used in the service evaluation that made a 
difference in uptake of the new technology. 
2. There were factors associated with staff involved in the RCT, as 
opposed to the service evaluation that made a difference in uptake of 
new technology. 
3. There were factors associated with randomised controlled trial (RCT) 
methodology approach, as opposed to service evaluation that made a 
difference in uptake of the new technology. 
There was insufficient evidence to accept the following hypotheses: 
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4. Doncaster was significantly different in its experience of uptake of 
telehealth innovation compared to other districts in England. 
5. There were factors related to the patients’ group recruited for the RCT 
as opposed to the service evaluation that made the difference in 
uptake of the new technology. 
8.3  What needs to be done to help new technologies 
embed in routine healthcare practice? 
This section discusses what needs to be done to help new technologies 
embed in routine healthcare practice. From the evidence synthesised in 
Section 8.2, there were three possible explanations as to why new 
technologies fail or succeed to embed in routine healthcare practice. They 
related to factors associated with staff, technology and evaluation 
methodology used. This section focuses on these three areas in exploring 
what could be done to enable new technologies to embed in routine 
practice. 
8.3.1 Staff 
From the conclusions of this research, factors related to staff could not be 
excluded as possible reason as to why new technologies embed or not in 
routine healthcare practice. The pragmatic trial and the service evaluation 
showed the important role played by staff in ensuring proper management of 
implementation of new technologies. A range of measures related to staff 
can enable new technologies succeed in routine practice. One of these is 
training. Incorporating on-going programme of training and education is 
281 
 
 
essential if new technologies are to embed into routine use in order to 
ensure basic standard of service delivery.  
Staff in the field also identified the need for having a professional network in 
place to discuss emerging challenges related to implementation of new 
technologies. It is also important to acknowledge that staff are people and 
therefore, there is need to consider human psychology as part of 
implementation of new technologies.  Staff need to contextualise what a new 
technology means for them and their interaction with patients, as described 
in NPT (May and Finch, 2009). Thus there needs to be proper consultation 
upfront to ensure that staff understand the technology and the problem that 
it is intending to address. They also need to understand any evaluation 
strategies. 
Organisations need to set the right culture where new technological 
innovation thrives. Failure in implementation of new technologies should be 
taken as an opportunity to learn from and develop on it, as highlighted by 
expert in the field of innovation (Lundin, 2009).  
There is still a mismatch between the intent and the reality of encouraging 
research and innovation in terms of giving protected time to staff in the 
health service who might be interested in undertaking relevant research on 
new technologies. For research to be translated into operational role of staff, 
it needs to be reflected in protected time of staff. 
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8.3.2  Technology 
8.3.2.1  Assessing effectiveness and cost-effectiveness of new 
technology 
In 1977, body scanners were introduced into the British National Health 
Service (NHS) with the funding from the Government (Stocking and 
Morrison, 1978). However, the authors did express concerns around the 
cost-effectiveness of the body scanners, which were sold at a cost of 
£250,000 (British Pound) per machine at the time; and a total of 11 
machines were bought in Britain. More than 30 years on (2015) after the 
introduction of the body scanners, the technology can be said to have 
normalised (embedded) into routine health service delivery; they can be 
found in major hospitals in the UK. 
The lessons that can be drawn from the body scanners case study are that 
more attention is needed in considering factors relevant for acquisition and 
sustainability of new technologies. These factors include consideration for 
current evidence of effectiveness and cost-effectiveness; as well as future 
costs (likely to reduce); diagnostic and technical accuracy; competing 
technologies; and the influence of policy makers (Stocking and Morrison, 
1978). For telehealth technology, this means that there are challenges that 
remain to be overcome related to its effectiveness and cost-effectiveness, 
and to improve its reliability and validity so as to gain the confidence of staff 
and users. Evidence from the literature (Chapter 4) shows that for some 
diseases, telehealth appeared to be effective, although evidence for long-
term conditions generally remains limited. For specific disease areas where 
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telehealth had been shown to be effective, the costs of the technology 
remain one of the obstacles in the implementation of telehealth in routine 
healthcare practice. Current level of costs of the new technology, are still too 
expensive to make the technology cost-effective, where evidence of 
effectiveness had been demonstrated (Chapter 4). The advances in new 
technologies, along with increased range of products in the market may 
drive down future costs, and thus make the service more cost-effective. It is 
likely that once these challenges are addressed, along with other factors, 
there will be more confidence in telehealth services, and the technology will 
normalise in the health service in decades to come. However, a continual 
assessment of the new technologies is required, along with the opportunity 
costs of investing in them against other competing health priorities (Stocking 
and Morrison, 1978). 
As the work by other authors showed (Arthur, 2009, Keen et al., 2012, 
Feldman and Orlikowski, 2011), it is more than just cost that will determine 
the adoption of new technologies. There will be the need for flexibility of 
adoption of new technologies to new use that fits with organisational goals. 
The designers of new technologies will also need to actively engage 
healthcare stakeholder from the early stage of development of the new 
technological services and right through to their implementation stages and 
evaluation. Synthesised evidence from the literature on implementation of 
new technologies related to factors that determine their embedding (see 
Chapter 4), needs to be considered and taken on board if future 
technologies are to embed in routine use. 
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8.3.2.2 Evaluation of interventions involving new technologies 
There is a broad consensus in the literature that evaluation is an important 
part of development of new technologies in order to assess their 
effectiveness and cost-effectiveness (Stocking and Morrison, 1978, Ekeland 
et al., 2012). However, there is uncertainty on what approach of evaluation 
was ideal for use: summative assessment versus formative assessment 
(Ekeland et al., 2012). In summative assessment (also referred to as 
positive paradigm), Ekeland et al. (2012) described how the assessors 
maintained objectivity, and were value free and there was assumed causal 
link, as typically found in RCTs. While in formative assessment, they 
acknowledged that objectivity was difficult to achieve, there were multiple 
causal links, all entities were continuously changing and shaping each other 
and the inquiry was value based. Ekeland and colleagues (2012) 
recommended both of these approaches in evaluation of new technologies, 
which seemed to be a reasonable way forward. This research has also 
demonstrated the value of using these two forms of evaluation. 
Measuring health outcomes has not always been straight forward as shown 
throughout the thesis. While commonly recognised health outcomes such as 
hospital admissions and mortality are considered to be the key health 
outcomes, there are a number of outcome measures that are rarely included 
in the evaluation of new technologies. These include outcomes related to 
quality of life, assurance and confidence, work efficiency, change in 
medication, keeping in touch with friends and relatives, being in control of 
managing health conditions, and living independently, among others 
(Morrison and Barnett, 2009). A report by the International Union for Health 
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Promotion and Education recognised these types of outcome measures as 
health promotion outcomes (intervention impact measures), or intermediate 
health outcomes (modifiable determinants of health) or health and social 
outcomes (ECSC-EC-EAEC, 2000), (Table 8.1).  
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Table 8.1: An outcome model for health promotion outcomes 
Health & 
Social 
Outcomes 
Social outcomes: measures include quality of life, 
functional independence, and equity. 
Health outcomes: measures include reduced morbidity, 
disability, and avoidable mortality. 
Intermediate 
Health 
Outcomes 
(modifiable 
determinants 
of health) 
Healthy 
lifestyles 
Measures include 
tobacco use, food 
choices, physical 
activity, alcohol 
and illicit drug 
use. 
Effective health 
services 
Measures include 
provision of 
preventive 
services, access 
to and 
appropriateness 
of health 
services. 
Healthy 
environments 
Measures include 
safe physical 
environment, 
supportive 
economic and 
social conditions, 
good food 
supply, restricted 
access to 
tobacco, and 
alcohol. 
Health 
Promotion 
Outcomes 
(intervention 
impact 
measures) 
Health literacy 
Measures include 
health-related 
knowledge, 
attitudes, 
motivation, 
behavioural 
intentions, 
personal skills, 
and self-efficacy. 
Social action 
and 
Influence: 
measures include 
community 
participation, 
community 
empowerment, 
social norms, and 
public opinion. 
Healthy public 
policy and 
organisational 
practice: 
measures 
include: policy 
statements, 
legislation, 
regulation, 
resource 
allocation, and 
organisational 
practices. 
Health 
Promotion 
Actions 
Education: 
Examples include 
patient education, 
school education, 
broadcast media 
and print media 
communication. 
Social 
mobilisation: 
Examples 
include: 
community 
development, 
group facilitation, 
and technical 
advice. 
Advocacy: 
Examples 
include: lobbying, 
political 
organisation and 
activism, and 
overcoming 
bureaucratic 
inertia. 
Source: (ECSC-EC-EAEC, 2000), page 6. 
 
RCT has been used to assess efficacy and effectiveness of new drugs or 
interventions. The distinction between efficacy and effectiveness is that: 
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“Efficacy refers to whether a drug demonstrates a health benefit over 
a placebo or other intervention when tested in an ideal situation, such 
as a tightly controlled clinical trial. Effectiveness describes how the 
drug works in a real-world situation.” (Thaul, 2012), page 4. 
In practice, undertaking trial of efficacy and effectiveness both would involve 
patients using telehealth machines and health professionals monitoring the 
readings generated from the machines and responding accordingly. 
However, the differences in conducting trials of efficacy and effectiveness of 
telehealth are outlined below. 
To conduct an efficacy of telehealth trial, tighter inclusion criteria would be 
required, along with dedicated staff. This was not realistic for Doncaster 
PCT, and indeed similar NHS organisations in England at the time, given the 
limited resource constrains. It was also not realistic to do efficacy trial on 
telehealth in Doncaster PCT because the prevailing culture in the 
organisation was not really fully established as an institution for doing 
research, even though it valued it. This can be seen from the evidence in 
Chapter 3, where most of the research activities in PCTs at the time involved 
observational study or service evaluation, and few interventional studies that 
assessed efficacy of interventions. Hence, it is really difficult to undertake a 
trial of efficacy of telehealth in routine NHS practice. 
On the other hand, a test of effectiveness should be undertaken once 
efficacy had been established. In this work, efficacy trial of telehealth was 
mainly derived from evidence in the published literature (Chapter 4). In 
practice, many pilots of telehealth were taking place in England at the time 
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of introduction of telehealth in Doncaster, and it was considered appropriate 
to undertaken a pragmatic trial of effectiveness of telehealth. Ideally, 
conducting a trial of effectiveness of telehealth should have flexible inclusion 
criteria. It requires the involvement of staff, who normally work in the 
organisation.  This might involve dedicated staff if that is how the 
intervention is envisaged, but they will not be research staff delivering the 
intervention.  
Therefore, efficacy is measured in as controlled environment as possible to 
maximum likelihood of identifying a benefit if it exists, whereas effectiveness 
is assessed in real life settings.  
Regarding embeddedness of a new practice in routine practice, a service 
evaluation, with a robust mix method of evaluation, seems to be the right 
approach to use for evaluation of new technologies. The RCT concept is still 
regarded as unacceptable by some front-line staff, both in health and social 
care organisations (Hendy et al., 2012). Staff felt opposed to RCT, as it 
allocated users whom staff regarded as suitable for new technologies into a 
control group where they ended up not receiving the anticipated technology 
(intervention). The underlying premise among these staff was that such new 
technology was beneficial to users, and by allocating them to a control 
group, the users were denied the potential health benefit from the 
technology. Hence the position that staff adopted was not at equipoise. 
The findings from the pragmatic trial concluded that telehealth was neither 
effective nor cost-effective. Study outcomes such as these could be the 
subject of publication bias due to the negative results on effectiveness and 
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cost-effectiveness. The knowledge gained from the pragmatic trial had been 
vital in informing the uptake of new technologies in subsequent service 
evaluation. The reporting of negative results from research studies needs to 
be viewed in a similar way as those with positive results by journal editors. 
8.3.2.3 Integration into mainstream healthcare use  
If new technologies, such as telehealth, are to be accepted and normalised 
into routine use, their features and use needs to be generally accepted to 
users and it must be integrated into social use. The social use of new 
technologies means that such technologies are widely accepted and used in 
social networks or activities. For example, some modern mobile phones and 
watches have features that can also measure vital signs of users. Such 
features need to be less obtrusive and be able to integrate with other 
technological devices in social use. There are emerging devices in the 
market with features that are less intrusive, although it may be sometime 
before they become widely available. For this to happen, designers need to 
work closely with those who are going to use the new technologies of the 
future in co-designing them. 
Users should have the option of owning the data generated from the new 
technologies, and they should be in control of the data and be able to 
determine who they can share it with. Current experience shows that 
patients did not have access to their own data. 
The technical accuracy and performance of new technologies need to be 
assured if they are to gain acceptance among professionals and users. 
Evidence in this thesis showed that on some occasions, the diagnostic 
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accuracies of new technologies were called into questions resulting into loss 
of confidence in the technologies and subsequently, health professionals 
abandoning their use in preference for old technologies that they were 
familiar with.  
8.3.2.4 Practical and ethical issues raised by new technologies 
The introduction of new technologies raises some practical and ethical 
issues, as identified by other researchers (Stocking and Morrison, 1978) and 
further presented in Chapter 4. In the pragmatic trial, it was found to be one 
of the reasons why health professionals were resistant to implement new 
technology because they considered RCT approach to be unfair. It can be 
seen that the health professionals were not at equipoise. Equipoise had 
been defined as a position where “there is genuine uncertainty in the expert 
medical community over whether a treatment will be beneficial” (Freedman, 
1987). From ethical point of view, it is unfair to withhold treatment where 
there is evidence that one form of treatment is better than the other. In the 
pragmatic trial that is reported in Chapter 5, the treatment was telehealth 
service (the intervention), while the control group received standard care. 
Healthcare professional appeared to believe that telehealth service was 
beneficial for their patients. This position was influenced by the Government 
(England) position, which supported the use of telehealth and saw it also as 
being beneficial for self-management of individuals (Chapter 3). Given the 
findings of the pragmatic trial, patients would not have been disadvantaged 
and indeed some may have been better off to be randomised to the control 
group (standard care) if it meant that they weren’t being frightened by red 
alerts given that there was no improvement in hospital admission rates or 
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death rates. However, there remained uncertainty in confidence that can be 
placed on the conclusions of the pragmatic trial, in view of the limitations 
discussed in Chapter 5. The position of health professionals was confirmed 
by findings from the qualitative study (Chapter 7), where patients appeared 
to be reassured by being on telehealth service, despite the levels of red 
alerts experienced. 
Current evidence around effectiveness and cost-effectiveness of new 
technologies presents a practical and ethical issue to practitioners and policy 
makers on whether to recommend new technologies to users widely before 
establishing their effectiveness and cost-effectiveness. It seems there is a 
gap between the current evidence of effectiveness and cost-effectiveness 
and policies about some new technologies and/or variations in interpretation 
of current evidence. Current evidence does not support the wider roll out of 
new technologies on cost-effectiveness ground. For example, the 
Department of Health in England seemed to advocate telehealth service 
before the evidence on cost-effectiveness was available, and had planned to 
roll out telehealth to 3 million users within five years (3MillionLives, 2012).  
The other practical issues in both the trial and service evaluation were to do 
with how red alerts were addressed, and if there were issues uncovered, 
whether they led to the appropriate course of actions. There had not been 
adequate exploration of actions related to the red alerts by community 
nurses. In future, audit of the actions based on response to patients’ 
telehealth readings should be an integral process of the new technological 
services on how patients are managed. From ethical point of view (Shickle 
and Chadwick, 1994), it may be unethical to generate unnecessary anxiety 
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among patients and staff from inappropriate alerts. The harm caused has to 
be outweighed by the benefits for the patients and/or significant public health 
benefits. This is consistent with the Declaration of Helsinki on the principles 
of undertaking ethical medical research involving human subjects (World 
Medical Association, 2013). 
8.3.3  Service Design 
8.3.3.1  Integrated whole-system service model 
A better service model is required that (1) has a sound procurement 
process, and (2) integrates with various elements in the health and social 
care system.   
Procurement process 
The existing procurement process used in both the pragmatic trial and the 
service evaluation, and those used elsewhere in England, for example in 
North Yorkshire (Evanstad, 2013), had some major limitations. In this type of 
service model, commissioners purchased the technological devices and pay 
for them regardless of whether they ended up using them or not. If these 
devices were not used, the organisation responsible for the purchase had to 
take responsibility for the storage of the devices, in addition to the 
inefficiency of not using equipment that had been purchased. These 
devices, as time progressed, also became obsolete, as newer versions were 
developed and released into the market. Experience showed that the turn-
over of new technologies occurred rapidly; with changes in new technologies 
coming into market every one to two years (Chapter 6). Experience of 
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introduction of whole body scanner in the UK in the 1970s also encountered 
similar problem of running costs, repairs, and storage among others, which 
were not included in the initial costs of the technology (Stocking and 
Morrison, 1978). To overcome these limitations, future service models need 
to address these challenges in the procurement processes such that 
commissioners of health services are clear about the initial and maintenance 
costs of new technologies into the future. It would be preferable for 
commissioners to pay for the actual machines used, regardless of the 
number of devices agreed in contracts. Commissioners should also have the 
option of terminating the service without any penalty or heavy losses 
incurred, including financial expenditures. This may entail commissioners 
renting the devices with the options to upgrade them, at supplier’s expense, 
when newer ones become available in the market. This needs to be built into 
contractual agreements. 
The Veteran Health Administration (VHA) model offers a particularly helpful 
model where a range of telehealth products were available for a care 
coordinator to choose from to suit the needs of individual users (Darkins et 
al., 2008). Although the telehealth technology used in the pragmatic trial and 
service evaluation had got ‘add-on’ peripherals, essentially the package of 
the technology was standard. In the future, front line staff should be able to 
determine what additional devices or peripherals of new technologies that 
they need for their patients. These peripherals should be compatible with 
each of the existing system if they are from different suppliers. 
Current model of telehealth service is driven by technology industries that 
are trying to find a market for the new technologies, rather than finding the 
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technologies to address identified health problems. A similar issues had also 
been highlighted by other researchers in relation to whole body scanners 
(Stocking and Morrison, 1978). The starting point for any commissioning of 
service must begin with an assessment of population health needs in order 
to ensure that the limited resource is targeted where more benefits can be 
gained in terms of population health outcomes. This process needs to be 
followed by systematic review of the literature to identify possible cost-
effective interventions. This will allow providers and/or commissioners to 
consider the options available in order to invest their limited resources. It is 
important to note that the Department of Health in England had a strong 
influence on healthcare providers as it directed priorities for health services 
in the country. However, the directives might not always be based on cost-
effectiveness evidence (3MillionLives, 2012). Therefore, future demand for 
new technology should be driven by health needs of the population.  
Integrated service 
Integration of new technologies with services provided by health (NHS) and 
social care (local authority) had been a desired ambition of the government 
in England when it funded the Whole System Demonstrator (WSD) 
telehealth RCT project, however, this goal was not achieved (Hendy et al., 
2012). The authors of the WSD pragmatic trial attributed the reasons for the 
failure of integration of telehealth to the following factors: different cultures 
between health and social care organisations, the problem with RCT itself as 
the study design, and lack of joined funding. It was likely that the technology 
did not help staff in those organisations to do their job better; hence they did 
not adopt it. This would be consistent with normalisation process theory 
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(NPT) which stipulated that people enacting a new innovation need to see 
meaning in it and how it could enhance their work (May and Finch, 2009). A 
better integration of new technologies among different organisations could 
be achieved if such an integration was supported by a common goal that 
addresses identified needs, pooled funding system, joint team that are 
working together, co-located and under joint leadership arrangements. 
Assessment of users and their subsequent monitoring also needs to be 
undertaken jointly, along with associated training of staff. 
Most of service designs for telehealth in England had been ‘in-working-
hours’ service (provided between 09:00 to 17:00 hours; Mondays to 
Fridays), as described in Chapter 3, and in the evidence from the literature 
(Chapter 4). There remained gaps in providing the service to patients ‘out-of-
hours’ (in the evenings between 17:00 hours to 9:00 hours and over the 
weekends) when patients were likely to be left exposed, anxious and 
vulnerable and the option available for them would be to turn up to accident 
and emergency departments of the local hospitals, if their conditions 
deteriorated. This gap represented more than three-quarters of the time per 
week that were not covered by telehealth service. This is a scenario, 
commissioners and health service providers would want to avoid in the 
future and therefore it needs to be addressed.  
Therefore, the future provision of new technology service needs to be 
integrated into the whole health and social care system and cover both ‘in-
working-hours’ and ‘out-of-hours’: i.e. 24-hours per day and 7 days per week 
across primary and secondary care interface, and embracing public health 
agenda of prevention. Integration should also be aimed at health and social 
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services, especially in certain common areas such as intermediate care. 
Operating systems, such as ICT (Information and Communication 
Technology) in organisations should incorporate mechanisms for information 
collection and sharing related to the new technologies. The service model 
should be an integrated model, as described in the literature review (Bartoli 
et al., 2009) where a committee will be responsible for the design of the 
services, including guidelines development, selection of patients, and related 
human resource planning (Chapter 4). 
8.3.3.2 Outcome measures 
The financial benefit from new technologies such as telehealth is difficult to 
quantify. There are some outcome measures that are hard to cost e.g. 
reassurance, quality of life, and independence for users. A system for 
quantifying and costing new technological service (e.g. tariff payment) would 
be helpful as financial incentive for providers and this could be used for 
evaluation.  In the UK, the National Institute for Health and Care Excellence 
(NICE) uses cost per QALY (quality adjusted life years), yet it does not cover 
all aspects of outcome measures that were expressed by users from the 
qualitative interviews (Chapter 7). 
A model for assessing effectiveness of health promotion intervention 
proposed appropriate levels of outcomes (ECSC-EC-EAEC, 2000) (Table 
8.1). Patient-reported outcomes measures (PROMs) are being recognised in 
current health service delivery in the NHS in England, and in the wider 
literature (Frost et al., 2007).  
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Based on the health promotion model of assessing health promotion 
interventions, the most appropriate outcomes measure for new technologies 
needed to include (1) health promotion outcomes (intervention impact 
measures related to health literacy), (2) intermediate health outcomes 
(modifiable determinants of health related to effective health services; and 
(3) health and social outcomes (ECSC-EC-EAEC, 2000). The latter category 
might be less specific to one particular intervention. In addition, some of the 
health and social outcomes might take a long time to realise; well after an 
intervention had taken place. 
Patient-related outcomes included information about patients’ symptoms, 
health-related quality of life (physical and social functions), treatment 
adherence, and satisfaction with treatment (Frost et al., 2007). Frost and 
colleagues (2007) identified that PROMs were particularly helpful to 
influence decisions when interventions showed similar outcomes to usual 
care or where the interventions provided only small clinical benefit. 
Lessons from the service evaluation showed that when choosing suitable 
quality of life questionnaires, it was important to involve front line staff in the 
choice of the questionnaire. One of the key characteristics for the choice of 
questionnaires was their simplicity (often one page) and they were easy to 
analyse (by adding up the score manually) and staff could establish the 
outcome of the assessment. Short instruments that are easy to analyse may 
not be valid. Therefore, it is important to use validated instrument or to do a 
formal validation process if the instrument is being developed from scratch 
(Frost et al., 2007). The instruments used to measure quality of life in this 
research were validated ones (EQ5D, Generalised Anxiety Disorder 7-
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dimentions or GAD-7, Minnesota Living with Heart Failure or MLHF), and 
they could be used and easily analysed by community nurses while they 
were with patients. 
Overall, this was found to have worked well in the service evaluation. This 
approach enables the quality of life questionnaires to embed in routine use, 
unlike those with several pages to complete such as SF-36 and St George’s 
Respiratory Questionnaire. Therefore, practitioners should promote the use 
of simpler questionnaires that are easy to analyse and interpret by frontline 
practitioners that can enable them to make management plan for users and 
provide on-going monitoring. 
8.3.3.3 Data source for selecting users of new technologies 
The use of hospital admission data proved to be an unreliable source of data 
for selecting patients for telehealth service due to limitations already 
discussed in Chapters 5. The limitations included: patients might be dead by 
the time the selection was being considered; not contactable; or simply the 
information was out of date to inform meaningful actions. As a result, future 
suitable alternative source of information for selecting users of new 
technologies should be derived from live source of data used by service 
providers. Such source of data could be staff existing workload, or 
information at the point of discharge from services or when patients are still 
in hospitals where they are considered for new technological service; and 
not after they are discharged from the services. 
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8.3.4 What could be done differently if starting the RCT again? 
If an RCT were to be carried out once again, a number of key lessons 
learned would be used to do the trial differently. For example, this will 
include careful consideration of factors influencing successful recruitment 
into pragmatic trial described in Chapter 5, key challenges in developing and 
implementing telehealth projects, and lessons from failed trial could be taken 
on board, as described in Chapter 4.  
An early engagement with relevant clinical staff and organisation will be held 
to secure engagement with the pragmatic trial and to discuss the trial 
objectives, and its conduct. The trial protocol will be developed with clear 
research questions, objectives, hypothesis, outcome measures, and 
methods of analysis (pre-specified outcomes – a priori analysis). A team will 
be assembled to develop, and implement and evaluate the trial. The trial will 
be registered with the Trial Register of Promoting Health Interventions 
(TRoPHI). 
Depending on funding, the choice of individual pragmatic RCT versus cluster 
RCT will be made, with the latter requiring more funding. A cluster pragmatic 
trial would be a preferred option. Cluster trial would allow participants to 
know whether or not they are in the intervention or control group, as 
evidence shows open design trial improved recruitment into trials (Treweek 
et al., 2011). If individual pragmatic trial is undertaken, however, 
consideration will be given to how participants are recruited. This could be at 
the point of discharge from hospital to avoid using hospital admissions as 
the basis for identifying patients. Alternatively, the choice could be using 
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community matron caseload as the source of selecting patients. The 
advantage of these sources of information is that they have live patients at 
the point of selection. 
Dedicated staff for the implementation of the project will be agreed and 
secured. There will be implementation plan and a business model for the 
pragmatic trial delivery, as outlined in Chapter 5 (Campbell et al., 2007). The 
intervention will need to be well understood and the associated components, 
how the model of delivery fits with existing health and social care system. 
Other processes that had been done before, which required to be carried out 
in a similar way will be conducted accordingly, such as ensuring the study is 
compliant with the ethical requirements and the necessary approvals are 
obtained.  
8.3.5  Areas for future research 
Future research in new technology in health needs to investigate the most 
appropriate health outcomes that need to be adopted that are valid and that 
reflect the intervention of the new technologies. Current outcomes, such as 
hospital admissions and mortality rates tend to be less sensitive outcome 
measures for new technological interventions. The reasons for this include 
the fact that these outcomes maybe attributed to multiple causes that are 
unrelated to, or have little association with, the interventions of interest such 
as new technologies. Therefore, in addition to the above outcomes, other 
more sensitive health outcomes measures need to be examined as well. 
Such outcomes may encompass: blood pressure, level of oxygen 
saturations, blood glucose, or weight, some of which had been reported in 
301 
 
 
Chapter 4. For quality of life, the health outcomes may need to include those 
identified by users in this thesis (Chapter 7) and other literature such as 
keeping in touch with social network (friends and families), being in control 
of one’s condition, and enabling patients to live independently (Morrison and 
Barnett, 2009). 
By suggesting that mortality and hospital admissions are less sensitive 
outcome measures of new technologies, this may potentially pose some risk 
of being seen as “moving the goalpost” for outcome measures in evaluation 
of interventions. Such risks could be justified if the suggestions made were 
seen as efforts to provide excuses for ineffective interventions that have 
failed to demonstrate their worth. In addition, such criticism could be labelled 
if the proponents and evaluators attempt to find outcome measures or 
intermediate outcome measures that are easy to measure. There is also the 
risk that by suggesting new and sensitive outcome measures, the existing 
outcome measures might be considered to be inappropriate ones. On the 
other hand, the notion that hospital admissions and mortality outcomes 
maybe considered to be less sensitive outcome measure can be viewed 
objectively. Firstly, new evidence gained from the work in this thesis 
demonstrate that there are other outcome measures, from patients’ 
perspective that have not been well reflected in a range of outcome 
measures observed in the published literature.  Examples from the field of 
health promotion, supports the view that outcome measures such as 
mortality are not meaningful when evaluating interventions whose 
appropriate impacts are intermediate health outcomes such as those likely 
to impact on healthy lifestyle, effective use of health service and health 
302 
 
 
literacy (State of Victoria, 2003, ECSC-EC-EAEC, 2000). Table 8.1 presents 
the evidence of health promotion effectiveness and the appropriate outcome 
measures. The intermediate outcomes enable patients to gain knowledge 
and skills to access health services, and make informed decision to improve 
their health (State of Victoria, 2003). Systematic reviews on new technology 
targeting lifestyle such as smoking supported the use of intermediate health 
outcomes (Sheikh et al., 2011).  
New technology such as telehealth can be viewed as a tool for educating 
patients and providing them with empowerment. Hence the appropriate 
outcomes are those related to health literacy, which can lead to modification 
of determinants of health (ECSC-EC-EAEC, 2000). 
Secondly, for patients’ groups targeted for intervention, as in the pragmatic 
trial and the service evaluation, their average age was around 70 years old, 
suggesting  that they were likely to have multiple co-morbidity, not all of the 
conditions would be amendable to intervention using new technology. 
Therefore, to attribute mortality outcomes among this group of patients, to 
the effects of new technologies may not be very sensitive outcome 
measures.  
Thirdly, by highlighting the case of sensitivity of hospital admissions and 
mortality as compared to intermediate outcomes for evaluating impacts of 
new technologies, new areas for research exploration are being suggested 
for further validation. This may lead to more realistic assessments of 
outcomes when effectiveness of new technologies is being made. Ideally, 
(1) health and social care outcomes on the one hand; (2) intermediate health 
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outcomes; and (3) health promotion outcomes; all of these need to be 
assessed in determining effectiveness and cost-effectiveness of new 
technologies. 
There is need to exercise caution in trying to establish a causal relationship 
between the effects of new technologies and mortality and hospital 
admissions outcomes. The assumption that such a relationship is causal is 
false when assessed against Bradford-Hill Criteria (Lucas and McMichael, 
2005). The Bradford-Hill criteria were formulated for determining cause-
effect relationship. For example, one of the criteria of Bradford-Hill relates to 
“specificity” in which exposure to a single agent must result in a particular 
outcome observed, if it is to be considered as a cause of the disease or 
outcome. As it was observed in the pragmatic trial (Chapter 5) and 
observational studies (Chapters 6 and 7), the mortality and hospital 
admission outcomes were also experienced among patients who received 
telehealth as well as those who did not. Therefore, this weakens any 
argument that there was a causal relationship between telehealth and health 
outcomes (e.g. mortality and hospital admissions). However, what both the 
trial and observational studies did was to lend argument to the strengths of 
the association between telehealth and the outcomes observed, rather than 
established a causal link. It leaves the possibilities open to the fact that the 
outcomes observed could be due to other factors. 
There is currently an inverse care law in the distribution of disease burden in 
the population and the use of new technologies by age groups; the burden 
of the disease falls disproportionately among older people whereas the use 
of new technologies is limited among them. More use of new technologies 
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among older people needs to be encouraged in order to help in managing 
the burden of long-term conditions that are predominant among older 
people. For younger people, new technologies that encompass health 
elements need to be incorporated, such as those that promote healthy 
lifestyles. While for the older population, there is evidence of increasing use 
of new technologies among this population (AgeUK, 2011), which needs to 
be encouraged. Current new technologies tend to be targeted at older 
people, due to high prevalence of morbidity and high usage of health 
services in this group of the population, although this may make sense from 
cost-effectiveness point of view, the strategy is less likely to achieve 
epidemiological health impact at population scale (Stocking and Morrison, 
1978). Therefore a preventive strategy is required for new technologies to be 
sustainable and to achieve epidemiological impact where a wider target 
population will benefit from them.  
8.4  Recommendations 
For new technology to embed in routine healthcare practice, the following 
are recommended: 
8.4.1  Implications for practice 
1. When introducing a new technology in routine practice, it is important 
for policy makers to regard the new technology service as being a 
whole system service, which includes the technological device, staff 
and other associated services, rather than the “black box” only. 
Implementation of new technology is a complex intervention; focusing 
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on the device alone would undermine it being embedded in routine 
health service delivery.  
2. New technological devices that are to be introduced for use in routine 
healthcare service need to be simple and easy to use for patients and 
staff.  
3. Where possible, new technology should be tailored to the needs of 
the individual patients; and frontline healthcare professionals should 
be empowered to choose the appropriate technologies for the 
patients. 
4. Before initiating the use of new technologies among new users, a 
period of initial assessment is required in order to agree threshold 
cut-offs as to what constitutes normal and what requires urgent or 
non-urgent follow-up for each an individual patients.  
5. There should be continuous process of education and training for 
staff who are involved in the implementation of new technological 
services.  This should include promoting regular network events for 
professional to share experiences related to the implementation of the 
services. Such training needs to be made mandatory requirements for 
the relevant staff involved in the service delivery. 
6. Education of users of new technologies needs to be embedded as 
part of a continuous process of implementation of the service in order 
to ensure that they fully understand the purpose of the service.  
7. There need to be a dedicated project coordinator and a project team 
to manage the implementation of new technology service in 
healthcare delivery.  
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8.4.2 Implications for policy 
8. When designing a policy for implementation of a new technology 
service, it needs to adopt a whole system delivery model, which 
covers patients’ pathway of care, for example, ensuring integration 
between primary and secondary health services.  
9. There is a need to ensure that new technologies are used to address 
identified health needs of the population.  
10. Effectiveness in practice as oppose to efficacy of new technology 
should be established in pilot sites to identify implementation issues, 
before the technology is recommended for widespread roll out.  
11. Policy-makers need to ensure that introduction of new technological 
services do not inadvertently exacerbate health inequalities. Some 
people may be disadvantaged in being able to access the new 
technology if there needs to be a landline telephone (some old people 
do not have landline telephone, while some young people do not 
have telephone landlines any more as they use their mobiles 
instead), computer access, or own a smartphone capable of running 
an app.  
8.4.3 Implications for research 
12. Research is needed in determining technical and diagnostic accuracy 
of new technology devices that are introduced in routine healthcare 
practice. This should continue to be monitored in the course of 
implementation, not only when the technologies are released for 
wider use. 
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13. More research is needed in determining the effectiveness (as 
opposed to efficacy) and cost-effectiveness of new technology in 
healthcare under routine healthcare conditions and in different 
disease areas and levels of disease severity. If a technology is tested 
on one category of patient, disease type or severity, it should not be 
assumed that it would also be effective or cost-effective in another. 
14. Research is needed in expanding appropriate health outcomes for 
assessing effectiveness and cost-effectiveness of new technologies 
that include intermediate health outcomes, health and social care 
outcomes and patient reported outcome measures (PROMS). 
15. Future research should assess which of the following sources are 
more reliable for helping to recruit participants into research studies:  
(1) historical routine data or “non-live data” sources (e.g. hospital 
admissions data); and (2) “live data” sources such as existing 
caseloads of health professionals. 
  
 Chapter 9: Reflections 
9.1  Introduction 
This final chapter of the thesis offers reflections on the following areas: the 
extent to which the research questions have been answered and the 
author’s own learning; the influence of the author’s public health background 
as well as his role as Consultant and Assistant Director of Public Health at 
Doncaster Primary Care Trust (PCT) in the conduct of the research; 
potential areas of conflicts; and the contributions of the PhD work to 
knowledge.   
9.2 The reflections 
9.2.1  The extent to which the research questions have been 
answered and author’s learning 
Reflections on the final research questions 
The final primary research question of this thesis was: Why does a new 
technology embed or not in a routine health service? There were five 
hypotheses that where developed (Chapter 1) to try to address the above 
research question. 
On the basis of the evidence available in the thesis, it was not possible to 
reject the stipulated hypotheses related to technology, staff and evaluation 
methodologies used. On the other hand, the evidence available could not 
allow the hypotheses related to setting and patients’ group to be accepted. 
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The answers to the research questions also formed important learning for 
the author on factors related to why new technologies fail or succeed in 
routine practice.  
The thesis has presented complex and technical sets of information in 
various chapters. It was a challenge to synthesize the information from the 
various chapters into Chapter 8, in order to address the research questions. 
Case study research method was found to be a very useful methodological 
approach to pull all the information together in order to confirm or reject prior 
hypotheses (Yin, 2009).  
Earlier on in the PhD research, a number of possible choices of appropriate 
theoretical frameworks were considered; some of them were not included in 
Chapter 2. Some of those that were not included in Chapter 2 included 
diffusion of innovation theory (Greenhalgh et al., 2004), and the DEPOSE 
(Design, Equipment, Procedures, Operators, Supplies and materials, and 
Environment) model which was related to investigation of systems failures of 
high risk technologies such as nuclear plants (Perrow, 1999). These two 
theories were discarded, as they were not considered to offer adequate 
explanation to the challenges posed in this thesis related to new 
technologies as used in routine healthcare. Of all the theories considered 
(Chapter 3), Normalisation Process Theory (NPT) was found to be the most 
appropriate and helpful one. It was useful in providing the explanation as to 
why new technologies fail or succeed to embed in routine practice. All the 
theories considered had some useful aspects in them that were relevant to 
this research and had some influence on the thinking of the author.  
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Reflections on the original research question 
The original research question of the PhD was: What effects will telehealth 
monitoring have on people with COPD, the care they receive and resources 
required to maintain that care? The attempt to address this research 
question was subsequently abandoned, as the pragmatic randomised 
controlled trial (RCT) that was envisaged to answer the research question 
was prematurely stopped. 
It was not feasible to address the original research questions with certainty 
given the limited resources using the pragmatic trial that had been reported 
in Chapter 5. As discussed in Chapter 8, more staff would have been 
needed, and the research would have to be designed differently as a cluster 
pragmatic trial.  
Some of the main learning points from undertaking the pragmatic trial 
included the following:  
• It was realised that undertaking an RCT in routine health service was not 
easy, especially involving the evaluation of new technology, which had 
been acknowledged as a complex intervention (Campbell et al., 2000). 
With the resources available, the trial was too ambitious. There were 
several original objectives, each of which could have formed a separate 
study. 
• There were lessons drawn from what did not work so well in the 
pragmatic trial, details of which were reported in Chapter 5 and 
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synthesised in Chapter 8. This learning was used to improve subsequent 
service design (Chapter 6 and 7), and to change the course of the PhD 
research, which focused on why new technologies failed or succeeded to 
embed in routine practice.  
By undertaking a systematic review of effectiveness and cost-effectiveness 
of telehealth service (Chapter 4), the original research question of the 
research was also addressed. In this sense, doing the systematic review 
was helpful in answering the original research question. However, a service 
evaluation would have been necessary, after effectiveness and cost-
effectiveness of telehealth service had been established. There are two 
forms of service evaluation that could be undertaken: (1) to test 
effectiveness of telehealth service in the “real world setting” such as in pilots 
sites before wider roll outs; and (2) to audit performance of service against 
standards of care. In the course of the implementation, lessons could be 
learned regarding practical application in routine healthcare setting. The 
service evaluation conducted in Doncaster was not the best approach for 
assessing effectiveness or cost-effectiveness of telehealth service because 
of its limitation related to high degree of bias, as per hierarchy of evidence 
(SIGN, 2011). The sources of biases include the fact that service evaluation 
does not usually have control group to compare the findings obtained, and 
the findings could be subject to regression to the mean.  
At the time the pragmatic trial was being planned, the evidence base from 
the literature was limited regarding effectiveness and cost-effectiveness of 
telehealth. If the author had undertaken a systematic review instead of 
conducting a pragmatic trial at the time, there were likely to have been 
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limited findings from the literature to support informed local decisions. More 
published papers on telehealth became available later on after the pragmatic 
trial was conducted (Chapter 4). A service evaluation would have still been 
necessary in order to provide assurance of the quality of service gained.  
From the literature review, the author learned more about effectiveness and 
cost-effectiveness of telehealth service, factors related to successful 
implementation of telehealth and how to improve uptake of participants in 
RCTs. 
There was a push from the Department of Health in England to implement 
telehealth service, for the National Health Service (NHS); and telecare, for 
the local authorities at the time of the pragmatic trial. This push was backed 
up by financial grant from central government to promote assistive 
technologies. Hence, the influence of the Department of Health in England 
was too great to ignore by local health and social care organisations. Similar 
influences still remain, at the time of completion of this thesis, in driving the 
implementation of new technologies in health and social care in the form of 
3Million Lives (3MillionLives, 2012) and its successor programme, the 
Technology Enabled Care Services (NHS England, 2015). The 
Government’s five year plan (2015/16 to 2020/21) for England’s “Five year 
Forward View” also highlighted the role of new technologies in health service 
delivery: “We will invest in new options for our workforce, and raise our 
game on health technology – radically improving patients’ experience of 
interacting with the NHS” (NHS England, 2014). 
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Was doing an RCT in Doncaster the right thing to do? At the time, it was 
probably thought to be the right thing to do an RCT when there was limited 
evidence of effectiveness of telehealth at the time. However, the 
infrastructure for undertaking such a trial was not in place in a routine NHS 
setting at the time. To do the RCT properly, it would have required more 
dedicated staff and financial resources than it was available at the time. The 
involvement of local hospital and academic partners would have improved 
the buy-in to the trial, and increased its likelihood to succeed in recruiting 
participants.   
The choice of doing the RCT was taken before the author chose the topic on 
telehealth for a PhD research. A number of other potential topics could have 
been chosen. The final choice of topic was made after discussions with one 
of the PhD supervisors at the University of Leeds prior to registration for 
PhD study. Therefore, the PhD did not influence the decision of doing the 
pragmatic trial. The author, however, maintained an interest in 
implementation of new technology and in doing a PhD. 
9.2.2 The influence of public health training in undertaking the 
research 
As a Consultant and Assistant Director of Public Health with Doncaster 
Primary Care Trust (PCT) at the time of conducting the pragmatic trial, the 
author’s public health training and values associated with public health 
practice had some influence in the ways how the research was conducted. 
The areas of influence for reflections were: (1) evidence base and its 
influence on practice, including exploration of whether doing the literature 
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review earlier by the author could have influenced actions; (2) the 
challenges of stakeholders being at equipoise during the evaluation of the 
telehealth service; and (3) the importance of population health, and regards 
to reducing health inequalities. 
The evidence base and the potential to influence commissioning of service 
One of the key strengths of public health is its focus on evidence base to 
inform interventions, and the expertise needed to appraise such evidence. 
RCTs are regarded as the gold standard in assessing evidence of 
effectiveness of an intervention where none existed. Systematic reviews that 
were reviewed at the time were of poor quality and were unable to answer 
the question of effectiveness and cost-effectiveness of telehealth service. 
The challenges of assessing effectiveness and cost-effectiveness of 
telehealth service are discussed in Chapter 4, and they included varying 
definitions of interventions used. At the time, given the small scale of 
telehealth technologies available, it was considered that the best way 
forward was to conduct a pragmatic RCT. Assessing effectiveness through 
observational study was thought to be more likely to yield biased results, as 
observed in pilot projects in England at the time. 
There are circumstances in which conducting an RCT might not be an 
appropriate thing to do. Examples, of these circumstances are:  
1. Where a service has been accepted as part of routine service 
delivery, it may not be possible to undertake an RCT. RCTs should 
be undertaken at the stage of equipoise, before the routine 
introduction of an intervention into practice to test its effectiveness 
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and cost-effectiveness. The problem that is faced in practice is that if 
the technology is already in use, then people may not be in equipoise 
and it becomes very difficult to stop it, and offer a placebo or standard 
care instead. 
2. In some situation, such as certain aspects of surgery, it had been 
observed that conducting RCT might be difficult, instead practitioners 
should follow guidelines recommended by professional bodies and 
adhere to ethical norms (Das, 2011). 
Evidence from the literature reviews could have influenced how telehealth 
was implemented in Doncaster. It could have informed a better 
implementation process. The procurement model, for example, might have 
been done differently, whereby the commissioners could have considered 
renting the equipment rather than purchasing them. There would have been 
a better service integration with mainstream health services, and the RCT 
study design could have been different, such as a pragmatic cluster trial.  
Equipoise 
The concept of equipoise related to a state of indifference in assigning 
research participants to one group rather than another in an RCT (Joffe and 
Miller, 2012). This concept was developed into what is currently referred to 
as clinical equipoise (Freedman, 1987, Joffe and Miller, 2012). In order to 
achieve clinical equipoise, it had been argued that the responsibility of ethics 
of the trial should rest with community of physicians rather than individual 
physician-investigator (Joffe and Miller, 2012). The following statement 
captures the essence of clinical equipoise: 
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“…So long as “there exists (or, in the case of a novel therapy, there 
may soon exist) an honest, professional disagreement among expert 
clinicians about the preferred treatment,” investigators may initiate a 
trial and, more importantly, individual physicians may participate in it 
or refer their patients to it even when doing so is contrary to their own 
treatment preferences.” (Joffe and Miller, 2012) 
Clinical equipoise in trials is important in generating knowledge that is 
generalisable to benefit future patients or population (Joffe and Miller, 2012). 
Therefore, it is ethically acceptable to randomised patients to intervention 
arm of trial rather than the control group (placebo, standard practice, or an 
alternative mode of care) if there is genuine uncertainty among the medical 
profession regarding the benefit of the intervention under investigation. 
There are, however, problems with clinical equipoise. For example, in the 
field of maternal-foetal surgery (MFS), Rodrigues and Van Den Berg (2014) 
argued that the concept of clinical equipoise was unsuitable. The reasons for 
their argument included: (1) misconception about clinical research and 
research subjects. In clinical equipoise, Rodrigues and Van Den Berg (2014) 
further argued that it incorrectly assumed that researchers had the duty to 
provide the best care for the patients; and that research participants were 
incorrectly assumed to have rights to interventions that was considered to be 
beneficial as standard care; (2) lack of clarity in determining who the 
research subjects were (mother or foetus); and (3) difficulties in determining 
who should be in equipoise where it was a multidisciplinary team.  
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Meanwhile, Joffe and Miller (2012) identified the problems of clinical 
equipoise as that of imposing ethics of medical care on the design and 
conduct of research; the challenge of defining clinical equipoise as there is 
limited professional consensus couple with lack of data to measure degree 
of clinical equipoise; and reliance on biased opinion of clinicians that were 
never validated.  
Research shows that an ethical committee would consider a trial to be 
unethical if the level of equipoise was beyond 80% i.e. 80% members were 
in favour of an intervention versus 20% in favour of an alternative treatment 
(Rahul and Barry, 2013). Note that in an ideal equipoise state between 
intervention and control arm of a trial, the level of indifference should be 
equal (50% versus 50%) in both arms of the trial. Ideally, equipoise should 
be assessed based on objective evidence as to whether treatment A is 
better than treatment B. This can be difficulty were more than one outcome 
is used in the assessment, and the weight put on each of them. 
The main issue with undertaking research in service delivery and policy 
oriented organisation, such as Doncaster Primary Care Trust, was that no 
one was at equipoise. This experience is not unusual in the real world, 
where various stakeholders may hold different views regarding the benefit of 
new technologies. These stakeholders include, among others, the 
manufacturers of new technologies, local healthcare organisations, 
academic institutions involved in research, patients or users, voluntary 
organisations, charities, professional bodies, arm-length government 
agencies, etc. Some of these stakeholders are advocate for new 
technologies while others are sceptics. In light of the various views held by 
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stakeholders, the question that arises is whether or not all stakeholders 
should be at equipoise in the course of the research. It is probably 
impossible for all stakeholders to be at equipoise. The innovators, for 
example, develop an idea that they consider are beneficial to society, before 
such an innovation undergoes field trials and evaluation. Manufacturers of 
new technologies, on the other hand, have primary interest of selling the 
new technologies, and the interest of benefit for users is secondary to them. 
However, those involved in evaluating new technologies should randomly 
allocate participants into a trial with objectivity when conduction an RCT to 
assess effectiveness of an intervention. 
There are stakeholders whose primary interest is that of patients or users. 
Such stakeholders are likely not to be at equipoise when a new intervention 
is being introduced in routine care. This is because they have to be 
convinced that a new technology is beneficial for their users before they can 
advocate for its introduction in routine use. Of course, there are some 
people who also assume that new treatments are better. This group includes 
health policy-makers, commissioners, service providers, clinicians, and 
patients or users of the technologies. However, it is important that evaluators 
/ researchers maintain skepticism about effectiveness of new technologies in 
order to ensure an objective and independent assessment of any claimed 
benefits are adequately assessed. Such evaluation findings need to be peer-
reviewed and published.  
The Department of Health in England and healthcare organisations seemed 
to be enthusiastic despite the lack of conclusive research with regards to 
introduction of new technologies in routine healthcare practice. Patients or 
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users are the ultimate target population for these new technologies. 
Depending on the information that is available to them and their level of 
health literacy to understand and critically appraise the information in order 
to make informed decision, they can decide for themselves whether or not 
new technologies are beneficial. If they are convinced of the benefits of new 
technologies, it has been shown that some patients or their carers were 
willing to buy some of the new technologies for their own use. On the other 
hand, users can also decide to abandon new technologies if they deemed 
them to be of no benefit or indeed harmful to themselves. It is important that 
such information about benefits or harms comes from independent and trust-
worthy source. This is important because each stakeholder is likely to be 
biased in favour of their position, regarding communicating information about 
the benefits and/or harms of new technologies. Independent arm-length 
bodies such as the National Institute for Health and Care Excellence (NICE) 
in England, is an example of an independent source of advice. However, 
NICE guidance is frequently contested and it has to operate within its terms 
of reference. 
Evaluators / researchers should maintain an equipoise position. However, it 
can be difficult to maintain an equipoise position in the assessment of new 
technologies. They should, however, need to ensure that they do not have 
conflicts of interest that undermine an objective assessment to be carried 
out. 
In Doncaster, at the time of implementation of the pragmatic trial, everyone 
came from a position that there was potential benefit for the new technology. 
This stance was built on limited evidence. The evidence base, at the time, 
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was also more in favour of implementation of telehealth service, and they 
were derived from poor quality studies or from different contexts to the 
situation in Doncaster.  
Population health and reducing health inequalities 
The challenges of long-term conditions were described in Chapter 3. A key 
part of public health practice is the concern with reducing health inequalities 
among the population of an area. New technologies could inadvertently, 
widen health inequalities between deprived and affluent sections of the 
population in an area. The author was cognizant of the fact that patients who 
had no landline telephone lines were excluded from the pragmatic trial and 
the likely impact this might have on widening health inequalities. As a result, 
in the observational study, provision was made in ensuring that patients 
without landline telephones were offered wireless telehealth technologies. 
Intervention, such as this, could contribute to widening health inequalities. 
However, there was no evidence to substantiate this claim. Data on impact 
of health inequalities may need to be built into future design for evaluating 
new technologies. 
9.2.3 Author’s role in Doncaster in influencing things 
The author was the lead professional responsible for commissioning of 
services for respiratory diseases in Doncaster at the time of conducting the 
research. He was employed with Doncaster Primary Care Trust. The author 
chaired Doncaster Respiratory Working Group, a multi-disciplinary and 
multi-agency group in Doncaster bringing together hospital staff (respiratory 
physicians, nurses, physiotherapist, and others), primary care staff (GPs, 
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community nurses, and managers), and PCT staff. The author chaired the 
meeting in which the pragmatic trial idea was conceived and subsequently 
developed. He worked with other members to make the case for the initial 
fund for the pragmatic trial. In addition, he made the case for additional fund 
to increase the size of the pragmatic trial (Chapter 5). The author was the 
research lead for the PCT, and a board member at South Yorkshire 
Comprehensive Local Research Network (SYCLRN, 2010). 
9.2.4  Potential areas of conflicts 
This section explores areas of potential conflicts in (1) the conduct of the 
research and performing the analysis of findings; and (2) securing additional 
resources for the research, and how the author maintained integrity during 
the process. 
The conduct of the research and performing the analysis of findings 
In the course of the research (both the trial and service evaluation study), 
the author was the lead professional staff in Doncaster Primary Care Trust 
on respiratory diseases. He was responsible for the implementation of 
telehealth service for managing patients with COPD, and later this expanded 
to include patients with heart failure and diabetes. Being the lead for health 
policy in a topic area was different from being a pure researcher. As a health 
policy-maker, there was a value-based position that was more in favour of 
telehealth service being effective because of the message emanating from 
the Department of Health, as discussed above under equipoise. On the 
other hand, taking the position of a researcher was different and it involved 
being more objective in determining effectiveness of telehealth. It was 
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difficult to separate the two positions; as a policy-maker and a researcher. 
Ekeland (2012) recognised two type of evaluation methodologies; one was a 
formative assessment or naturalistic paradigm, where realities were 
considered to be multiple, constructed and holistic, and objectivity was partly 
possible (Ekeland et al., 2012). In the second type of evaluation 
methodology (positivist paradigm or summative assessment), the researcher 
would assume a neutral positions, and objectivity; and the researcher was 
value-free  (Ekeland et al., 2012). Both of this methodological approaches 
were recommended in research (Ekeland et al., 2012). The author 
attempted to balance the two methodological approaches. During the course 
of the research, the author had maintained objectivity, as far as possible, for 
example, the final hypothesis of the trial was phrased such that it stated 
“telehealth made no difference”, rather than “telehealth was effective” at the 
beginning. It was impossible to be completely objective, as a policy-maker 
as well as a researcher; hence the line of assessment was more of a 
formative one.  
The conflicts in adopting a formative assessment or naturalistic paradigm in 
evaluation of intervention was that authors might look for results they like, 
including post-hoc analyses (analysis undertaken that were not pre-specific 
before the study begun). This conflict has been considered and addressed in 
Chapter 5. It was not clear before the trial commenced what additional 
statistical analyses could be used. With additional training in statistical 
methods, it was realised that it was possible to use certain statistical 
methods to carry out the analyses.  
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The author maintained integrity by acknowledging limitations of the 
research. With regards to statistical analyses, the author maintained integrity 
by seeking expert statistical advice from his PhD supervisor. 
Justification of the author’s role in securing further funding for telehealth 
The author’s role in securing further funding during the pragmatic trial was 
justified for technical reasons to strengthen the power of study so that the 
findings of the pragmatic trial could be more generalisable. The funding for 
the roll-out of telehealth, as part of the service evaluation study, was the 
decision of the organisation to embed telehealth service within integrated 
community care pathway. The author’s role was to evaluate the service. 
The original sample size of the trial was based on the minimum number of 
participants calculated in order to identify a true difference in readmission 
rates between intervention and control group patients, if such a difference 
existed. At the time, the minimum number of participants was just enough 
based on the resource requirements at the time. However, more funding 
became available in the organisation (Doncaster Primary Care Trust), to 
support “innovation”. The author made the case for more funding to support 
the expansion of telehealth project, which could also strengthen the power of 
the trial. The application for additional funding for telehealth service met the 
requirements for the innovation fund and was subsequently funded. The 
increased funding could have allowed more participants to be recruited into 
the trial, thus strengthening the findings of the study and making it more 
generalisable. However, due to the challenges reported in Chapter 5, the 
trial had to be stopped prematurely.  
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The author maintained integrity in relation to seeking for funding. The 
assessment of funding application for telehealth service was made by an 
independent group. The author accounted to the PCT for the fund obtained 
for the telehealth service. 
9.3  Statement of contributions to knowledge 
This thesis contributes to knowledge in the following areas: (1) 
understanding of why new technologies fail or succeed to embed in routine 
health services; (2) effectiveness and cost-effectiveness of telehealth 
service; and (3) embeddedness of new technology in routine practice. Both 
abstract and particular knowledge contributions in each of the above three 
areas are outlined below. 
9.3.1  Why new technologies fail or succeed to embed in routine 
health services 
The thesis has demonstrated the utility of normalisation process theory 
(NPT) in helping to explain why new technologies embed or not in routine 
practice. The specific propositions and how they related to the work of the 
thesis are described in the relevant parts of this section. 
(a) Technology 
The thesis contributes to our understanding of factors associated with the 
technology that determine the uptake of new technologies in practice. This 
knowledge was gained from the conduct of the pragmatic trial, service 
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evaluation, and systematic review literature on implementation of telehealth 
service.  
The thesis also contributes to specific aspects of propositions of NPT and 
our understanding of embedding of new technologies in routine practice. 
Proposition 1.1 of NPT stated that: “Embedding is dependent on work that 
defines and organizes a practice as a cognitive and behavioural ensemble” 
(May and Finch, 2009). Telehealth service appeared to be better accepted 
by staff in the context of routine implementation examined in the service 
evaluation as opposed to implementation within a trial context.  
The second proposition (1.2) related to factors that promoted or hindered 
actors’ apprehension of a practice as meaningful. The factors related to the 
technology that promoted or hindered actors’ apprehension of a practice as 
meaningful included the following: 
• Physical features of the telehealth technology; 
• Symptom questions in the machines; 
• Remote access to telehealth readings of patients’ health information 
by staff; and  
• Technical accuracy, red alerts and associated workload of staff. 
The thesis adds to our understanding of proposition 1.3, which states that: 
“The production and reproduction of coherence in a practice requires that 
actors collectively invest meaning in it” (May and Finch, 2009). The 
collective investments of meanings in telehealth service was demonstrated 
through work involving the implementation of the pragmatic trial, systematic 
review of evidence on implementation of new technology, and the service 
326 
 
 
evaluation. There appeared to be a better collective investment in meaning 
by staff in the context of implementation of telehealth service examined in 
the service evaluation as opposed to implementation within a trial context. 
(b) Staff 
The thesis contributes to our understanding of staff factors associated with 
uptake of new technologies. After examining a number of factors associated 
with staff in the context of a pragmatic trial and service evaluation, it was not 
possible to reject the stipulated hypothesis: “there were factors associated 
with staff involved in the RCT, as opposed to the service evaluation that 
made a difference in uptake of new technology”. Proposition 2.1 of NPT 
stated that: “embedding is dependent on work that defines and organises 
the actors implicated in a practice”.  The thesis adds to our understanding 
how staff involved in the implementation of telehealth service found the 
service compatible with their work practice and it also helped to introduce 
some new ways of working.  
The thesis contributes to our understanding of factors that promote or inhibit 
actors’ participation (NPT proposition 2.2). These factors included: 
• Capacity of staff and team involved in the management of telehealth 
service; 
• Project management; 
• Staff resistance; and 
• Training. 
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The thesis advances knowledge in relation to Proposition 2.3 of NPT, which 
stated that: “The production and reproduction of a practice requires that 
actors collectively invest commitment in it” (May and Finch, 2009). There 
was evidence of stakeholders’ engagement and organisational investments 
to realise the outcomes related to telehealth service. 
The thesis contributes to understanding of work that defined and 
operationalizes a practice of embedding of telehealth (NPT proposition 3.1). 
Interactions between healthcare professionals and patients appeared to 
have improved in the context of routine implementation examined in the 
service evaluation as opposed to implementation within a trial context.  
(c) Evaluation 
The thesis contributes to knowledge about factors associated with 
randomised controlled trial (RCT) methodology approach, as opposed to 
service evaluation in relation to uptake of new technology. On the basis of 
the evidence available, it was not possible to reject the stipulated hypothesis 
that: “there were factors associated with randomised controlled trial (RCT) 
methodology approach, as opposed to service evaluation that made a 
difference in uptake of new technology”. Proposition 4.2 of NPT stated that 
“Embedding work is shaped by factors that promote or inhibit appraisal” 
(May and Finch, 2009). This thesis contributes to our understanding of 
factors that promote or inhibit appraisal work to embed new technologies, 
and they include: 
• Sources of data for recruiting participants; 
• Randomisation process; and 
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• Inclusion criteria 
The work of the thesis contributes to knowledge on embedding and how it 
helped to define and operationalize everyday practice (proposition 4.1 of 
NPT), through the work of the steering group. Through the same group, 
there was a collective investment in understanding of the work on telehealth 
service, which is consistent with NPT proposition 4.3. 
(d) Setting 
The thesis adds to our understanding of the relationship between 
geographical setting and embedding of new technologies in routine health 
service. There was no evidence to support the view that new technologies 
cannot be implemented in particular setting. This knowledge has been 
derived specifically from uptake rate of telehealth service in Doncaster, 
where no significant difference was observed in comparison with other 
districts in England. In the same setting, it was shown that uptake of 
telehealth service was lower during a pragmatic trial than in a service 
evaluation study. 
(e) Patient group 
The thesis contributes to our understanding of uptake of new technologies in 
various studies in relation to factors associated with patients’ group. It was 
found that there was limited evidence to accept the proposition that the 
uptake of telehealth service in the pragmatic trial, and the service evaluation 
was explained by differences in types of diseases of patients. 
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9.3.2 Effectiveness and cost-effectiveness of telehealth service 
The thesis contributes to our understanding of effectiveness and cost-
effectiveness of telehealth service, from the literature review and conduct of 
the pragmatic trial. 
The evidence from the systematic reviews showed that there was limited 
evidence of effectiveness of telehealth services for patients with long-term 
conditions. However, for some specific disease areas such as COPD, heart 
failure, severe asthma and diabetes, there was evidence of modest 
effectiveness in reducing hospital admissions and mortality. Patients 
seemed to be generally satisfied with telehealth services. Evidence of cost-
effectiveness of telehealth was mixed, and the impact on quality of life was 
limited from systematic reviews. While evidence from the pragmatic trial 
showed that telehealth service had no effects on hospital admission rates, 
mortality rates, and it was not cost-effective. The findings from systematic 
reviews were updated, and therefore they were more recent than those 
obtained from the pragmatic trial reported in Chapter 5. 
9.3.2  Embeddedness of new technologies in routine practice 
The thesis contributes to knowledge on assessing embeddedness of 
telehealth service in routine healthcare practice. Acceptance rate of 
telehealth service by patients was used as a marker of embeddedness. The 
rate of acceptance in the observational study was compared with that 
obtained from systematic reviews. It was found that the acceptance rate of 
telehealth service during the observational study was significantly better 
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[81.0% (95% CI: 74.7, 87.3%); p = 0.001] compared to  that reported in 
systematic review [67.9% (95% CI: 64.9, 70.9%)] (Gorst et al., 2014).  
There appeared to be high compliance rates by patients to telehealth service 
in the context of routine implementation examined in the service evaluation 
as well as within a trial context. The levels of red alerts from telehealth 
service appeared to have reduced in the service evaluation context as 
opposed to a trial. Satisfaction of patients with telehealth service in the 
context of routine implementation examined in the service evaluation 
appeared to be high.  
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 Annex 1.1: Literature search strategy on Ovid Medline 
 
Table A1.1: Search history of Ovid Medline: 1996-2012 
S/No. Searches Results 
1 telehealth.mp. or exp Telemedicine/ 12159  
2 
exp Relative Biological Effectiveness/ or exp Comparative 
Effectiveness Research/ or effectiveness.mp. 145463  
3 cost.mp. or exp "Costs and Cost Analysis"/ 190762  
4 chronic disease.mp. or exp Chronic Disease/ 108777  
5 2 or 3 307464  
6 1 and 5 2174  
7 2 and 6 695  
8 healthcare.mp. or "Delivery of Health Care"/ 92128  
9 7 and 8 115  
10 limit 9 to humans 104  
11 Limit 10 to review articles 25 
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Table A1.2: Updated literature search history on effectiveness and cost 
effectiveness of telehealth for patients with LTCs from systematic 
reviews (Web of Science database) 
Set Results Search History 
# 7 Approximately  
30  
#6 AND #5  
Timespan=All years 
Search language=Auto    
# 6 Approximately  
4,860,458  
TOPIC: (review*) OR TOPIC: (systematic 
review*)  
Timespan=All years 
Search language=Auto    
# 5 Approximately  
138  
#4 AND #3  
Timespan=2012-2015 
Search language=Auto    
# 4 Approximately  
428  
#2 AND #1  
Timespan=2012-2015 
Search language=Auto    
# 3 Approximately  
483,879  
TOPIC: (chronic disease*) OR TOPIC: (long 
term condition) OR TOPIC: (long term 
illness) OR TOPIC: (long-term condition) OR 
TOPIC: (long-term illness)  
Timespan=2012-2015 
Search language=Auto    
# 2 Approximately  
1,102,211  
TITLE: (effect*) OR TITLE: (cost*) OR 
TITLE: (cost-effectiveness) OR TITLE: 
(effective*)  
Timespan=2012-2015 
Search language=Auto    
# 1 2,542  TITLE: (telehealth) OR TITLE: 
(telemedicine) OR TITLE: (telecare) OR 
TOPIC: (telemonitoring)  
Timespan=2012-2015 
Search language=Auto    
 
Search conducted on 11 July 2015, Web of Science. All databases in Web 
of Science were searched: Web of Science core collection; BIOSIS 
Previews; BIOSIS citation index; Data citation index; KCI – Korean Journal 
Database; Medline; and SciELO (Scientific Electronic Library Online) citation 
index. 
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Table A1.3: Literature search history of review articles on trials that fail to 
recruit participants to their targets (Web of Science database) 
Set Results Search History 
# 7 1  #6 AND #5  
Timespan=All years 
Search language=Auto    
# 6 Approximately  
1,076,234  
TITLE: (systematic review*) OR TITLE: (review*)  
Timespan=All years 
Search language=Auto    
# 5 22  #4 AND #3  
Timespan=All years 
Search language=Auto    
# 4 Approximately  
12,285  
#2 AND #1  
Timespan=All years 
Search language=Auto    
# 3 Approximately  
107,232  
TITLE: (recruitment*) OR TITLE: (participant*)  
Timespan=All years 
Search language=Auto    
# 2 Approximately  
678,545  
TITLE: (fail*)  
Timespan=All years 
Search language=Auto    
# 1 Approximately  
754,103  
TITLE: (trial*) OR TITLE: (RCT) OR TITLE: (randomised 
controlled trial)  
Timespan=All years 
Search language=Auto    
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Annex 1.2: An example of appraised systematic review 
articles on COPD  
 
Systematic review article: (McLean et al., 2011)  
Key of Score: 2 = Yes; 1 = somewhat; 0 = No or can’t tell 
QUESTIONS SCORE  COMMENTS 
REVIEW FOCUS   
1. Did the review address a 
clearly focussed issue?  
 
 
2 COPD patients were studied. 
 
Primary outcomes: total 
exacerbation; Quality of life (QoL), 
emergency department visits; 
hospitalisation, and deaths.  
Secondary outcomes: FEV1, FVC, 
patient satisfaction, study 
withdrawal, costs, and cost-
effectiveness. 
2. Did the review assess a 
clearly focussed 
technology? 
 
1 Intervention (telehealth) used 
varied, not only telehealth, or poorly 
described. 
3. Did the authors look for 
the appropriate sort of 
papers? 
 
2 10 RCTs were included. 
Review question was the focus. 
VALIDITY OF REVIEW 
RESULTS 
  
4. Do you think the 
important, relevant 
studies were included? 
 
2 A comprehensive search strategy 
and process was demonstrated 
5. Did the review’s authors 
do enough to assess the 
quality of the included 
studies? 
 
2 Appropriate consideration appeared 
to have been given to assess the 
quality of the studies included, 
including risk of bias, measure of 
treatment effect, unit of analysis, 
and heterogeneity, among others. 
6. Were the studies 
accurately described? 
 
 
1 Some descriptions of the 
technologies were described, but 
not adequately. There were no 
reports of compliance with the 
technologies. 
7. Are the results of 1 Meta-analysis did not present study 
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individual studies reported 
in a clear and meaningful 
way or just listed with no 
real flow? 
outcomes by type of technologies 
used. 
8. If the results of included 
have been combined, was 
it reasonable to do so? 
(overall result presented 
from more than one study 
or meta-analysis) 
1 Meta-analyses were performed. 
However, the outcomes were not 
stratified by technologies used. 
9. Did the review 
demonstrate awareness 
of its own limitations? 
2 Limitations of the studies were 
discussed, and future research gaps 
were suggested by the authors. 
RESULTS   
10. Does the review present 
an overall result? 
 
2 Yes, overall results were presented 
related to study questions. The 
authors’ conclusions were 
precautionary in favour of telehealth. 
11. How precise are the 
results? 
2 Odds ratios and 95% CI were 
presented. 
APPLICABILTY   
12. Implications for policy 
makers and or those 
considering implementing 
such technologies? 
Appropriate based on 
findings? 
2 The authors were cautious against 
widespread adoption of the 
technology without further evidence 
from larger RCTs. 
13. Are the results 
generalisable beyond the 
confines of the setting in 
which the work was 
originally conducted? 
0 It hard to generalise the findings of 
the review, given the various 
telehealth technologies used, and 
different settings of the studies. 
14. Were all important 
outcomes considered? 
1 Some outcomes around workflows, 
practitioners’ performance and 
negative outcomes were not 
reported. 
15. Are you able to assess 
the benefit versus harm 
and costs? 
1 To some extent. Not all costs 
associated with the technologies 
were accounted e.g. cost of staff 
time, patients and carers’ time, 
among others. 
CASP Total Score 22/30 
(73%) 
 
 
 
 Annex 2:  Ethical approvals and considerations 
Annex 2.1: Research Ethics Approvals (reference number 
06/Q1105/64) 
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Annex 2.2:  NREC Advice on Service Evaluation of Telehealth 
(Case Study 2) 
 
From: NRES Queries Line [mailto:queries@nres.npsa.nhs.uk]  
Sent: 11 June 2010 14:43 
To: Joseph, Victor - Doncaster PCT 
Subject: RE: Service Evaluation clarification 
 
Your query was reviewed by our Queries Line Advisers. 
Our leaflet “Defining Research”, which explains how we differentiate 
research from other activities, is published at: 
 
http://www.nres.npsa.nhs.uk/rec-community/guidance/#researchoraudit 
 
Based on the information you provided, our advice is that the project is not 
considered to be research according to this guidance. Therefore it does not 
require ethical review by a NHS Research Ethics Committee.  
I'd deem this an evaluation.  
If you are undertaking the project within the NHS, you should check with the 
relevant NHS care organisation(s) what other review arrangements or 
sources of advice apply to projects of this type. Guidance may be available 
from the clinical governance office.  
Although ethical review by a NHS REC is not necessary in this case, all 
types of study involving human participants should be conducted in 
accordance with basic ethical principles such as informed consent and 
respect for the confidentiality of participants. When processing identifiable 
data there are also legal requirements under the Data Protection Act 2000. 
When undertaking an audit or service/therapy evaluation, the investigator 
and his/her team are responsible for considering the ethics of their project 
with advice from within their organisation. University projects may require 
approval by the university ethics committee.  
This response should not be interpreted as giving a form of ethical approval 
or any endorsement of the project, but it may be provided to a journal or 
other body as evidence that ethical approval is not required under NHS 
research governance arrangements. 
However, if you, your sponsor/funder or any NHS organisation feel that the 
project should be managed as research and/or that ethical review by a NHS 
REC is essential, please write setting out your reasons and we will be 
pleased to consider further.  
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Where NHS organisations have clarified that a project is not to be managed 
as research, the Research Governance Framework states that it should not 
be presented as research within the NHS. 
If you have received advice on the same or a similar matter from a different 
source (for example directly from a Research Ethics Committee (REC) or 
from an NHS R&D department), it would be helpful if you could share the 
initial query and response received if then seeking additional advice through 
the NRES Queries service. 
 
However, if you have been asked to follow a particular course of action by a 
REC as part of a provisional or conditional opinion, then the REC 
requirements are mandatory to the opinion, unless specifically revised by 
that REC.  Should you wish to query the REC requirements, this should 
either be through contacting the REC direct or, alternatively, the relevant 
local operational manager. 
 
Regards  
 
Queries Line 
National Research Ethics Service 
National Patient Safety Agency 
4-8 Maple Street 
London 
W1T 5HD  
 
The NRES Queries Line is an email based service that provides advice from 
NRES senior management including operations managers based in our 
regional offices throughout England. Providing your query in an email helps 
us to quickly direct your enquiry to the most appropriate member of our team 
who can provide you with accurate written response. It also enables us to 
monitor the quality and timeliness of the advice given by NRES to ensure we 
can give you the best service possible, as well as use queries to continue to 
improve and to develop our processes. 
 
Website: www.nres.npsa.nhs.uk 
Email:  queries@nres.npsa.nhs.uk  
 
Ref:  04/02 
 
Streamline your research application process with IRAS (Integrated 
Research Application System). To view IRAS and for further 
information visit: www.myresearchproject.org.uk  
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  Help save paper - do you need to print this email? 
 
 
From: Joseph, Victor - Doncaster PCT 
[mailto:Victor.Joseph@doncasterpct.nhs.uk]  
Sent: 11 June 2010 09:15 
To: NRES Queries Line 
Cc: vuni.joseph@tinyworld.co.uk 
Subject: Service Evaluation clarification 
 
Dear Sir / Madam, 
 
Can you confirm if I need ethical application for a service development of 
Telehealth roll out in Doncaster? Community matrons will be using 
Telehealth to aid in their case management. We would like to evaluate the 
service using before-and-after related to hospital admissions avoidance and 
get feedback from staff and patients, consistent with the practice the PCT 
would use for any other service it commissions. 
 
I would be grateful if you can confirm that I do not need ethical approval to 
carry out the evaluation? 
 
Thanks. 
 
Victor Joseph, Dip Med, MPH, Dip Epid(FPH), FFPH, FRIPH.  
Consultant in Public Health and  
Assistant Director of Public Health  
Directorate of Public Health  
NHS Doncaster  
GE House, Ten Pound Walk, Doncaster, DN4 5HW  
Direct Tel: 01302 566124 
 Kirstie Jones (Secretary): 01302 566029 
Mobile: 077 6644 3769 
Email: Victor.joseph@doncasterpct.nhs.uk  
Safe Haven Fax: 01302 556321  
This e-mail and any files transmitted with it is intended only for the use of the 
addressee.  If the reader of this message is not the intended recipient, you 
are hereby notified that any dissemination, distribution or copying of the 
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information contained herein is strictly prohibited.  The information contained 
in this e-mail may be subject to public disclosure under the Freedom of 
Information Act 2000.  Unless the information is legally exempt from 
disclosure, the confidentiality of this e-mail and your reply cannot be 
guaranteed. 
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Annex 2.3: The University of Leeds Research Ethics Committee 
Approval 
 
 
 Annex 3:  Questionnaires used for Interviews with patients 
and staff 
 
Annex 3.1: Questionnaires for interview with patient  
 
Note: Introduction of self to Interviewee 
1. Explain purpose and nature of the study 
2. Give assurance that respondent will remain anonymous in any written 
report and responses given will be treated in strictest confidence. 
3. Some of the questions may be difficult to understand; there is no right 
or wrong answer. 
4. Feel free to interrupt, ask for clarification of the interview, and criticize 
a line of questioning. 
5. Interviewer will tell respondent something about himself/herself e.g. 
area of work. 
6. Interviewer is to ask permission to tape-record the interview, explain 
why he/she wishes to do this. 
 
 
Your feedback helps us to continuously improve the home care services we 
provide. Thank you for taking the time to complete this survey and for 
participating in our Monitoring Programme. 
 
Listed in the box below are a number of questions about your recent 
telehealth experience. Please answer each question by marking the box that 
best indicates your opinion.   
 
Strongly 
Agree 
 
Agree 
No 
Opinion 
 
Disagree 
Strongly 
Disagree 
I received an explanation of how to 
use the monitor, in terms I could 
understand. 
€ € € € € 
The Telehealth monitor is easy to use. € € € € € 
The peripherals are easy to use         €    €      €      €       € 
The Telehealth monitor is/was useful 
in assisting me to manage my health. € € € € € 
I felt more involved in my care by 
participating in the Telemonitoring 
Programme. 
€ € € € € 
I believe daily monitoring assisted the 
clinicians in understanding changes in 
my condition.  
€ € € € € 
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Home monitoring provided me with a 
sense of security and peace of mind. € € € € € 
I am happy to continue using 
Telehealth, or would use the 
Telehealth Monitoring System in the 
future. 
€ € € € € 
I would recommend the use of daily 
home monitoring to my family and 
friends. 
€ € € € € 
 
 
Unstructured Interview Questions 
 
1. Tell me about: the first time the nurse mentioned to you Telehealth 
machine: 
a. What did you think? 
b. What were you told? 
c. Your Community Matron or Nurse recommended you to use 
the Telehealth equipment, how did you feel being chosen to 
use Telehealth machine? 
2. What is your experience of using Telehealth so far? 
3. How do you describe the relationship with your community Matron 
after having been on Telehealth?  
 
4. What impact, if any, has Telehealth has on your self-confidence and 
independence? 
 
5. Overall, how would you describe the impact of being on Telehealth for 
you?  
 
6. How would you describe the impact on your family members (or 
carer) of having been on Telehealth? 
 
7. How could we improve the service? 
 
THANK YOU  
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Annex 3.2: Questions for interviews with staff 
 
Unstructured Interview Schedule with Staff 
 
 
Note: Introduction of self to Interviewee 
1. Explain purpose and nature of the study 
2. Give assurance that respondent will remain anonymous in any written 
report and responses given will be treated in strictest confidence. 
3. Some of the questions may be difficult to understand; there is no right 
or wrong answer. 
4. Feel free to interrupt, ask for clarification of the interview, criticize a 
line of questioning. 
5. Interviewer will tell respondent something about himself/herself e.g. 
area of work. 
6. Interviewer is to ask permission to tape-record the interview, explain 
why he/she wishes to do this. 
 
 
 
 
 
Unstructured Interview Questions 
 
1. Tell me about: the first time you were involved in Telehealth in 
Doncaster: 
a. What did you think? 
b. How did you feel about Randomised Controlled Trial? (if involved 
in it) 
c. How did you feel about service evaluation of the Telehealth 
Monitoring? (if involved in it) 
2. What is your experience of monitoring patients on Telehealth so far? 
 
3. How do you describe the relationship with your patients after having 
been involved with Telehealth?  
 
4. What impact, if any, has Telehealth has on your workload? 
 
352 
 
 
5. Overall, how would you describe the impact on patients’ care resulting 
from Telehealth?  
 
6. How would you describe the impact on your staff of having been on 
Telehealth? 
 
 
7. How could we improve Telehealth service in Doncaster? 
 
THANK YOU
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